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ABSTRACT 
There are many benefits associated with participation in cardiac rehabilitation exercise 
programmes following MI, CABG and PTCA. Sustaining these benefits requires 
maintenance of physical activity in the long-term. Evidence suggests that 
improvements in physical activity decline following completion of formal exercise 
programmes. The research is limited on interventions to improve maintenance of 
physical activity after completion of exercise-based cardiac rehabilitation. Exercise 
consultation is based on established behaviour change theories and uses strategies to 
promote and maintain physical activity. A pilot study found that exercise consultation 
improved short-term maintenance of physical activity following completion of a phase 
III exercise programme. However, the long-term effect of the exercise consultation has 
not been studied. 
Aims: The primary aim of this randomised-controlled trial was to evaluate the effect of 
an exercise consultation (experimental condition) compared with standard exercise 
information (contr91 condition) on maintenance of physical activity six and 12 months 
following completion of a phase III hospital-based exercise programme. Secondary 
aims included assessing the effect of an exercise consultation compared with exercise 
information on physiological and psychological variables at six and 12 months. 
Methods: Seventy cardiac patients were recruited on completion of a phase I II 
exerc,ise programme. The experimental group received an exercise consultation and 
exercise information at baseline and six months, and a support phone call at three and 
nine months. The control group received exercise information at baseline and six 
months, and a support phone call at 3 and 9 months to maintain equal contact time 
between the groups. Measurements recorded at baseline, six and 12 months were; 
physical activity (Stanford Seven-Day Physical Activity Recall, CSA accelerometer and 
Stage of Exercise Behaviour Change); cardiorespiratory fitness, processes of exercise 
behaviour change, lipid profile, anxiety and depression (HADS), quality of life (SF-36), 
mortality and morbidity. 
Results: At baseline, total activity measured by the 7 -Day Recall was 300 
minutes/week in the experimental group and 275 minutes/week in the control group, 
thus both groups were meeting guidelines for regular physical activity. Total activity 
assessed by the 7 -Day Recall was maintaine~ in the experimental group compared to 
the control group from baseline to 12 months (98%CI -295, -20). Total activity did not 
significantly change from baseline to six (98%CI -43, 191) and 12 months (98%CI -63, 
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154) in the experimental group. Similarly, total activity counts/week measured by the 
CSA accelerometer remained unchanged from baseline to six (98%CI -705643, 
860599) and 12 months (98% CI -381927, 504719) in the experimental group. In the 
control group, total activity measured by the 7 -Day Recall significantly decreased by 
115 minutes/week from baseline to 12 months (98%CI -228, -28) and 63 
minutes/week from six to 12 months (98%CI -126, -5). Additionally, CSA 
accelerometer counts/week decreased from baseline by 5.2% (98%CI -680366, 
349212) at six months and 8% (98%CI -906564, 268168) at 12 months, although this 
decline was not significant. A comparable, significant decrease in peak oxygen uptake 
(V02) was recorded from baseline to 12 months by 6.7% (1.8 ml/kg/min; 98%CI -3.2, -
0.3) in the experimental group and 9.4% (2.3 ml/kg/min; -3.8, -0.8) in the control group. 
Conversely, exercise duration (seconds) did not significantly change from baseline to 
six and 12 months in the either group. There was a significant improvement in the V02 
at the lactate threshold (V02 L T) in the experimental group compared to the control 
group from baseline to 6 months (98%CI -185.4, -12.6) and 12 months (98%CI -
216.7, -34.6). In t~e control group, there was a trend for a decrease in V02 LT by 52 
ml/min (98%CI -116, 12) from baseline to six months. In the experimental group, there 
was a trend for an increase in V02 L T by 47ml/min from baseline to six months (98%CI 
-14, 109) and a significant increase by 81 mllmin from baseline to 12 months (98%CI 
22, 140). The frequency of using nine out of 10 processes of exercise behaviour 
change did not Significantly change from baseline to six and 12 months in either group. 
From baseline to 12 months, there was a significant decrease in the use of dramatic 
relief in the control group (98%CI -2.5, -0.5) and environmental re-evaluation in the 
experimental group (98%CI -3, -0.5). Weight and BMI did not significantly change over 
the study period in either group. Median lipid values at baseline were within the normal 
range in both groups. No significant changes in total cholesterol, triglycerides and low 
density lipoproteins (LDL) cholesterol were observed from baseline to follow-up in 
either group. There was a significant increase in high density lipoproteins (HDL) 
cholesterol by 0.11 mmol/I from baseline to 12 months in the experimental group 
(98% CI 0.04, 0.18), with no significant change in the control group. Median values for 
anxiety and depression were within the normal range at baseline and did not 
significantly change at six and 12 months in either group. Baseline scores for all quality 
of life subscales were high in both groups and did not significantly change from 
baseline to follow-up in either group. However, there was a trend for an improvement 
in social function, pain, role limitations due to physical problems, role limitations due to 
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emotional problems and energy/vitality from baseline to follow-up in the experimental 
group. In the control group, there was a trend for a decline in role limitations due to 
emotional problems, energy/vitality, and physical function from baseline to follow-up. 
Mortality was 5.7% (2/35) in the control group and 0% in the experimental group over 
12 months. The revascularisation rate (i.e. CABG and PTCA) in the experimental and 
control group was 11.40/0 (4/35) and 00/0, respectively. 
Conclusions: This study demonstrated that the exercise consultation was more 
effective than exercise information in maintaining self-reported physical activity for 12 
months after completion of a phase III exercise programme. However, the change in 
CSA accelerometer readings over the 12-month study period did not parallel the 
significant decrease in self-reported physical activity observed in the control group. 
The exercise consultation was not effective in maintaining exercise capacity for 12 
months after completion of phase III. Significant decreases in peak V02 from baseline 
to 12 months were observed in both groups. In contrast, an improvement in the V02 at 
the lactate threshold, which is an index of submaximal endurance capacity, was 
recorded in the experimental group compared to the control group from baseline to 
follow-up. Finally, the exercise consultation had no significant effect on processes of 
exercise behaviour change, lipid profile and psychological function. These variables 
were normal at baseline and were maintained over the study period in both groups. 
The results of this study demonstrate that the exercise consultation may be an 
effective intervention for maintaining physical activity after completion of phase III 
hospital-based exercise programmes. The exercise consultation is a minimal 
intervention that could be delivered by physiotherapists to patients at the end of phase 
III or by British Association of Cardiac Rehabilitation (BACR) trained exercise 
instructors to patients in phase IV. 
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CHAPTER ONE 
INTRODUCTION 
This chapter reviews the literature that is relevant to this thesis. Section one 
describes the definitions and phases of cardiac rehabilitation, the benefits of 
exercise-based cardiac rehabilitation and participation in exercise-based cardiac 
rehabilitation. Section two discusses theoretical models that have been used to 
understand physical activity behaviour change. In addition, interventions based on 
theoretical models to improve maintenance of physical activity are discussed. 
Sections three and four critically review methods for measuring physical activity and 
psychological function, respectively. The literature review was conducted using 1) 
internet databases (Le. Medline, Web of Science and Embase) using keywords and 
phrases appropriate to the topic being reviewed, 2) Evidence from systematic 
reviews and meta-analyses and 3) A search of the scientific literature using 
references cited in relevant literature reviews and published papers. 
SECTION ONE 
EXERCISE-BASED CARDIAC REHABILITATION 
Definitions of Cardiac Rehabilitation 
Cardiac rehabilitation has been defined as comprehensive, long-term programmes 
encompassing medical evaluation, cardiac risk factor modification, prescribed 
exercise, education and counselling. These programmes are designed to limit the 
physiologic and psychological effects of cardiac illness, reduce the risk for sudden 
death or reinfarction, control cardiac symptoms, stabilise or reverse the atherosclerotic 
process, and enhance the psychosocial and vocational status of selected patients. 1 
Recent national guidelines on cardiac rehabilitation published by the Scottish 
Intercollegiate Guidelines Network (SIGN)2 described cardiac rehabilitation as "the 
process by which patients with cardiac disease, in partnership with a multidisciplinary 
team of health professionals are encouraged and supported to achieve and maintain 
optimal physical and psychosocial health." 
1 
Four Phases of Cardiac Rehabilitation 
In the UK, cardiac rehabilitation is divided into four phases. UK guidelines have 
provided recommendations on the structure and content of cardiac rehabilitation 
programmes. 3 However, few cardiac rehabilitation programmes actually adhere to 
these guidelines.4 Thus, cardiac rehabilitation programmes vary considerably In 
content, client groups offered the service, length of intervention, the type of health 
professionals involved in the delivery and the setting for that delivery.5 
Phase I (in-patient) 
Phase I occurs during the inpatient stage or after a step change in the patient's cardiac 
condition. A step change is defined as myocardial infarction (MI), the onset of angina, 
any emergency hospital admission for coronary heart disease (CHD), cardiac surgery 
or angioplasty, or the first diagnosis of heart failure. The key elements of this phase 
are medical evaluation, reassurance, information/education, correction of cardiac 
misconceptions, risk factor assessment, mobilisation and discharge planning. Family 
and partners are usually involved from this stage. 
Phase II (early out-patient) 
Phase II is the immediate post discharge period and can vary in length from 4 to 6 
weeks, depending on the cardiac condition (e.g. after CABG this phase can be 
approximately six weeks, whereas post MI this period may last four weeks). In this 
phase, patients and family receive support from hospital or community-based health 
professionals through home visits or telephone contact. Additional education and 
information is provided to reinforce risk factor modification and behavioural change. 
Further medical evaluation risk stratifies the individual for future management. 
Phase III (intermediate out-patient) 
Exercise training, education, psychological support and risk factor modification are the 
key components of phase III programmes. A recent survey of cardiac rehabilitation 
services in Scotland found that the majority of phase III programmes involved 
supervised exercise training once or twice per week in a hospital setting.s However, 
some programmes offered exercise training in community or home-based settings. 
The duration of phase III exercise programmes varied from five to 13 weeks, with a 
median duration of 11.5 weeks. Most of the programmes had an educational 
2 
component, which provided patients with information on the CHD process, risk factors, 
benefits of exercise, drug therapy, relaxation training and stress management. Some 
programmes also offered psychological and vocational counselling. 
Phase IV (long-term maintenance) 
Phase IV involves the long-term maintenance of physical activity and other lifestyle 
changes in the community. Cardiac support groups, which offer group exercise 
classes or phase IV maintenance exercise programmes delivered by exercise leaders 
trained by the British Association of Cardiac Rehabilitation (BACR) are available in 
some areas. Generally, patients do not receive follow-up from cardiac rehabilitation 
staff in phase IV. Instead, the majority of patients receive most or all of their care in 
primary care. 2 The patient's clinical status, medication and risk factors should be 
regularly reviewed by his or her general practitioner and other primary care health 
professionals during phase IV. 
The structure of cardiac rehabilitation in North America is different from UK 
programmes. Phase I is the in-patient stage, which is similar to the UK. In America, 
patients in phase II attend supervised hospital-based exercise programmes lasting 
approximately 12 weeks. Phase III involves hospital or community-based supervised 
exercise programmes lasting three to six months. Phase IV is the long-term 
maintenance stage, similar to UK programmes. 
Exercise Prescription for Health and Fitness 
Exercise Prescription for Healthy Adults 
In 1990, the American College of Sports Medicine (ACSM) published guidelines on the 
quantity and quality of exercise needed to develop and maintain cardiorespiratory 
fitness in the healthy adult.6 These guidelines, summarised in Table 1, recommend 20 
minutes or more of continuous, moderate to vigorous intensity aerobic exercise (60% 
to 90% of maximum heart rate or 50% to 85% of maximum aerobic capacity) on 3 
days a week to improve cardiorespiratory fitness. To maintain the training effect, 
exercise must be continued on a regular basis, as a significant reduction in 
cardiorespiratory fitness occurs after 2 weeks of stopping training. Although the 
minimal level of exercise necessary to maintain fitness is not known, evidence 
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suggests that missing an exercise session periodically or reducing the frequency and 
duration of training will not adversely effect cardiorespiratory fitness as long as training 
intensity is maintained. 7 
More recent evidence demonstrates that lower levels of physical activity, than the 
amount required to improve fitness, can produce substantial health benefits. 
Therefore, the quantity and quality of activity needed to attain health-related benefits 
differ from what is recommended for fitness benefits.6 In 1995, the American College 
of Sports Medicine (ACSM) and Centers for Disease Control and Prevention (CDC) 
published guidelines on the quality and quantity of physical activity required to improve 
health and prevent disease.8 These guidelines, summarised in Table 1, recommend 
accumulating at least 30 minutes of moderate intensity physical activity on most days 
of the week. Thirty minutes of moderate activity each day can be achieved by adding 
some moderate physical activity into the daily routine. For example, taking the stairs 
instead of the lift, and brisk walking instead of driving short distances. Furthermore, 
many daily activities such as gardening, household chores and washing the car can 
contribute to the 3D-minute per day total if performed at a moderate intensity (i.e. effort 
equal to a brisk walk). 
The 1995 recommendation is intended to complement the 1990 exercise guideline. 
For example, sedentary individuals or those who are not regularly active will gain 
substantial health benefits by increasing their physical activity to achieve 30 minutes of 
moderate activity on most days. In addition, it is much easier for these individuals to 
incorporate small amounts of moderate activity into their daily routine rather than 
engaging in structured, planned programmes of exercise. However, individuals who 
are moderately active will gain additional health and fitness benefits by achieving the 
1990 exercise recommendations. 6 
Table 1 Physical Activity Recommendations for Healthy Adults 
1990 ACSM exercise recommendation to improve and maintain 
cardiorespiratory fitness: 
• A minimum of 3 x 20 minutes of continuous, moderate to vigorous 
intensity aerobic exercise per week. 
1995 ACSM and CDC physical activity recommendation to promote health 
and prevent disease: 
• Accumulate at least 30 minutes of moderate intensity physical activity on 
five or more days per week. 
The 1995 recommendation is distinct from the 1990 guideline as it emphasises 
moderate intensity activity, the 30 minute a day total can be achieved by accumulating 
short bouts of activity, and this amount of physical activity produces health benefits, 
but may not nece~sarily improve fitness. 8 
Exercise Prescription for Cardiac Rehabilitation Participants 
The primary goals of exercise training in cardiac rehabilitation are to counteract the 
deleterious effects of bed rest, avoid the deconditioning effects of physical inactivity 
imposed by CHD, increase aerobic capacity and modify risk factors. 3 In 1995, the 
British Association of Cardiac Rehabilitation (BACR) produced guidelines on the 
amount of exercise required to achieve these benefits. 3 Patients in phase I (in-patient) 
are advised to engage in self-care activities, general range of motion exercise and 
walk short distances to counteract the deleterious effects of prolonged bed rest. In 
phase II, patients undertake daily living activities and gradually increase the duration, 
frequency and intensity of walking to increase functional and endurance capacity. In 
phase III, 20 to 30 minutes of moderate to vigorous intensity (70% to 85% of maximum 
heart rate) exercise on three days a week is recommended to improve aerobic 
capacity and modify risk factors. Results from a systematic review found that 
exercising at this level for three months increased exercise tolerance by 30% to 50% 
and peak V02 by 10 to 20%.1 However, recent SIGN guidelines
2 
state that participation 
in low to moderate intensity exercise (50% to 75% of maximal HR) is sufficient for 
most cardiac patients. Most phase III programmes offer supervised exercise once or 
twice a week, thus SIGN guidelines recommend that patients should be encouraged to 
5 
participate in moderate activity on days that formal exercise training is not taking place 
to achieve the exercise prescription.2;3 
The exercise prescription for phase IV participants is not as clearly defined as the 
recommendations for patients in phases I to III. BACR guidelines recommended that 
patients in phase IV should engage in 20 minutes or more of continuous, moderate to 
vigorous intensity aerobic exercise on three days per week to improve and maintain 
fitness. 3;6 This exercise prescription is similar to the 1990 ACSM exercise 
recommendations to increase fitness in healthy adults.3 Recent SIGN guidelines2 state 
that phase IV participants should continue regular moderate intensity exercise in the 
long-term to sustain benefits, however the frequency and duration of this exercise was 
not described. American cardiac rehabilitation guidelines9 have endorsed the 1995 
ACSM/CDC physical activity recommendation of accumulating at least 30 minutes of 
moderate intensity physical activity on five days per week to promote health.8 This 
level of physical activity may be easier for cardiac patients to incorporate into their daily 
routine and sustain in the long-term. Table 2 summarises the physical activity 
recommendations for cardiac patients in phases III and IV. 
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Table 2 Physical Activity Recommendations in Phase III and IV Cardiac 
Rehabilitation 
Phase III Cardiac Rehabilitation 
• ~o to 30 minutes (excluding warm-up and cool down) of low to moderate 
Intensity aerobic exercise (e.g. walking, cycling, circuit training) on three days 
a week. 
And 
• Moderate intensity physical activity (e.g. walking) on days when not 
participating in formal exercise training. 
Phase IV Cardiac Rehabilitation 
• A minimum of 20 minutes (excluding warm-up and cool down) of moderate 
intensity exercise on three days per week. 
And/Or 
• Accumulate 30 minutes or more of moderate intensity physical activity on at 
least five days per week. 
The Need for Cardiac Rehabilitation 
Compared with the rest of the UK, Scotland has a disproportionately high incidence 
and prevalence of coronary heart disease (CHO). S Every year in Scotland, 
approximately 8,000 people survive a myocardial infarction, 6,000 people undergo 
coronary artery bypass surgery or angioplasty, and 13,000 people require emergency 
admission to hospital with chest pain (excluding MI). All of these patients would benefit 
from participation in cardiac rehabilitation services. In addition, cardiac rehabilitation 
would also be beneficial for an estimated 33,000 angina patients, 6,000 heart failure 
patients and 500 additional patients having other forms of cardiac surgery (e.g. 
transplantation). In total, approximately 66,500 patients annually may be eligible for 
cardiac rehabilitation in Scotland.s 
Provision of Cardiac Rehabilitation 
Despite the need for cardiac rehabilitation services, the provision of programmes in 
the UK is inadequate. 10-12 A recent survey estimated that only 17% to 25% of eligible 
patients attend cardiac rehabilitation annually in Scotland. 11 Another Scottish survey 
found that the proportion of patients discharged from hospital with a diagnosis of 
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CHD who attended cardiac rehabilitation varied between 2% to 46% in different 
health board areas. 10 A assessment of cardiac rehabilitation services in the UK 
, 
reported that approximately 14% to 23% of infarct patients, 33%) to 56% of CABG 
patients and 6 to 10% of PTCA patients are enrolled in programmes. 12 Generally, 
cardiac rehabilitation is offered to patients following MI or CABG, whereas the 
provision is limited for women, elderly patients, and those with angina or heart 
failure. 10-14 Studies on the provision of cardiac rehabilitation in North America have 
found similar results. 15;16 Thus, it seems that many patients that would benefit from 
cardiac rehabilitation are not being offered these services. 
Uptake to Cardiac Rehabilitation 
Even when patients are offered cardiac rehabilitation, uptake rates to programmes 
are variable and can be low. The percentage of patients attending cardiac 
rehabilitation programmes, following invitation, ranges from 13% to 74%14;17-20. In 
1996, Pell18 found that 59% of MI patients, who were invited, participated in phase III 
rehabilitation programmes based in four Glasgow hospitals. 
Factors associated with uptake to cardiac rehabilitation 
Numerous studies have identified factors influencing uptake to supervised phase II 
and "' cardiac rehabilitation exercise programmes, whereas the research is limited 
on variables associated with maintenance of physical activity in phase IV. 
Research has found that participation in formal cardiac rehabilitation programmes 
following a MI was significantly higher for men (49%) compared to women (34%), 
and younger patients of both sexes were more likely to attend compared to older 
patients. 21 Other studies have shown comparable results for age 14;22;23 and 
gender,17;23 whereas Pell24 found that these factors did not influence participation in 
cardiac rehabilitation. The strength of the physician's recommendation to attend 
rehabilitation is an important determinant of participation,23;25 and this 
recommendation was stronger for men compared to women. 23 Other reasons 
associated with non-participation in cardiac rehabilitation include; conflicting work 
and family commitments,26 medical problems,25 inconvenient timing of 
programmes,25;27 transport problems,10;25 social deprivation,14;24 being under the care 
of a GP compared to a cardiologist,18 inactive leisure habits,17 and being moderately 
functionally impaired. 17 Utilisation of rehabilitation is lower for single or widowed 
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patients compared to those who are married and uptake rates are higher for 
employed patients or those who are better educated. 17 Patients with a strong belief 
that their cardiac disease is controllable and those who attributed their heart 
condition to their lifestyle are more likely to attend rehabilitation. 22 Finally, uptake is 
not predicted by a patient's intention to attend cardiac rehabilitation.22 
Menu-Based Cardiac Rehabilitation 
Generally, cardiac rehabilitation programmes provide a fixed package of rehabilitation 
due to resource limitations, which may not to meet the needs of many patients. 5 This 
may explain the low referral, uptake and adherence rates to cardiac rehabilitation 
programmes among certain patient groups. National guidelines recommend that 
rehabilitation should be menu-based, which means tailoring rehabilitation services to 
suit the patient's needs and their readiness to make lifestyle changes.2 A flexible 
menu-based approach may improve participation in cardiac rehabilitation and prevent 
certain patient groups such as the elderly and heart failure patients from being 
excluded. However, few cardiac rehabilitation programmes in the UK are currently 
providing menu-based services.2 
Benefits of Exercise-Based Cardiac Rehabilitation 
This section reviews the benefits of exercise-based cardiac rehabilitation on 
mortality, morbidity, exercise capacity, physical activity, psychological functioning 
and coronary risk factors. 
Terminology 
In this literature review, cardiac rehabilitation programmes that include exercise 
training, education and risk factor modification are termed "comprehensive cardiac 
rehabilitation programmes." Early clinical trials of cardiac rehabilitation included 
exercise training as the sole intervention, thus these programmes are referred to as 
"exercise only rehabilitation." The term "exercise-based cardiac rehabilitation" 
includes both comprehensive and exercise only rehabilitation programmes. In 
addition, most the trials investigating the efficacy of exercise-based cardiac 
rehabilitation have included phase II and III cardiac rehabilitation programmes, 
whereas few studies have evaluated the effect of interventions in phase IV. 
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Therefore, evidence for the benefits of exercise-based cardiac rehabilitation are 
primarily based on phase II and III programmes. 
Mortality and Morbidity 
A number of randomised-controlled trials have reported a reduction in mortality with 
exercise-based cardiac rehabilitation compared to usual care following myocardial 
infarction, although only a few trials have reported a statistically significant reduction. 
In the majority of these studies, the sample size was too small to detect a significant 
difference between the intervention and control group.28 Combining the data from 
these trials in a meta-analysis increases the power of the statistical analysis,29 
thereby providing a more accurate estimate in the size of the effect of exercise-
based cardiac rehabilitation on mortality and morbidity. 
Oldridge30 conducted a meta-analysis investigating the effect of comprehensive 
cardiac rehabilitation following myocardial infarction on total and cardiovascular 
mortality and re.currence of non-fatal MI. Ten randomized-controlled trials of 
comprehensive rehabilitation, which included risk factor management and exercise 
training after myocardial infarction with at least a two year follow-up period were 
included in the analysis. In the majority of trials, the intervention was initiated 6 to 12 
weeks after myocardial infarction. Results revealed a significant reduction in total 
mortality by 24% and cardiovascular mortality by 25% with cardiac rehabilitation 
compared to usual care. The duration of the rehabilitation programmes varied from 6 
weeks to 48 months; subgroup analysis revealed that longer interventions had a 
greater benefit on total mortality than short-term programmes. In contrast, cardiac 
rehabilitation had no significant effect on the recurrence of non-fatal myocardial 
infarction. Similarly, another meta-analysis31 of 22 randomised controlled trials of 
exercise-based cardiac rehabilitation after MI reported a significant decrease in total 
mortality by 20% and cardiovascular mortality by 22% after an average of three 
years follow-up. Furthermore, cardiac rehabilitation had a significant beneficial effect 
on the recurrence of fatal MI throughout the three-year follow-up period. In contrast, 
the rates of non-fatal MI were comparable between the two groups throughout the 3 
years. The time from myocardial infarction to randomisation ranged from 1 to 3 
months in the majority of studies. A recent meta-analysis conducted by Jolliffe28 
included more studies (41) and a greater number of patients (n = 7683) who had 
suffered an MI, angina, or undergone CABG or PTCA compared to the earlier meta-
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analyses.
30
;31 In addition, Jolliffe excluded a number of trials that were included in the 
previous reviews because they lacked a true control group or a clear method of 
randomisation. This study found that exercise only rehabilitation significantly reduced 
total mortality by 27%, cardiac mortality by 31 % and fatal MI by 35% compared to 
usual care.
28 
Comprehensive cardiac rehabilitation produced a non-significant 
reduction in total mortality by 13% and Significantly lowered cardiac mortality by 26% 
and fatal MI by 28%. Conversely, both exercise only and comprehensive 
rehabilitation had no significant effect on rates of non-fatal MI, or revascularisation 
(Le. CABG or PTCA) compared with usual care, although few trials reported CABG 
or PTCA as an outcome. 
Although the three meta-analyses varied considerably in the trials they included and 
excluded, they consistently found that exercise-based cardiac rehabilitation 
improved survivaI. 28;30;31 In addition, all three meta-analyses determined the separate 
effect of exercise only and comprehensive cardiac rehabilitation on survival. Jolliffe28 
reported greater. mortality benefits for exercise only rehabilitation compared to 
comprehensive rehabilitation. However, the difference in mortality between exercise 
only rehabilitation and comprehensive rehabilitation exercise were not significant. 
Oldridge30 found that both types of intervention were comparable, whereas 
O'Conner31 stated that comprehensive rehabilitation was more effective than 
exercise only rehabilitation. These inconsistent findings, the small number of 
exercise only trials and the possibility that advice on risk factors was included in 
exercise only interventions does not allow definite conclusions to be reached about 
the independent effect of the exercise component of cardiac rehabilitation on 
mortality. There are several mechanisms by which exercise-based cardiac 
rehabilitation may improve survival of cardiac patients. They include improved 
coronary blood flow, decreased ventricular arrhythmias, improved cardiovascular risk 
factor profile, reduced psychological distress32 improved cardiovascular fitness, or 
increased patient surveillance. 3o 
There are concerns regarding the results of these meta-analyses. Firstly, most 
studies involved predominantly middle-aged males following myocardial infarction, 
thereby limiting the generalisability of the results to women, elderly patients and 
other cardiac groups. Secondly, thrombolysis and medication was not reported in 
many trials, which would have affected clinical outcomes if more intervention 
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patients received these treatments compared to control patients. Finally, it is 
impossible to identify the optimal duration and content of cardiac rehabilitation 
programmes to improve survival due to the different interventions used in the 
studies. The exercise component of the programmes varied from supervised 
exercise training to home-based walking programmes, which differed in the 
frequency, duration and intensity of exercise. In addition, many programmes 
included stress management, diet, smoking cessation and psychological 
interventions. The duration of rehabilitation ranged from 6 weeks to greater than 1 
year. The time from the cardiac event to initiation of the intervention, length of follow-
up and type of participant were not consistent across trials, which creates problems 
in the interpretation of the results. A review of exercise-based cardiac rehabilitation 
stated that evaluating the cardiac rehabilitation literature is difficult due to the 
variability of the interventions and populations studied. 33 
Exercise Capacity 
Exercise capacity may be reduced following a myocardial infarction due to infarct-
related damage to the myocardium and the deconditioning effects of physical 
inactivity during hospitalisation.34 Conversely, a spontaneous improvement in 
exercise capacity occurs in the first 3 months after myocardial infarction without 
exercise training. 35-41 In addition, increases in exercise capacity after treatment of 
CHD with CABG and PTCA have been observed in the absence of exercise 
training. 34 However, further improvements in exercise capacity with training following 
MI, CABG and PTCA have been documented, as discussed in the next section. 
The effect of exercise-based cardiac rehabilitation on exercise capacity has been 
widely studied. A systematic review1 published in 1995 found that the majority of 
randomised and non-randomised controlled trials reported statistically significant 
improvements in exercise capacity with exercise-only or comprehensive cardiac 
rehabilitation compared to usual care in patients with CHD. The review reported that 
exercise tolerance on the treadmill increased by 30 to 50% and peak oxygen uptake 
increased by 10 to 20% after three months of moderate to vigorous intensity exercise 
three times a week for 20 to 40 minutes. The current exercise prescription for phase III 
participants is based on these findings. However, most of the studies included in the 
systematic review involved predominantly middle-aged male patients of low to 
moderate risk following a MI. Thus, the benefit of exercise-based cardiac rehabilitation 
12 
to increase exercise capacity is well established in this patient population. Although, 
several trials have reported significant, comparable improvements in exercise capacity 
after exercise-based cardiac rehabilitation in men and women,3S;42-44 and in patients 
older and younger than 70 years of age.4S;46 This systematic review was published in 
1995, thus more recent randomised-controlled trials evaluating the effect of cardiac 
rehabilitation exercise training on exercise capacity are described in Table 3. In 
addition, the review did not report the long-term effect of cardiac rehabilitation on 
exercise capacity, thus Table 3 also includes randomised-controlled trials reporting the 
long-term effect of cardiac rehabilitation on exercise capacity. 
As illustrated in Table 3, eighteen of these controlled trials reported an improvement 
in exercise capacity with exercise-based cardiac rehabilitation compared to usual 
care. 3S-37;47-S0;S4-63;67 In contrast, three randomised-controlled trialss1 ;s2;79 reported no 
significant difference in exercise capacity between the intervention and control 
groups. Although the evidence suggests that participation in exercise-based cardiac 
rehabilitation imp~oves exercise capacity, it is important to determine whether this 
increase in exercise capacity is maintained following programme completion. 
Nine studies have investigated the effect of exercise-based cardiac rehabilitation on 
exercise capacity in the long-term after programme completion (see Table 
3).37;SO;S1;S3;SS;S6;63;67;79 Liddell randomised 116 patients 5 weeks after MI to a phase "" 
comprehensive rehabilitation programme or usual care. S6 In phase I (in-patient) 
patients received education and support, in phase" (out-patient) they participated in 
5 months of supervised and home-based exercise training, group education on 
lifestyle modification, and received support phone calls. Patients in usual care 
received information on risk factors and leisure activities, and attended outpatient 
clinics one, three and 12 months after MI. Results revealed that exercise capacity 
was significantly higher in the intervention group compared to the control group at 6 
months (end of programme) and at five years follow-up. However, the change in 
exercise capacity from baseline to follow-up was not documented in this study. 
Similarly, Lisspers and Hofman-Bang reported that the improvement in exercise 
capacity with 12 months of comprehensive cardiac rehabilitation compared to usual 
care was maintained for a further 12 months following programme completion.63 
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In contrast, seven studies have found that improvements in exercise capacity with 
cardiac rehabilitation exercise training are not sustained in the long-term after 
I t· 37'50'51'53'55'67'79 55 programme comp e Ion. ' , , , " Carson compared the effect of a 12 week 
exercise programme with usual care on exercise capacity in 303 male patients who 
had suffered a MI in the previous 6 weeks. The improvement in exercise capacity 
was significantly greater in the intervention group compared to the control group at 5 
months (end of the programme), and at 1 and 2 years follow-up. However, exercise 
capacity was similar in the intervention and control groups at 3-years, due to a 
gradual decline in exercise capacity in the intervention group during the follow-up 
period. Similarly, Oldridge found that the increase in exercise capacity after 8 weeks 
of comprehensive rehabilitation had declined at 12 months, reaching a similar level 
to the control group.37 Stahle compared three months of supervised exercise training 
with standard care on exercise performance and self-reported physical activity in 101 
elderly patients (>65 years) discharged after a MI or unstable angina. Three months 
of exercise training significantly improved self-reported physical activity and exercise 
tolerance compa~ed with standard care.67 However, there were no differences in 
physical activity and exercise tolerance between the groups at 12 months.67 The 
authors suggested that continued exercise training is required to prevent a decline in 
initial improvements in physical activity and exercise capacity. 
Overall, the literature suggests that improvements in exercise capacity with exercise-
based cardiac rehabilitation may not persist in the long-term, suggesting that many 
patients do not continue to exercise after they have completed a cardiac 
rehabilitation programme. However, only one of these trials assessed patients' 
physical activity levels during the follow-up period.67 Cardiac rehabilitation guidelines 
recommend continuation of exercise following completion of formal exercise 
programmes to sustain the initial improvements in exercise capacity.1 
Mechanisms for Increased Exercise Capacity after Exercise Training 
The significance of an increase in exercise capacity is that CHD patients will be able 
to accomplish all submaximal activity at reduced physiological stress. Ades found 
that increases in self-reported physical functioning after 3 months of cardiac 
rehabilitation exercise training was significantly associated with improvements in 
exercise capacity.69 The mechanism for the improvement in exercise capacity after 
training in individuals with CHD is primarily due to peripheral (skeletal muscle and 
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vascular) adaptations rather than central (cardiac) adaptations.70-73. Peripheral 
adaptations include increases in arteriovenous oxygen difference,74 blood flow74;75 
and aerobic metabolism76 in active skeletal muscle at maximal exercise. 
Furthermore, increases in fibre area, capillary density and oxidative enzyme activity 
have been observed in skeletal muscles after training.74 These peripheral changes 
reflect an improvement in the supply of oxygen to active skeletal muscles, and 
enhanced oxygen extraction and utilisation by the exercising muscles. Some 
researchers have reported enhanced cardiac performance with exercise training, 
including increases in ejection fraction,61 cardiac output,?? stroke volume and oxygen 
pulse61 at maximal exercise, which indicates an increased capacity of the 
cardiovascular system to transport oxygen to skeletal and cardiac muscle. Whereas, 
other studies found no changes in cardiac function with exercise training. 74;75 These 
inconsistent findings could reflect differences in the methods used to assess cardiac 
function and to variations in the duration and intensity of exercise training. It has 
been suggested that intense exercise training for one year or more may be required 
to increase cardiac function of individuals with CHD.70;78 
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Table 3: Effect of Exercise-Based Cardiac Rehabilitation on Exercise Capacity (EC) after MI, CABG and PTCA 
Study 
BetheU36 
RCT 
Oldridge37 
RCT 
DeBusk35 
RCT 
DeBusk47 
RCT 
Subjects 
N=200, 6 wks post MI. 
1000/0 males, <65 years 
N=201, 6 wks post MI. 
90% males, 52 years. 
Patients had moderate 
anxiety or depression. 
N=70, 3 wks post MI 
21Gs& 1CG 
100% males, 52yrs. 
N=585, 3-6 wks post MI 
78% males, 57 years (all 
<70 years). 
Design Results 
Intervention: Community-based sup circuit training 3 times/week for Sig greater improvement in estimated V02max 
12 weeks. in IG vs CG. 
Usual care: Advice on unsupervised exercise. 
FU: 3 m from baseline (4-5 m post MI). 
Intervention: 8 wk hospital-based CPo Sup exercise (65% maxHR), Sig i in EC in both groups from baseline to 8 
2 times/week for 50 mins. Weekly gp counselling. wks & 12 m. Sig difference favouring IG at 8 
Usual care: not described. wks but not 12 m. (EC J.. in IG at 12 m). 
FU: End of programme & 12m. 
Intervention: 8 wks of Sup exercise 3 times/wk, 60 mins or home Sig i in estimated METs in all three gps, but i 
exercise 5 times/wk, 30 mins at 70-85% maxHR. was sig greater in the 2 IGs vs CG. EC i by 
Usual care: not described. 34% in CG, 41 % in home gp & 53% in sup gpo 
FU: 11 weeks. 
Intervention: Home-based CPo Exercise, 60-85% maxHR, 5 EC sig i by 2.1 METs in the IG group. At 6 m, 
days/wk, 30 mins. Behavioural intervention for smoking, exercise & EC was sig greater in IG vs CG (9.3 METs vs 
lipids. Mail & phone contact for 1 yr. 8.4 METs). Baseline EC was not reported. 
Usual care: Education on smoking, diet and exercise. 
FU: 6m. 
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Dugmore48 
Non-
randomised 
Dressend49 
RCT 
Liddell56 
RCT 
N=124, 3 wks post MI 
98% males. 
Subjects split into good & 
bad prognosis gps. 
N=50 4 wks post MI 
31G & 1 CG 
100% males, 54 years 
N=116, 5 wks post MI 
870/0 males, 56 yrs (all 
<66 yrs) 
Intervention: 12m hospital sup exercise 3 times/wk. Good 
prognosis:65 to 800/0 pkV02. Bad prognosis: 50 to 65% pkV02. 
Usual care: not reported 
FU: 4, 8 and 12 months. 
Intervention: 5 wk phase II hospital-based sup exercise training 
(70% V02max), 35 mins/session either 1, 2 or 3 times/wk. 
Usual care: restricted to light activities «50% V02 max) at home. 
FU: End of 5 wk programme. 
Peak V02 , RPP and exercise duration were 
sig higher in good and bad prognosis IG vs 
matcheq CG at 4, 8 and 12 m. Did not report 
change from baseline. 
Treadmill duration sig t in IGs (20-25%) & CG 
(100/0). Sig t in V02 max in IGs by 16% (1/wk), 
19% (2/wk), 20% (3/wk) & NS t by 8% in V02 
max in CG. t in treadmill duration & V02 max 
was sig greater in the IGs training 2 & 3 
times/wk vs CG. 
Intervention: CP involving Phase 1 (inpatient) education & support. EC was sig higher in the IG vs CG at 6 m & 5 
Phase II (outpatient) sup exercise for 1 hour/wk & education for yrs. t in EC from baseline to FU not reported. 
6m. Patients encouraged to exercise unsupervised. Frequent 
phone contact. 
Usual care: Information on risk factors, & attended outpatient 
clinics 1, 3 and 12m post MI & GP annually. 
FU: 6m (end of phase 2) & 5 yrs. 
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Heldal50 
RCT 
Holmback51 
RCT 
N=37, 4 wks post MI 
1000/0 males, 53 years 
(all <66 years). 
N=69, 6 wks post MI 
97%) males, 55 years 
Kalli052 & N=375, 2 wks post MI 
Hamalainen 80% males, <65 years. 
53 RCT 
Roman54 N=193 2m post MI 
RCT 100% males, 54 years, 
(all <71 years). 
Intervention: Hospital, outpatient intensive exercise programme for 
4 wks. Sup exercise 5 days/wk, 2 hrs/session, 85% HR max. 
Usual Care: encouraged to walk at a moderate speed. 
FU: 4 wks (end of intervention) & 6m post MI. 
Intervention: 12-wk hospital prog involving sup exercise, 2 
times/wk, 45 mins/session. Intensity 70-85% HRmax initially, then 
100% max HR. Patients told to exercise after programme. 
Usual Care: regular medical care, no emphasis on exercise. 
FU: 1 yr post MI. 
Intervention: CP including smoking & diet advice, psychological 
counselling & sup exercise. No detail on content & length of 
training. Programme was intense for 3m, but patients had contact 
with staff for 3 yrs. Frequent medical review. 
Usual care: follow-up by own GP. 
FU: 1, 2, 3, 6, 10 yrs post MI. 
Intervention: Hospital outpatient sup exercise, 50% V02 max, 3 
times/wk for a mean of 42 m. 
Usual Care: not detailed. 
FU: 6 & 12m post MI. 
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From Om to 4 wks, EC t sig more in IG vs CG. 
From Om to 6m, there was a NS t in EC by 
6% in CG & a sig t by 14% in IG. Between gp 
diff for the change was NS. 
EC t sig by 10% in IG & NS t by 2%) in CG. 
The between group difference for the change 
was not sig. 
No sig difference in EC between IG vs CG 
throughout the 10-yr FU. But changes from 
baseline were not reported. Similar % of 
patients exercising regularly in IG & CG, but 
actual percentages not reported. 
Peak V02 sig t IG after 6m of training and a 
further NS t at 12m. EC did not sig change in 
CG. Sig diff between gps at 6 & 12m. 
Carson55 
RCT 
Froelicher57 
RCT 
Wosornu58 
RCT 
Oldenburg59 
RCT 
N=303, 6 wks post MI 
100% males, 51 years 
(all <70 years). 
N=53, mean time from 
CABG to study entry was 
2 yrs, range 6m - 9 yrs. 
1000/0 males, 54 years. 
Intervention: 12 wk outpatient circuit training twice/wk. Intensity not 
specified. Told to exercise after programme. 
Usual care: not detailed. 
FU: 5 months, 1,2 and 3 years. 
Intervention: 12m hospital sup exercise programme, 8 wks of 
exercise with ECG monitoring, 45 mins, 3 times/wk, 60% V02 max. 
After 8 wks, patients attended a walk/jog programme. 
Usual care: offered a walking programme <50% V02 max 
FU: 12m 
N=81, CABG in past 12m Intervention: 6m hospital sup aerobic exer or strength training, 12 
(median 12 wks). to 40 mins, 3 times/wk. Intensity based on ACSM 1990 guidelines. 
2 IGs & 1CG Usual care: Told to engage in usual activities. 
100% males, ~7 years. FU: 3 & 6m. 
N=86 4-8 wks post CABG Intervention: Hospital CP, 6 weekly gp sessions for 3 hrs, booster 
90% males, 59 years 
(all<70 years). 
sessions at 8 & 12m, sup exercise & education on risk factors. 
Behavioural skills included, goal-setting, skills training, self-
monitoring & support. Exercise goals: 30-40 mins/day. 
Usual Care: not detailed. 
FU: 4 & 12m post CABG. 
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From baseline to 5m, exercise duration sig t 
in both groups. EC was sig higher in IG vs CG 
at 5m, 1 & 2 yrs. No diff between gps at 3 yrs. 
Mean attendance at exercise sessions was 
82% (range 65-97%). V02 max t by 7.1 % in 
IG & ~ by 2.90/0 in CG. Between gp difference 
for the change in EC was sig. 
EC sig t by 1.4 METs at 3m & 2 METs at 6m 
in the aerobic gp vs no change (0.2 METs) in 
CG. From baseline to 6m, METs t by 29%) in 
aerobic gp, 15% in strength gp & 2% in CG. 
Baseline to 4m, peak V02 t by 6.2 ml/kg/min 
(21 %) in CG & 4.5 ml/kg/min (14%) in IG. 
Baseline to 12m, peak V02 t by 6.7 (21 %) 
ml/kg/min in IG & 5.5 ml/kg/min (19%) in CG. 
t in EC was sig greater in IG vs CG at 12m 
but not 4m. 
Willoughbl N=92 6 wks post CABG 
o Non- 2 IGs & 1 CG 
randomised 830/0 males, 69 years (all 
>63 years). 
Intervention: 12 wk phase II hospital programme, sup exercise for 
20-45 mins, 3 times/week, 65% maxHR (low intensity gp) or 85% 
maxHR (high intensity gp). Patients did not exercise outwith phase 
II. 
Usual care: no formal programme. 
FU: 12 wks (end of programme). 
Exercise duration & V02 max sig t in the 2 
IGs vs CG. V02 max ,J, by 2%) in CG & sig t by 
23% in low intensity gp & 38% in high intensity 
gpo The t in EC was sig greater in high vs low 
intensity gp, thus found a dose response 
effect. 
Higgins79 
RCT 
N=99 post-PTCA Intervention: 2m home CP, involved 3 home visits & monthly phone Similar sig tin EC in IG & CG at 10 wks & 
Lisspers62 & 
Hofman-
Bang63 
RCT 
Majority males, 48 yrs (all calls, unsupervised moderate walking & behavioural strategies to 12m, no diff between groups. 
<64 yrs). 
N=87 2 wks post PTCA 
85% males, 53 years 
«65 years). 
modify risk factors; goal-setting, self-monitoring, feedback, skills 
training & support. 
Usual care: in-patient education on CHD. 
FU: During admission, 10 wks & 1 yr post PTCA. 
Intervention: 12-month CPo Phase 1(4 wks): lectures, discussions, 
skills training, goal setting & relapse prevention to t motivation for 
changing stress, exercise, diet & smoking. 11 m home programme 
(phase II), regular contact, self-monitoring, feedback of changes, 
problem solving & replanning discussions. 
Usual Care: followed-up by own physician. 
FU: 12 & 24m. 
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Baseline to 12m, EC sig t by 11 % in IG & no 
change in CG, sig between group difference. 
This difference was maintained at 24m. 
Belardinelli61 
RCT 
N= 118 25 days post 
PTCA 
80% males, 57 years. 
Intervention: 6m hospital sup exercise 3 times/week, 30 mins, 60% 
peakV02. 
Usual care: given a list of suitable "mild" activities & activity diary 
FU: 6m from study entry. 
Peak V02, lactate threshold, & oxygen pulse 
at a given workload sig t in IG vs CG. Peak 
V02 t by 26% in IG. 83% of IG & 7% of CG t 
their EC by ~ 1 MET. 76% of CG had a lower 
peak V02 at 6m vs baseline. 
Note. MI = myocardial infarction, CABG = Coronary artery bypass graft, PTCA = Percutaneous transluminal coronary angioplasty, FU = Follow-up, Gp = Group, IG = 
Intervention group, CG = Control Group, EC = Exercise capacity, RCT = Randomised controlled trial, m = month, wks = weeks, yrs = years, CP = comprehensive programme, 
diff = difference, prog = programme, NS = non-significant, Sup = Supervised, t = increase, ~ = decrease, Sig = Significant, RPP = rate pressure product. 
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Submaximal Endurance Capacity 
In addition to increased exercise capacity, exercise training also improves 
submaximal endurance capacity in patients with CHD, as demonstrated by a 
significant reduction in patients' rate of perceived exertion (RPE) at submaximal 
levels of exercise49;68;8o and a delayed onset of the lactate threshold. 61 ;75;81;82 These 
effects are beneficial to the daily activities of cardiac patients. The lactate threshold 
is the exercise V02 at which the concentration of lactate in arterial blood increases 
above the resting value due to the supplementation of aerobic energy production 
with anaerobic metabolism during heavy exercise.83 Below the lactate threshold, 
exercise at a given work rate can be sustained for a prolonged period of time without 
fatigue and with relatively little stress to the subject. In contrast, work rates above 
the lactate threshold lead to metabolic acidosis, an increased ventilatory response 
and fatigue, thus exercise above this threshold cannot be sustained as long. The 
delayed onset of the lactate threshold after exercise training enhances an 
individual's ability to perform exercise at a given work rate. Proposed mechanisms 
for the higher lactate threshold after training include improved oxygen supply to 
active skeletal muscles, increased oxidative capacity of mitochondria and delayed 
activation of type II muscles fibres that function anaerobically.83 Hambrecht reported 
a 7% increase in V02 at the lactate threshold after 12 months of unsupervised and 
supervised exercise training compared with an 8% decrease in the control group in 
patients with CHD.84 Although, this study found that patients had to expend 1400 
calories per week, which equated to 3.3 hours of vigorous intensity exercise, to 
delay the onset of the lactate threshold. In contrast, other studies have found 
significant improvements in the lactate threshold after 3 to 6 months of training at a 
lower intensity and frequency of exercise.61 ;75;81 
Angina and Ischaemia 
A major benefit of exercise training for patients with CHD is the delayed onset of 
angina and ischaemia during exercise. Angina and ischaemia occurs at a fixed rate 
pressure product (RPP), which is an index of myocardial oxygen demand and is the 
product of heart rate and systolic blood pressure (HR x SSP).34 Several studies have 
reported a lower myocardial oxygen demand with exercise-based cardiac 
rehabilitation, demonstrated by a significant decrease in RPP during submaximal 
exercise. 49;57;58;80;82;85 A decline in RPP is a result of a decrease in heart rate and 
systoliC blood pressure at a given submaximal workload. In addition, a lower 
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submaximal heart rate increases the period of diastole, thus coronary blood flow will 
be enhanced as 80% of blood flow through the coronary arteries takes place during 
diastole. The overall effect is that at any given submaximal level of exercise, 
myocardial oxygen demand is reduced and coronary blood flow is enhanced, thus 
patients can perform a greater amount of work before the onset of angina or 
ischaemia.
70 
Debusk reported a significant reduction in angina and ECG determined 
ischaemia during exercise testing after 8 weeks of supervised exercise training 
compared to controls in a group of post MI patients.35 Other studies found improved 
myocardial perfusion during exercise testing, indicating a reduction in myocardial 
ischaemia with exercise training in CHD patients. 61 ;86 
Physical Activity Levels 
This section reviews the evidence on the effect of exercise-based cardiac 
rehabilitation on physical activity. The literature was searched from 1979 to 2003 
using Embase and Medline databases. The following key words were used: cardiac 
rehabilitation, myocardial infarction, coronary artery bypass surgery (CABG), 
coronary heart disease (CHD), percutaneous transluminal coronary angioplasty 
(PTCA), coronary artery disease, exercise, physical activity, compliance and 
adherence. In addition, relevant studies were identified from references cited in 
published papers and reviews of cardiac rehabilitation. Thirteen randomised 
controlled trials,39;56;59;62;63;67;79;84;88;90-94 1 non-randomised controlled trial,98 1 case-
control study97 and 5 observational studies20;87;89;95;96 investigating the effect of 
exercise-based cardiac rehabilitation on physical activity are described in Table 4. 
Short-term Effect 
Ten randomised-controlled trials39;56;62;63;67;79;84;88;91;98 and two observational 
studies89;96 reported increases in physical activity after participation in exercise-based 
cardiac rehabilitation (see Table 4). In contrast, two randomised controlled trials 
reported comparable significant increases in physical activity in both rehabilitation 
and control groups at follow-up. The major limitation of these trials involves the 
method used to measure physical activity. These studies relied on self-report 
measures of physical activity, and except for one studl9 objective measures of 
physical activity were not employed. In addition, only four studies84;88;89;96 used a 
valid and reliable questionnaire to measure physical activity. 
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Physical activity guidelines for cardiac patients and healthy adults recommend 
accumulating 30 minutes of moderate activity on at least five days per week, which 
is equivalent to expending a minimum of 1000 calories per week during physical 
activity to achieve health and fitness benefits.8;9;34 Thus, results from two of the 
observational studies discussed in Table 4 demonstrate that exercise-based cardiac 
rehabilitation improves patients' physical activity habits to levels recommended by 
current guidelines. 89;96 Although, these studies did not assess whether patients 
continued to achieve these guidelines in the long-term. However, greater amounts of 
physical activity than those recommended by current guidelines may be required to 
slow the progression of coronary atherosclerosis in CHD patients. Hambrecht found 
that expending a minimum of 1600 calories per week during leisure physical activity 
was required to slow the progression of CHD, whereas regression of CHD was 
noted in highly motivated patients who expended an average of 2200 calories per 
week, amounting to between 5 and 6 hours of vigorous physical exercise.84 
Although, it is unlikely that the majority of patients with CHD would engage in this 
amount of physical activity. 
Long-Term Effect 
Twelve studies investigated the long-term effect of exercise-based cardiac 
rehabilitation on physical activity (see Table 4).20;56;59;63;67;79;84;87;91 ;94;96;98 Two 
randomised-controlled trials59;63 found that improvements in physical activity with 
cardiac rehabilitation were maintained following programme completion. In addition, 
Hambrecht84 found that physical activity related energy expenditure measured by 
questionnaire was significantly higher in the intervention group compared to controls 
56"67"79"91"94"98 
at 12 months follow-up. In contrast, six randomised controlled trials ' , , , , and 
three observational studies20;87;96 found a decline in patients' physical activity levels 
following completion of cardiac rehabilitation exercise programmes. Bock evaluated 
the proportion of patients meeting current physical activity guidelines (i.e. 
accumulating 30 minutes or more of moderate activity on most days of the week) 
and measured physical activity by self-report in 62 cardiac patients who attended a 
12-week supervised cardiac rehabilitation exerCise programme.96 At the beginning of 
rehabilitation, 43% of participants were meeting the physical activity guidelines. On 
programme completion, 96% of participants were meeting the guidelines and the 
amount of time spent in moderate and hard intensity physical activity had increased 
significantly. In contrast, three months after rehabilitation, the proportion of patients 
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achieving the recommendations had decreased to 80% and nearly 50% of 
participants had reduced their physical activity levels compared to the end of the 
programme. Similarly, Stahle reported a significant improvement in exercise capacity 
and physical activity with three months of exercise training compared to usual care. 67 
However, physical activity levels and exercise capacity were similar between the 
groups at 12 months, as physical activity and fitness had declined in the intervention 
group. 
Bethell reported a significant increase in exercise capacity and physical activity after 
three months of supervised exercise training compared to usual care. 91 In a fo"ow-
up study, the number of patients who continued to exercise regularly after 
completing the rehabilitation programme was assessed annually for 11 years using a 
postal questionnaire. The response rate was greater than 70% throughout the 11 
year follow-up. In the intervention group, the proportion of patients exercising 
regularly rapidly fell from 70% to 40% during year one and then gradually declined 
over subsequent years, until only 25% of rehabilitated patients were exercising 
regularly from year seven onwards. In addition, 25% of patients in the control group 
reported exercising regularly throughout the 11-year follow-up period. These results 
suggest that a short-term exercise programme was more effective than usual care in 
improving physical activity habits for up to six years. However, these findings also 
show that the majority of patients were not exercising regularly in the long-term 
following cessation of supervised exercise training. Similarly, other studies 
(described in Table 4) have reported that only 12% to 50% of patients continue to 
exercise regularly 12 months to 9 years after completion of exercise-based cardiac 
rehabilitation. 20;56;87;94;95 The major limitation of these studies is definition of regular 
exercise, which varied greatly and was not based on current physical activity 
recommendations. For example, in studies by Bethell91 and Prosser,94 patients were 
categorised as regular exercisers if they engaged in vigorous physical activity (e.g. 
swimming, jogging etc), whereas moderate intensity activities were excluded. 
Current cardiac rehabilitation guidelines2 recommend moderate intensity exercise for 
most cardiac patients, thus these studies may have underestimated the proportion of 
patients who maintained a sufficient level of physical activity to benefit their health. 
In other studies, patients were considered to be regular exercisers if they exercised 
twice a week8? or "had started to exercise post MI.,,56 Thus, the number of patients 
who remain regularly active after exercise-based cardiac rehabilitation is variable 
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and depends on the length of follow-up and the definition of regular physical activity. 
Only one study used the current physical activity guidelines to determine the 
proportion of patients who remained regularly active after exercise rehabilitation. 96 
Nine randomised-controlled trials and three observational studies examined the 
long-term impact of cardiac rehabilitation on physical activity. Six of the nine 
randomised-controlled trials found that improvements in physical activity with cardiac 
rehabilitation declined in the long-term. In addition, all three observational studies 
reported that physical activity was not maintained in the long-term. However, the 
results of the observational studies must be interpretetd with caution as these 
studies are more prone to potential bias and confounding factors than controlled 
trials. 
In summary, the evidence suggests that participation in exercise-based cardiac 
rehabilitation can improve physical activity levels. However, it seems that the impact 
of cardiac rehabilitation exercise programmes on long-term maintenance of physical 
activity is limited .. Several studies reported that increased levels of physical activity 
are not maintained in the long-term following completion of formal programmes. 
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Table 4: Effect of Exercise-Based Cardiac Rehabilitation on Physical Activity 
Study 
Heath88 
RCT 
Bertie39 
RCT 
Engblom90 
RCT 
Patients Design 
N=65 10d Intervention: 12-wk sup or home exercise programme, 30-40 mins 5 
post CABG times/wk, 70-90% peakHR. Exercise counselling & prescription after 
21Gs & 1 CG programme. Usual Care: Information on risk factors & activity. 
N=81 3 wks 
post MI 
N=228, 
CABG. 
87% males, 
54 years (all 
FU: 6 - 8m post CABG. 
Outcomes: Leisure PA in kcals/wk assessed by questionnaire. 
Intervention: 4 wk hospital CP involving risk factor advice, sup exercise 
twice/wk & encouraged to do an exercise video daily. 
Usual care: Information on risk factors. 
FU: 4m post hospital discharge. 
Outcomes: Mean km walked/day using a pedometer 
Intervention: Hospital CPo Phase I: 3d pre-CABG, information on surgery & 
recovery. Phase II: 6 wks post-CABG, risk factor education, & 21 hrs sup 
exercise for 3 wks. Phase III: 8m post CABG, 2d refresher of phase II. 
Usual care: Instructions on gradually t activity. FU: 6 & 12m. 
< 65 years). Outcomes: Self-report PA. No definition of regular exercise. 
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Results 
PA was sig lower in CG (1089 kcals/wk) vs 
home IG (2058 kcals/week) & sup IG (2,549 
kcals/week) at FU. 
At Om, distance walked per day was 4.5 km in 
CG & 5.1 km in IG. At 4m, distance 
walked/day was sig higher in IG (8.2 km) vs 
CG (6.6 km). 
From pre CABG to 6 & 12m FU, % of patients 
exercising regularly sig t in IG (22% to 42%) & 
CG (t 10% to 38%), no diff between gps. 
Bethell91 
RCT 
Stahle67 
RCT 
Higgins79 
RCT 
N=200 6 Intervention: 12 wk community sup exercise 3 times/wk. 
wks post MI Usual care: advice on unsupervised exercise. 
FU: annually for 11 yrs. 
Outcomes: Self-reported PA. Regular exercise defined as participating in 
vigorous exercise. Duration or frequency not assessed. 
N=101 6 Intervention: Hospital sup exercise 3 times/wk for 3m & once/wk for further 
wks post MI 3m. After programme, patients encouraged to attend community classes. 
or unstable Usual Care: Advised to walk daily & attended monthly meetings. 
angina FU: 3 & 12m. 
N=99 post 
PTCA 
Outcomes: PA on a 6-point scale: 1 =sedentary & 6= strenuous exercise 
(e.g. jogging, swimming) 23hrs/wk. 
Intervention: 2m home CP, home visits & phone calls, unsupervised 
moderate PA & behavioural strategies to modify risk factors; goal-setting, 
self-monitoring, feedback, skills training & support. 
Usual care: in-patient education on CHD. 
FU: pre-PTCA, 10 wks & 1 yr post PTCA. 
Outcomes: % patients exercising = 1-3 times/wk for 20 mins/session. 
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Questionnaire response rate was approx 70%. 
0/0 of IG exercising regularly ~ from 70% to 
40% in yr 1, then gradually ~ to 25% at yr 7, 
remained at that level. 25% CG exercised 
regularly over 11 yrs. 
PA sigt in IG (mean 4.5) vs CG (mean 3.9) at 
3m. at 12m, PA was 3.8 in IG & 3.6 in CG, no 
diff between gps. Changes in PA at 3m were 
not maintained at 12m in IG. 
% of IG exercising sig t from 35% at Om to 
88% at 10 wks & 72% at 12m. % of CG 
exercising did not sig change from 53% at Om, 
to 59% at 10 wks, to 61 % at 12m. Sig diff 
between gps at 10 wks, not 12 m. 
Oldenburg59 
RCT 
Lisspers62 & 
Hofman-
Bang63 
RCT 
Liddell56 
RCT 
N=864-8 
wks post 
CABG 
90% males, 
59 years 
(all<70 
years). 
N=87 2 wks 
post PTCA 
85% males, 
53 years 
«65 years). 
N=116,5 
wks post MI 
Intervention: 6wk hospital CP, 1 gp session/wk for 3 hrs & booster sessions PA sig t in both gps from Om to 4m & this 
at 8 & 12m. Sup exercise & education on risk factors. Behavioural skills: level was maintained at 12m. No sig diff 
goals, skills training, self-monitoring, support. Exercise goals: 30mins/d walk between gps. Did not report levels of PA 
Usual Care: not detailed. participation. 
FU: 4 & 12m post CABG. 
Outcomes: Regular exercisers: ~ 3/wk, moderate exercisers: 2/wk & non-
exercisers: ::; 1/wk. 
Intervention: 12-month CPo Phase I: 4 wks, lectures, discussions, skills 
training, goal setting & relapse prevention to change stress, exercise, diet & 
smoking. 11 m home programme (phase II), regular contact, self-monitoring, 
feedback, problem solving & replanning discussions. 
Usual Care: followed-up by own physician. 
FU: 12 & 24m. 
Outcomes: Exercise session = effort equal to brisk walk for 20 mins. 
Intervention: CPo Phase 1 (inpatient) education & support. Phase II 
(outpatient) sup exercise 1 hr/wk & education for 6m. Patients were 
From Om to 12m, the frequency of exercise 
sessions t sig in IG (2.5 to 5/wk) vs CG (2.5 to 
3/wk) , which was maintained at 24m. At 12m, 
56% of IG & 41 % of the CG exercised at least 
twice/wk. 
87% males, encouraged to exercise unsupervised. Frequent phone contact. 
% patients exercising was sig greater in IG 
(67%) vs CG (28%) at 1 yr. No sig diff 
between IG (41%) & CG (28%) at 5 yrs. 
56 yrs (all Usual care: Risk factor information & attended clinics 1,3 & 12m post MI. 
<66 yrs) FU: 1 & 5 yrs. 
Outcomes: PA assessed by statements "started to exercise post Min 
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Carlsson92 
RCT 
Hambrecht84 
RCT 
Haskell93 
RCT 
N=1684 
wks post MI 
N=62 with 
CHD. 
Intervention: 3m CP, counselling on diet, smoking & PA. 40mins of sup 
exercise ~2/wk. End of programme, received exercise plan & education. 
Usual care: medical evaluation, risk factor education & exercise programme. 
FU: 12m. 
Outcomes: PA: 1 =sedentary, 2=walking/cycling daily for ~30 mins, 3=sport 
activities ~1/week, 4=sport activities ~2/wk, 5=vigorous exercise. 
Intervention: 3 wk inpatient programme; low fat diet & sup exercise 6 
times/d for 10 mins at 75% maxV02. Out-patient programme; unsupervised 
exercise, 30 mins/d & 2 sup exercise sessions/wk 60 mins. 
Usual care: information on exercise & diet. 
FU: 12 months 
Outcomes: EE (kcals/wk) by Minnesota leisure time PA questionnaire. 
N=300 with Intervention: Home CP, individualised goals to modify risk factors. PA 
CHD programme involved daily PA e.g. walking, climbing stairs, & aerobic 
years, 80% exercise for ~30mins on 5d at 70-85%maxHR. Phone & mail contact. 
males. Usual Care: medical review by GP. 
FU: annually for 4 yrs. 
Outcomes: PA measured by 7 day PA recall. 
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At hospital admission, 69% IG & 78% of CG 
were physically active (i.e. categories 2 - 5). At 
12 m, 77% of IG & 70% of CG were physically 
active. 78% IG & 67% CG who were sedentary 
at baseline were active at 12m, no sig diff 
between gps. 
At 12m, EE was 1,876 kcals/wk IG & 1,187 
kcals/wk CG (p<0.05). In total gp, EE was sig 
lower in patients with progression of CHD 
(1022 kcals/wk), vs no change in CHD (1533 
kcals/wk) or regression of CHD (2204 
kcals/wk). 
At baseline, 79% of IG & 72% of CG exercised 
regularly (p>0.05). At FU, % of IG exercising 
regularly sig t to 90% vs CG (70%). 
Prosser94 
RCT 
N=291 6 Intervention: 3m sup exercise for 45 mins/session, twice/wk. 
wks post MI Usual care: not mentioned. FU: 6-9 years post MI. 
Outcomes: Questionnaire on % patients exercising vigorously (> 6 METs). 
> 70% response rate. 19% IG were exercising 
at FU vs 2% of CG. 
Ben-Ari98 N=175 1 wk Intervention: 12 wk CP involving education on risk factors & sup exercise 45 
mins, 2-3d/wk at 70-85% maxHR. 
% of patients exercising ~ 2 times/wk 89% in 
IG and 72% in CG at 3m (p<0.05). No sig diff 
at 18m (75% IG vs 70% CG). 
Non- post PTCA. 
randomised 
controlled trial 
Morrin89 
Cohort 
Perk97 
Case-control 
Usual Care: information on risk factors & PA. 
FU: 3 & 18m. 
Outcomes: self-report PA. 
126> 6 wks Intervention: 6m hospital CP, education, sup exercise twice/wk, 50-75% 
post cardiac HRR & unsupervised activity for 200-400 mins/wk (1,200-2,000 kcals/wk). 
event. Individualised goals for risk factors, feedback on risk factors at 0,3 & 6m. 
FU: 3 & 6m. Outcomes: EE in kcal/wk assessed by 7 Day PA Recall. 
81 % adherence rate to the programme. Sig t 
in PA from Om (830kcals/wk) to 3m (1345 
kcals/wk) & 6m (1325 kcal/wk). 
N=1576 
wks post 
CABG 
Intervention: 3m hospital CPo Education, sup exercise 2/wk, 100% maxHR & 66% of IG were regular exercisers vs 460/0 of 
individualised home exercise programme. After 3m, patients attended a CG (p=0.05). IG, mean duration of training/wk 
community programme. was 6.5 hrs vs 5.2 hrs/wk CG (p=0.07). 
Usual care: medical review at 1 year. 
FU: Mean 38 months after CABG. 
Outcomes: PA assessed by a mailed questionnaire (not validated). 
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Kinsel7 
Cohort 
Fontana20 
Cohort 
Vidmar95 
Cohort 
Bock96 
Cohort 
N=48 post-
CABG 
N=50 post 
Mlor 
CABG. 
N=138 
patients 
N=62 after 
MI, CABG 
or PTCA. 
Intervention: 12 wk phase II home exercise programme. Patients were 
advised to walk or cycle 3- 4 times/wk after programme. 
FU: 4 yrs. Outcomes: leisure PA, including frequency, intensity &duration. 
Intervention: Hospital sup exercise for 35 mins/session, 3 times/wk, 85% 
maxHR for 12 wks. FU: 12 weeks, 6 and 12 months. 
Outcomes: % patients attending programme, % completing programme, & 
% continuing to exercise after programme. 
Intervention: 12wk phase II hospital CP, exercise training & education on 
risk factors. 
FU: patients who had completed phase II in the past 8 yrs 
Outcomes: PA questionnaire (not validated). 
Intervention: 12wk phase II CP, sup exercise 1 hr, 3 times/wk, 60-80% 
HRR, risk factor education & guidelines for home activity. 
FU: 12 wks (programme completion) & 6m. 
Outcomes: 7 -Day PA Recall (mins/wk) & Stage of Exercise Behaviour 
Change. Regular PA = accumulate ~ 30mins moderate PA on 5d /wk. 
80% compliance to programme. 41 % were 
exercising at least twice/wk at 4 yrs. 
52% attended programme. 39% completed 
programme. % continuing to exercise after 
prog was 60% at 12 wks, 30% at 6m & 37%) at 
12m. 
39% (138/352) response rate. 87%) of patients 
were exercising, either unsupervised or at a 
phase III maintenance programme. 44% 
engaged in moderate PA for 40 mins~ 3/wk. 
26% dropped out programme. At Om, 47% 
patients were regularly PA. At 12 wks, 96% 
were regularly PA & mins/wk of PA sig t. 6 m, 
80% were regularly PA. 12 wks to 6m, 42% 
participants regressed (i.e. mins/wk of PA .J,). 
Note. MI = myocardial infarction, CABG = Coronary artery bypass graft, PTCA = Percutaneous transluminal coronary angioplasty, CHD = coronary heart disease, FU -
Follow-up, Gp = Group, IG = Intervention group, CG = Control Group, EC = Exercise capacity, PA = Physical activity, EE = Energy expenditure, RCT = Randomised 
controlled trial, m = month, wks = weeks, Sup = Supervised, t = increase, .,l.. = decrease, Sig = Significant, d = days, diff = difference, CP = comprehensive programme, 
HRR = heart rate reserve. 
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Psychological Functioning 
Psychological distress following myocardial infarction is common and can lead to 
poor outcomes.2 The prevalence of depression in patients following MI ranges from 
15% to 45%.2 Patients diagnosed with major depression according to DSM-III-R 
(Diagnostic and Statistical Manual of Mental Disorders revised third edition) criteria 
(16%) seven days after a MI were at a significantly greater risk of dying over the 
subsequent 6 months than non-depressed patients. 10o Furthermore, the increased 
risk remained after controlling for previous MI, ejection fraction and other clinical 
indicators of disease severity. Another study reported that moderate symptoms of 
depression measured using the Beck Depression Inventory (score ~ 10) immediately 
after MI predicted mortality over the following 18 months. 101 Again this effect was 
independent of other post MI risk factors. Mayou observed that patients suffering 
from psychological distress (15%) measured using the Hospital Anxiety and 
Depression Scale three days after MI reported poorer quality of life, more cardiac 
symptoms, exercising less, continuing to smoke, and greater use of health services 
over the subsequent 12 months compared to nondistressed patients. 102 Evidence 
also suggests that depressed patients are less likely to adhere to medical treatment 
or lifestyle changes including exercise programmes.103-105 In addition, psychological 
distress after an acute cardiac event does not improve in many patients without 
treatment. 102;106 Therefore, as distressed subjects are at an increased risk of adverse 
outcomes following a MI, an aim of cardiac rehabilitation is to "limit the psychological 
effects of cardiac illness and to enhance psychosocial status".1 
Numerous studies have examined the effect of exercise-based cardiac rehabilitation 
I f .. d·b d· T bl 5 32;37;38;51;59;61;63;66;67;79;89;107-109 on psychologica unctlonmg, as escn e In a e . 
Most of these studies found that exercise-based cardiac rehabilitation produced 
psychological benefits with exercise-based cardiac 
rehabilitation. 32;37;38;51;59;61;63;66;67;79;89;107-109 Similarly, systematic reviews found that the 
majority of controlled trials reported statistically significant improvements in 
psychological functioning with comprehensive rehabilitation compared to usual 
care. 1;246 However, it is impossible to determine which components of 
comprehensive cardiac rehabilitation programmes (e.g. exercise training, education, 
individual and group counselling etc) were responsible for the psychological benefits. 
The reviews also found that exercise training as the sole component of cardiac 
rehabilitation improved psychological wellbeing and quality of Iife. 1;246 However, the 
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direct effect of exercise training on psychological outcomes is confounded by the 
consequence of group interaction, the formation of social support networks during 
supervised exercise programmes, and support and guidance from cardiac 
rehabilitation staff, which are likely to affect anxiety, depression and quality of life. It 
is thought that improved psychological function with exercise training was a result of 
increased fitness. However, Newton reported that improvements in psychological 
functioning after a 10-week rehabilitation exercise programme compared with routine 
care were independent of changes in fitness. 38 Overall, evidence suggests that 
exercise-based cardiac rehabilitation enhances psychological wellbeing. In addition, 
Denollet found that reducing psychological distress with comprehensive 
rehabilitation improved long-term mortality.32 
Long-term Effects 
The long-term effects of exercise-based cardiac rehabilitation on quality of life and 
psychological functioning have been examined.37;51;59;61;63;66;67;79;107;109;11o A 
randomised controlled trial of 118 patients following PTCA reported significant 
improvements in quality of life assessed using the Short-Form 36 after 6 months of 
supervised exercise training. 61 Furthermore, the positive change in quality of life was 
maintained six months after programme completion. In contrast, quality of life did not 
significantly improve in the control group over the 12-month study period. Similarly, 
other controlled trials have found that 6 to 12 weeks of comprehensive rehabilitation 
enhanced psychosocial functioning compared to usual care for 6 to 12 months after 
MI and CABG. 110;111 
Conversely, several randomised controlled trials found no significant difference in 
psychological functioning between the intervention and control groups in the long-
term. 37;51;59;63;66;67;79 Stahle randomised 101 elderly patients 6 weeks following MI to a 
3 month supervised exercise programme or usual care. 67 Significantly greater 
improvements in many quality of life dimensions, assessed by a disease-specific 
questionnaire, were observed after 3 months of exercise training compared to usual 
care. However, quality of life gradually improved in the control group and declined in 
the rehabilitated group, thus similar scores were observed between the groups at 12 
months. Similarly, Oldridge37 found that 8 weeks of supervised exercise training and 
psychological group counselling significantly improved anxiety, emotions and total 
quality of life measured using the Quality of Life after MI (QLMI) compared to 
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standard care. However, these differences were no longer significant at 12 months 
because anxiety levels and quality of life had significantly improved over time in the 
control group. 
There are several explanations for the lack of long-term effects of exercise 
rehabilitation on psychological outcomes. Firstly, improvements in psychological 
functioning and quality of life following MI,37;66;67 CABG59 and PTCA63;79 have been 
observed in both rehabilitated patients and control patients in the long-term. It is 
expected that many patients will experience an enhanced quality of life after CABG 
and PTCA due to relief from angina and increased functional capacity without 
rehabilitation. Similarly, improvements in quality of life after MI may be due to the 
natural course of recovery after an infarct. Therefore, it is possible that a short-term 
comprehensive rehabilitation programme accelerates the improvements in quality of 
life, whereas without rehabilitation the improvements occur at a slower rate. 
Secondly, in several studies usual care patients received more contact with health 
care professional.s than normal,59;67;79 which may have contributed to the gradual 
improvement in quality of life observed in control patients. Finally, compliance to 
lifestyle changes may decline after completion of exercise-based cardiac 
rehabilitation leading to the deterioration in quality of life in the long-term viewed by 
some researchers. 66;67 
In summary, studies determining the long-term effects of cardiac rehabilitation on 
psychological outcomes produced inconsistent results. Several authors reported no 
significant differences between intervention and control groups in psychological 
functioning and quality of life in the long-term, due to gradual improvements in these 
outcomes in control patients over time and possibly as a result of poor long-term 
compliance with lifestyle changes in rehabilitated patients. Furthermore, the 
instruments used to measure psychological outcomes differ widely (see Table 5), 
and these variations may account for the inconsistent results observed. 
Psychologically Distressed Patients 
The greatest psychological benefits of exercise-based cardiac rehabilitation may 
occur in patients with poor quality of life and high levels of psychological distress at 
study entry.108;110;112;113 Lewin110 randomised 176 patients 3 days after MI to a 6 
week home-based comprehensive rehabilitation programme or usual care and 
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measured psychological distress using the Hospital Anxiety and Depression Scale 
(HADS) at 6 weeks, 6 months and 1 year. Fifty two percent of the study group were 
psychologically distressed at baseline, determined by a HADS score ~ 8 on anxiety 
or depression subscales. In the distressed group, mean anxiety and depression 
scores significantly decreased in the rehabilitation group and remained unchanged 
in the control group at 6 weeks, 6 months and 1 year. In the non-distressed group, 
mean anxiety and depression scores were low at baseline and did not significantly 
change in either group during the 12-month study period. Thus, the psychological 
benefits of exercise-based cardiac rehabilitation were confined to patients who were 
psychologically distressed immediately after MI. 
A large observational study found that depressed patients had a reduced exercise 
capacity, higher levels of anxiety and hostility (measured using the Symptom 
Questionnaire) and poorer quality of life (assessed with the Short-Form 36) 
compared to nondepressed patients who had recently experienced aMI, CABG or 
PTCA. 108 Followi~g 12 weeks of comprehensive rehabilitation, improvements in 
anxiety, depression and most subscales of the Short-Form 36 were significantly 
greater in the depressed group compared to the nondepressed group. Overall, it 
seems that patients with poor quality of life or suffering from psychological distress 
following an acute cardiac event may be particularly responsive to the psychological 
effects of cardiac rehabilitation. 
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Table 5: Effect of Exercise-Based Cardiac Rehabilitation on Psychological Function 
Study Subjects Design Outcomes 
Oldridge37 N=201 6 wks post MI Intervention: 8 wk hospital-based CPo Sup QoL: Time Trade-off, 
RCT 90% males, 52 years. exercise (65% maxHR), twice/week, 50 mins. Quality of life after MI 
All patients were Weekly gp counselling. (QLMI) & Quality of 
moderately anxious or Usual care: not described. Wellbeing (QW8). 
depressed. FU: 8 wks, 4, 8, & 12m. 
Stern66 N=91, 6wks-12m MI Intervention: 12 wk out-patient sup exercise Scaled Interview to 
RCT 86% males, 54 yrs. training 3 times/wk at 85% maxHR. 12 wks of Assess Maladjustment 
Subjects were high gp counselling on managing stress & risk (SSIAM), National 
risk. factors, relaxation & education. Institute of Mental 
Usual care: told not to engage in sup exercise Health (NiMH) Self 
or counselling. Report Mood Scale. 
FU: 3, 6, & 12m. 
Newton38 N=22 6 wks post MI Intervention:10 wk hospital CP, 3 exercise Beck Depression 
RCT sessions/wk (2 sup, 1 home), 60-80% maxHR & Inventory (BOI) and 
education on risk factors. Profile of Mood States 
Usual Care: Education on risk factors. (POMS). 
FU: 10 wks (end of programme). 
37 
Results 
Similar, ig, t in all QoL measures in IG & 
CG at 12m. Sig i in QLMI & anxiety in IG 
vs CG at 8 wks. QLMI t in 67% of IG & 
52% CG at 8 wks (p <0.05). At 12m, 70% 
of IG & CG had i QLMI. 
At 3m, IG had sig lower scores for 
depression & fatigue (NiMH), less 
dependent on spouses & more sociable 
(SSIAM) vs CG. Other QoL changes were 
similar in IG & CG from Om to FU. QoL i 
over time in CG & improvements in IG J. 
from 6 to 12m. 
Anxiety, & depression (POMS) & 
depression (BOI) sig J- in IG vs CG. Sig 
improvement in anger & total mood 
disturbance (POMS) in IG vs CG. Sig i in 
fatigue (POMS) in IG & CG. 
Denollee2 N=150 3-6 wks post Intervention: 3m hospital CP, sup exercise 3 Mortality & emotional Sig improvement in negative affect in IG v: 
Non- MlorCABG times/wk at 50-75% pkV02. psychosocial gp distress (positive & CG. Greater % of IG improved & smaller 
randomised 100% males, 58 sessions & individualised psychological therapy negative affect) using % deteriorated in negative affect vs CG. 
years. if needed. Global Mood Scale 17% CG & 4% IG died at 9yrs (p<0.05). 
Usual Care: not documented. (GMS). Mortality was associated with deterioration 
FU: 3m, mortality assessed at 9yrs. in negative affect. 
Engblom107 N=228, CABG. Intervention: Hospital CPo Phase I: pre-CABG, Beck Depression Depression was sig lower in IG vs CG at 
RCT 87% males, 54 years information on surgery. Phase II: education, 21 Inventory (801), 60m. 30% of IG & 34% CG were 
(all < 65 years). hrs of sup exercise for 3 wks & psychology Nottingham Health depressed (BDI ~13) pre-CABG. At 60m, 
Patients were counselling. Phase III: 8m, 2-d refresher of Profile (NHP). 22% IG & 29% CG were depressed 
randomised pre- phase II. Phase IV: 30m, 1-d refresher. (p>O.05). Physical mobility (NHP) was sig 
CABG. Usual care: instructions on t activity. better in IG vs CG at 60m. 
FU: 2, 8, 30 & 60 months post CA8G. 
Milani108 N=338 4-6 wks post Intervention: 12 wk phase II hospital CPo Depression, anxiety & At Om, depressed gp had poorer EC, SF-
Observation MI, CA8G or PTCA. Education on risk factors & psychological somatisation measured 36 & more anxious vs non-depressed gp 
78% males, 61 years. adaptation to CHD, sup exercise 3 times/wk, using Symptom (p<0.05). FU, sig improvement in all scores 
30-40 mins, 70-85% maxHR & encouraged to Questionnaire. in depressed gpo Sig greater improvement 
exercise unsupervised 1-3 times/wk. Depression: cutoff> 6. in scores in depressed vs non-depressed 
FU: 12 wks. QoL assessed using group. 67% of depressed gp were not 
Short-Form 36 (SF-36). depressed at FU. 
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Stahle67 
~~-
Several QoL scales t sig in IG and CG at N=101 6 wks post MI Intervention: Hospital sup exercise 3 QoL: Disease-specific 
RCT or unstable angina times/week for 3m & once/wk for a further 3m. Karolinska FU. Sig diff between gps at 3m, for 
75% males, 71 years After programme, patients were encouraged to Questionnaire symptoms, PA & fitness, no sig diff at 12m 
(>64 years). attend community classes. Wellbeing: visual 3m changes in IG were not maintained. 
Usual Care: Advised to walk daily & attended analogue scale. 
monthly information meetings. 
FU: 3 & 12m. 
Morrin89 N= 126 > 6 weeks post Intervention: 6m hospital CP, education, sup QoL assessed by Short- Sig t in SF-36 scales at 3 & 6m, except 
Observation cardiac event. exercise twice/wk, 50-75% HRR & Form 36. mental health which sig improved by 6 
74% males, 61 years. unsupervised activity for 200-400 mins/wk. Set months, but not 3 m. At baseline, QoL was 
individual goals for risk factors & given lower vs USA norms. At 6m, most scales 
psychological counseling if required. were similar in patients vs USA norms. 
Follow-up: 3 & 6m. 
Holmback51 N=69, 6 wks post MI Intervention: 12 wk hospital programme, sup Questionnaire (not No diff between IG & CG for changes in 
RCT 97% males, 55 years exercise, 2 times/wk, 45 mins/session. 70 to validated) measured QoL measures. But the change in QoL 
85% HRmax initially, then 100% max HR. QoL (anxiety, from Om to 1 yr was not reported. 
Patients told to exercise after intervention. depression, self-
Usual Care: regular medical care. confidence) & perceived 
FU: 1 yr post MI. physical performance. 
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Oldenburg59 
RCT 
Higgins79 
RCT 
N=86 4-8 wks post 
CABG 
900/0 males, 59 years 
(all<70 years). 
N=99 post-PTCA 
Majority males, 48 yrs 
(all <64 yrs). 
Intervention: Hospital CP, 6 weekly gp sessions 
for 3 hrs & booster sessions at 8 & 12m. Sup 
exercise & education on smoking, diet & 
exercise. Behavioural skills included goal 
setting, skills training, self-monitoring & support. 
Usual Care: not detailed. 
FU: 4 & 12m post CABG. 
Intervention: 2m home CP, involved home visits 
& phone calls, unsupervised walking & 
behavioural strategies to modify risk factors; 
goal-setting, self-monitoring, skills training & 
support. 
Usual care: education on CHD. 
FU: During admission, 10 wks & 1 yr. 
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QoL assessed by ST AI, 
depression, anxiety & 
somatisation scales of 
SCL-90 & General 
Health Questionnaire 
(GHQ). 
EC assessed with 
Seattle Angina 
Questionnaire (SAQ). 
Psychological 
Adjustment to Illness 
Scale (PAIS-SR). 
QoL, subscales of the SCL -90 & % of 
patients with a high score on GHQ sig 
improved in IG & CG over time, with no difi 
between gps. 
PAIS-SR & EC sig t in IG & CG over time, 
with no diff between gps. 
Hofman-
Bang63 
RCT 
N=87 2 wks post 
PTCA 
85% males, 53 years 
«65 years). 
Belardinelli61 N=118 25 days post 
PTCA 
RCT 80% males, 57 years. 
Sandler109 N=215 6 wks post MI 
RCT 90% males, 55 years 
«72 years). 
Intervention: 12-month CPo Phase I: lectures, 
discussions, skills training, goal setting & 
relapse prevention for changing risk factors. 
11 m home programme, regular contact, self-
monitoring, problem solving. 
Usual Care: FU by own physician. 
FU: 12 & 24m. 
Intervention: 6m hospital sup exercise 3 
times/week, 30 mins, 60% peakV02. 
Usual care: given a list of suitable "mild" 
activities & activity diary. FU: 6 & 12m. 
Intervention: 6 wk hospital CP, 2 1-hr sup 
Anxiety using STAI & No sig diff between gps for anxiety, 
depression using SOl. depression or QoL at 12 or 24m. Many of 
Angina Pectoris QoL: these outcomes improved in both gps. 
activity, symptoms, 
emotional distress & life 
satisfaction. 
QoL measured using 
Short-Form 36 & Duke 
Activity Status Index 
(DASI). 
Hospital Anxiety and 
DASI and all SF-36 scales, except social 
functioning sig tin IG, with no change in 
CG. Sig between gp diff for the change in 
SF-36 scores at 6 & 12m. 
exercise classes/wk, 1 education & relaxation Depression Scale 
At Om, 24% IG & 18% CG were clinically 
anxious. % of anxious patients ,J.. to 9% in 
IG & t to 21 % in CG at FU. Anxiety sig ,J.. session/wk, 3 1-hr gp sessions on psychological (HADS), 10 was cut off 
issues. score for clinical anxiety in IG, no change in CG. No change in 
Usual Care: not detailed. or depression. depression in IG or CG, 3% of patients 
FU: 6, 12, 24 wks were depressed at Om. 
Note. QoL = Quality of Life, MI = myocardial infarction, CASG = Coronary artery bypass graft, PTCA = Percutaneous transluminal coronary angioplasty, FU = 
Follow-up, Gp = Group, IG = Intervention group, CG = Control Group, EC = Exercise capacity, RCT = Randomised controlled trial, m = month, wks = weeks, Sup = 
Supervised, t = increase, -i = decrease, Sig = Significant, Diff = difference, CP = comprehensive programme, QoL = quality of life. 
-1-1 
Lipids 
Elevated levels of total cholesterol and LDL cholesterol, and low levels of HDL 
cholesterol are risk factors for recurrent coronary events after a myocardial 
. f t' 114;115 R . In arc Ion. andomlsed controlled trials have demonstrated that a reduction in 
total cholesterol and LDL cholesterol with lipid lowering therapy significantly decreased 
mortality, the incidence of non fatal MI and the need for coronary revascularisation in 
patients with CHD.116-119 Thus, national guidelines recommend that individuals with 
CHD should have a total cholesterol and LDL cholesterol level less than 5 mmol/l and 
3 mmolll respectively to reduce the risk of recurrent cardiac events.2;115 In addition, 
American guidelines state that triglyceride concentrations should be less than 5.2 
mmol/l and HDL cholesterol should be greater than 0.91 mmol/1. 120 To achieve and 
maintain these lipid targets, interventions to modify diet, increase physical activity and 
reduce weight are recommended,120 and lipid lowering medication should be 
prescribed to individuals with a total cholesterol 2 5mmolll or LDL cholesterol 2 3 
mmo1/1.2;115 Although, recent results from the Heart Protection Study indicate that CHD 
patients should be prescribed lipid lowering medication irrespective of their initial 
cholesterol level. 119 This study found that a reduction in total cholesterol and LDL 
cholesterol with medication in individuals with baseline concentrations of total 
cholesterol and LDL cholesterol below the recommended targets significantly reduced 
cardiovascular mortality, the incidence of non fatal MI and the need for coronary 
revascularisation. 119 
Evidence suggests that exercise only rehabilitation has little impact on blood lipids in 
patients with CHD.1;28 Recently, a meta-analysis28 reported that exercise only 
rehabilitation did not improve total cholesterol, LDL cholesterol, HDL cholesterol and 
triglycerides compared with usual care, although the results were based on only 
three studies. In agreement with these findings, a systematic review reported that 
studies using exercise only rehabilitation documented inconsistent effects on lipid 
levels.1 In contrast, a recent randomised controlled trial61 reported a significant 
decrease in total cholesterol, LDL cholesterol, triglycerides and a significant increase 
in HDL cholesterol after 6 months of moderate- intensity exercise training compared 
to non exercising controls in a group of post PTCA patients. An observational study 
reported that three months of exercise training significantly increased HDL 
cholesterol by 8%, with no effect on the other lipid levels. 121 Patients with abnormal 
lipid levels at baseline demonstrated significant improvements with exercise training. 
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Conversely, comprehensive rehabilitation programmes, which combine dietary 
modification and exercise training, are effective in managing lipids in patients with 
CHD 1;28;47;79;84;89;93;108;122;123 R It f . 28 
. esu s 0 a meta-analysIs found that comprehensive 
rehabilitation substantially decreased total cholesterol and LDL cholesterol 
I 
produced a small significant decrease in triglyceride levels and had no significant 
effect on HDL cholesterol compared to usual care. Similarly, a systematic review1 
reported that the majority of randomised and non-randomised controlled trials of 
comprehensive rehabilitation, which included exercise training, and dietary 
intervention documented significant improvements in total cholesterol, LDL 
cholesterol and triglyceride levels. Whereas, few trials recorded significant increases 
in HDL cholesterol with comprehensive rehabilitation compared to usual care. 
Improvements in lipid levels with comprehensive rehabilitation viewed in several 
studies were influenced by increased use of lipid lowering medication during the 
study period in the intervention group.47;89;93;123 Debusk found that 12 months of 
home-based comprehensive rehabilitation was more effective than usual care in 
reducing total cholesterol and LDL cholesterol, and significantly more intervention 
patients had an LDL cholesterol value below the recommended level at 6 and 12 
months.47 In contrast, there was no significant difference between groups for 
triglyceride or HDL cholesterol levels. However, a substantial proportion of patients 
in the intervention group (83%) had been prescribed lipid-lowering medication during 
the study period compared to the patients receiving usual care (20%). The authors 
attributed most of the reduction in total cholesterol and LDL cholesterol to the 
medication effects. Other trials documenting improved lipid profiles with exercise-
based cardiac rehabilitation have not reported whether changes in lipid lowering 
medication occurred over the study period, although this factor may have 
confounded the results. 55;79;108;122 
The evidence suggests that cardiac rehabilitation exercise training is not 
recommended as a sole intervention for lipid modification because of its inconsistent 
effects on lipid levels. Comprehensive cardiac rehabilitation, which includes dietary 
advice, lipid-lowering therapy and exercise training is the most effective programme 
to produce favourable lipid profiles and reach national lipid targets in patients with 
CHD.9 
Adherence to Exercise-based Cardiac Rehabilitation 
Adherence (or compliance) is the extent to which recommendations (e.g. exercise, 
diet or medication) to patients by health professionals are followed. 1 
Supervised Exercise Programmes 
In the UK, the majority of phase III cardiac rehabilitation programmes involve group 
exercise training for 5 to 13 weeks.s It has been estimated that between 9% to 49% of 
cardiac patients drop out of supervised rehabilitation exercise programmes lasting 12 
weeks or less. 18;43;44 In addition, approximately 40% to 50% of patients dropout of 
longer-term supervised exercise programmes lasting 6 months or longer.1;124-127 These 
dropout rates are similar to attrition rates from exercise programmes in the general 
population. 128 Additionally, Dorn 127 reported that adherence to a 3 year cardiac 
rehabilitation exercise programme declined over time and only a small proportion of 
patients were attending the programme at 3 years. However, a dropout from a 
supervised exercise programme does not necessarily mean that the patient has 
stopped exercising. Oldridge 19 found that 50% of dropouts from a 6-month supervised 
exercise programme continued to exercise regularly. One third of the dropouts stated 
that they discontinued the supervised programme because they felt better and had 
gained what they had wanted from the exercise classes, thus 6 months of supervised 
exercise training was not required for all patients. 
Factors Influencing Adherence to Supervised Exercise Programmes 
A number of demographic, medical and psychosocial variables have been shown to 
influence adherence to supervised cardiac exercise programmes. Factors associated 
with dropout from supervised exercise programmes include having a blue-collar 
occupation,19;129;130 angina,130 a reduced ejection fraction,131 inactive leisure habits,19;129 
. .. 24 I k' 19;129;130 D 127 b d greater socio-economlc deprivation, and current y smo Ing. orn 0 serve 
lower attendance rates at supervised exercise for men with a less favourable CHD risk 
factor profile; such as a current smokers, lower exercise capacity, higher levels of 
cholesterol and triglycerides and a 8MI greater than 25. Common reasons for 
programme dropout or poor attendance at group exercise cited by patients included 
transport problems,18;43 medical problems,43;130 work or domestic commitments, 18;26;43;44 
lack of motivation or interest,26;130 inconvenient timing of programmes26 and beliefs 
that rehabilitation would not be beneficial. 18 Presence of anxiety or depression have 
been shown to be important predictors of non-compliance to cardiac rehabilitation 
. 103'104'131 
exercise programmes. " A large observational study found that depressed 
patients were twice as likely to dropout of cardiac rehabilitation compared to 
d d f 104 non epresse pa lents. Age and gender have not shown any consistent pattern in 
predicting who will adhere. Higher dropout rates and lower adherence rates to cardiac 
rehabilitation have been reported for women compared to men,44;132;133 although these 
findings have been inconsistent. 23;43 Several studies found that age did not influence 
dh t d' h b'I' . 103'104'125'131 127 a erence 0 car lac re a I Itatlon ' , , whereas, Dorn reported that older men 
were more compliant than younger men. Old ridge 130 also found that younger patients 
were more likely to dropout of supervised exercise. 
Maintenance of Physical Activity after Programme Completion 
Several trials have shown a decline in patients' physical activity levels, fitness and 
quality of life following completion of cardiac rehabilitation exercise 
19'20'56'67'79'91'94-96'98 . . . programmes. ' , , , " , Furthermore, the majority of patients do not continue 
to exercise regularly after cessation of supervised exercise training. 20;56;87;94;95 
Factors Influencing Maintenance of Physical activity 
As previously discussed, numerous studies have identified factors that predict 
dropout and adherence in supervised exercise programmes. In contrast, the 
research is limited on the factors that influence maintenance of exercise and 
physical activity following programme completion. Understanding these factors is an 
important step in the development of interventions to improve maintenance of 
physical activity and exercise in the long-term. 
Patients are expected to remain regularly active in the long-term in phase IV after 
completion of phase III exercise programmes. However, the transition from phase III 
to phase IV is a challenging time for cardiac patients as they do not receive the 
support and follow-up from cardiac rehabilitation staff that they received during 
phase 111.2 Instead, they have to maintain physical activity and other health 
behaviours on their own. Membership of cardiac support groups, which offer group 
exercise or attending cardiac maintenance programmes delivered by BACR trained 
exercise leaders may help patients to remain active in this phase, However, these 
exercise opportunities are not available in all areas, Furthermore, many patients 
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would not be able to attend community programmes due to barriers associated with 
supervised exercise training including transportation problems, limited access, and 
work and domestic conflicts. In addition, the effectiveness of phase IV exercise 
programmes to maintain the benefits gained during phase III exercise training 
including exercise capacity and increased physical activity has not been assessed in 
the UK.2 
Improving Maintenance of Physical Activity in Cardiac Rehabilitation 
In the UK, the majority of phase III cardiac rehabilitation programmes involve 
supervised exercise training lasting 6 to 12 weeks. Although supervised exercise is 
important to teach patients to self-monitor their exercise intensity and increase 
patients' confidence for exercise, it is unlikely that participation in a supervised 
exercise programme will facilitate independent exercise after programme completion.2 
This is reflected by the low proportion of patients who continue to engage in regular 
physical activity in the long-term after completion of supervised exercise programmes. 
In addition, high ~ropout rates from supervised exercise programmes is associated 
with barriers such as; the programmes may be inconvenient or may interfere with work 
or domestic commitments, the location may be difficult to access (especially in rural 
areas), and even if accessed, parking or transport may cause problems. It is now 
recognised that this restricted approach to exercise prescription does not meet the 
varied needs and goals of the CHD population. Therefore alternative models to 
traditional exercise-based cardiac rehabilitation have been proposed. 
Studies have found that home-based exercise programmes for low to moderate risk 
patients are as effective as supervised exercise training.41 ;8o;88;179 Other trials have 
reported significant improvements in exercise habits, functional capacity and blood 
lipids with home based comprehensive cardiac rehabilitation compared with usual 
care. 47;79;86;110 Therefore, home exercise programmes may overcome some of the 
barriers associated with supervised exercise and improve exercise adherence. In 
addition, SIGN guidelines on cardiac rehabilitation recommend that participants of 
phase III supervised exercise programmes should also incorporate moderate physical 
activity into their daily lifestyle to produce better adherence to exercise in the long-
term.2 
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In a recent study, Carlson99 compared the effect of a traditional phase III 
programme, involving three supervised exercise sessions a week for 6 months, with 
a modified phase III programme designed to enhance patients' self-efficacy for 
independent exercise. The study found that both interventions produced significant 
and comparable improvements in body weight, exercise capacity, and blood lipids at 
6 months. However, significantly fewer participants dropped out of the modified 
programme (80/0) compared to the traditional programme (24%). In addition, the total 
number of exercise sessions and the mean number of sessions per week were 
significantly higher for patients in the modified programme compared to the 
traditional programme. These results show that encouraging phase III participants to 
exercise independently and enhance their self-efficacy for independent exercise 
improves exercise adherence. The high dropout rates from facility-based exercise 
highlights the importance for developing independent exercise behaviour in cardiac 
patients so that physical activity can be maintained in the long-term. Thompson 180 
recommended that low risk cardiac patients should move rapidly from hospital-based 
exercise training .to unsupervised exercise (when they are able to self-monitor their 
exercise intensity) with regular support from rehabilitation staff to ensure that 
increased exercise levels are carried over from formal rehabilitation programmes. 
The study by Brubaker is the only trial to investigate the efficacy of phase IV 
exercise programmes. 181 This study randomized 31 patients, who had completed a 
12 week phase III supervised exercise programme to either a 9 month phase IV 
home-based maintenance programme or standard care. In addition, a comparison 
group (n = 17) who attended a phase IV supervised maintenance programme after 
completion of phase III were randomly selected. The phase IV home-based 
programme lasted 9 months and included an initial one to one discussion with the 
patient on monitoring of exercise intensity, self-monitoring of daily activity levels, 
problem solving exercise barriers, and regular telephone contact to discuss exercise 
compliance, feedback on exercise levels and to provide support and 
encouragement. Standard care involved advice on continuing with exercise and 
other lifestyle modifications. The comparison group attended a phase IV supervised 
maintenance programme for 9 months, involving supervised exercise training three 
times a week and regular counselling on exercise compliance and modification of 
other risk factors. Exercise capacity, blood lipids, and body composition were 
assessed before and after phase III and at 9 months follow-up. Results revealed 
comparable, significant improvements in these outcomes in all 3 groups on 
completion phase III. In addition, these improvements in blood lipids, exercise 
capacity and body composition achieved in phase III were maintained in all groups at 
9 months follow-up. Thus, although the standard care patients received no further 
intervention in phase IV, they also maintained these changes. However, a number of 
patients stated knowing that they were being reassessed at 12 months motivated 
them maintain lifestyle changes. These findings suggest that a home-based exercise 
programme is just as effective for patients who cannot attend a phase IV supervised 
maintenance exercise programme. The fact that the standard care patients did just 
as well suggests that follow-up testing alone may be sufficient to maintain lifestyle 
changes after phase III. 
SUMMARY OF SECTION ONE 
Overall, there are many physiological and psychological benefits to be gained by 
participating in e~ercise-based cardiac rehabilitation following MI, CABG and PTCA. 
Achieving these benefits depend on good adherence to cardiac rehabilitation 
programmes. In addition, sustaining these benefits and preventing further cardiac 
events requires maintenance of regular physical activity and other lifestyle changes 
in the long-term. However, the evidence suggests that improvements in exercise 
capacity, physical activity and quality of life decline over time following programme 
completion. Many studies have examined the factors affecting dropout and 
adherence to supervised exercise programmes. Whereas, the research is limited on 
the factors that contribute to maintenance of physical activity following programme 
completion. Understanding these factors is an important step in the development of 
interventions to improve maintenance of physical activity and exercise in the long-
term. 
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SECTION TWO 
PHYSICAL ACTIVITY BEHAVIOUR CHANGE 
Theoretical Models of Behaviour Change 
In a recent review, Biddle states that predicting, understanding and explaining 
behaviour should be carried out within a theoretical framework. 134 A number of 
theoretical models of behaviour change have been used to understand adherence to 
exercise and physical activity in the general population. These include; the Health 
Belief Model, Theory of Reasoned Action, Theory of Planned Behaviour, Social 
Cognitive Theory, Decisional Balance, Relapse Prevention Model, and the 
Transtheoretical Model. Several of these models have also been used to understand 
participation in physical activity in cardiac rehabilitation settings. In addition, these 
models have provided a theoretical framework for the development of effective 
interventions to enhance adherence to exercise and physical activity in the general 
population.134 There is little research on effective strategies to improve exercise 
adherence in cardiac rehabilitation settings. 
Health Belief Model 
Oldridge used the Health Belief Model (HBM), which predicts the likelihood of an 
individual taking recommended health action to prevent or control a disease,135 to 
predict compliance and dropout in a 6 month cardiac rehabilitation exercise 
programme.129 Results revealed that the components of the HBM; barriers to exercise, 
benefits of exercise, and susceptibility of disease were not significantly different 
between compliers and dropouts. In contrast, cues to exercise were significantly 
associated with compliance to cardiac rehabilitation. The life threatening nature of 
coronary heart disease may serve as a cue to initiation of exercise behaviour change 
for many patients. Furthermore, the severity of disease threat was significantly 
associated with compliance to the exercise programme, but in the opposite direction to 
that proposed by the HBM. The threat of disea~e was greater for dropouts compared 
to compliers, thus individuals who perceived their condition as more severe were less 
likely to comply with the exercise programme. In general, the study found that the HBM 
was of limited use in predicting compliance to exercise-based cardiac rehabilitation. 
Similarly, Biddle and Mutrie stated that the HBM has been somewhat unsuccessful in 
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predicting adoption and maintenance of physical activity and exercise in a variety of 
I t· 136 Th· popu a Ions. IS may be because many people adopt and adhere to exercise for 
motives other than to prevent or control a disease. 
Theories of Reasoned Action and Planned Behaviour 
The theory of reasoned action (TRA) 137 proposes that behaviour is directly determined 
by an individual's intention to perform a behaviour. Intention is determined by two 
variables: 1) a person's attitude, which is indicated by the person's beliefs about the 
behaviour, as well as the evaluation of the likely outcomes of the behaviour; 2) 
subjective (social) norm, which is the beliefs of significant others (e.g. family, friends or 
health professionals) and the extent to which the individual is motivated to comply with 
such beliefs or people. This theory has been used to predict attendance at exercise-
based cardiac rehabilitation. 22 Cooper found that 72% of cardiac rehabilitation patients 
stated that they intended to participate in cardiac rehabilitation, however the 
attendance rate was only 40%.22 This finding suggests that intention alone may not 
predict future hea.lth behaviour. This may be because even though many people have 
a strong intention to exercise, there are barriers that may interfere with their ability to 
do so. 
The Theory of Planned Behaviour (TPB) 138 extends the TRA by adding the factor of 
perceived behavioural control. Perceived behavioural control is defined as the 
perceived ease or difficulty of performing the behaviour, and takes into account 
barriers that may prevent individuals from performing the behaviour. A recent meta-
analysis has provided support for the utility of the TBP to predict exercise behaviour 
in the general population. 139 Results revealed that attitude towards exercise and 
perceived behavioural control are important determinants of both intention to 
exercise and actual exercise behaviour. In addition, intention to exercise had a 
substantial effect on exercise behaviour, whereas subjective norms had a moderate 
effect on intention, and no effect on behaviour. 
Blanchard140 found that the TPB was useful for understanding exercise adherence 
during an 8-week phase 1/ cardiac rehabilitation exercise programme. This study 
reported that attitude towards exercise, subjective norms and perceived behavioural 
control were significant predictors of exercise intention (i.e. intention to attend 
scheduled exercise sessions). In addition, exercise intention was the sole significant 
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predictor of adherence to the phase II exercise programme, However, as exercise 
intention explained only 12% of the variance in exercise adherence in this study, it 
seems that other factors may explain additional variance in exercise adherence during 
phase II cardiac rehabilitation. This theoretical model has not been used to understand 
exercise adherence after completion of cardiac rehabilitation exercise programmes. 
Social Cognitive Theory 
The Social Cognitive Theory (SCT) proposes that personal (e.g. cognitions, body 
composition, age), environmental (e.g. social support, weather, access to facilities, 
stimulus control) and behavioural (e.g. intensity, and frequency of physical activity) 
factors influence behaviour. 136 An important component of the SCT, social support, 
has been found to influence participation in cardiac rehabilitation. 132;141 A significant 
relationship between exercise adherence and perceived benefits and barriers to 
exercise has been demonstrated in patients with CHD.142-144 Tirrell reported that 
individuals who perceived a greater number of benefits and fewer barriers to exercise 
reported greater adherence to exercise between 6 and 18 months following CABG. 143 
Self-efficacy is defined as an individual's confidence in his or her ability to perform a 
specific behaviour.145 There is a significant positive relationship between self-efficacy 
and compliance to exercise in cardiac rehabilitation settings.95;142 A cross-sectional 
study examined the relationship between exercise self-efficacy and exercise 
adherence in a group of cardiac patients who had completed a 12-week phase II 
supervised exercise programme.95 Questionnaires were used to assess exercise 
behaviour, and two components of self-efficacy; the individual's perceived ability to 
perform daily living activities (e.g. walking, jogging, climbing stairs etc) and the 
individual's perceived ability to continue to exercise regularly over the next 3 months 
despite certain barriers (exercise barriers efficacy). The study found that both 
components of self-efficacy were significantly higher for individuals who continued to 
exercise regularly following programme completion. Results suggest that identifying 
barriers to exercise and influencing sources of self-efficacy to overcome exercise 
barriers could improve maintenance of exercise following completion of supervised 
rehabilitation programmes. 
Overall, it seems that self-efficacy, social support and perceived barriers to exercise 
have important influences on adherence to exercise in cardiac rehabilitation. Similarly, 
these factors are significant determinants of physical activity behaviour in the general 
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population. 128 
Interventions Based on Social Cognitive Theory (SCT) 
General Population 
Interventions based on the SeT have improved adherence to exercise in healthy 
subjects. Strategies such as enhancing social support,146;147 goal setting, 148 decision 
balance-sheet techniques 146;149 and relapse prevention training 147;150 improved 
attendance at exercise programmes and maintenance of exercise following 
programme completion. Decisional balance-based interventions, which involve 
comparing the perceived costs (cons) and benefits (pros) of engaging in a behaviour, 
have been shown to increase attendance at supervised exercise programmes 146 and 
was effective in maintaining attendance at a fitness centre. 149 Providing individuals with 
personalised feedback and praise during exercise and involving individuals in setting 
flexible exercise goals significantly increased attendance at a 10 week exercise 
programme and enhanced maintenance of exercise for three months after termination 
of the exercise programme.148 
Cardiac Rehabilitation 
Several researchers have incorporated strategies based on the SeT into their 
cardiac rehabilitation programmes.47;59;62;79;93;99;151;152 However, some of these 
studies47;59;62;79;93 have used SeT strategies to modify multiple health behaviours, 
thus it is not always clear whether these techniques were applied to exercise in 
cardiac rehabilitation. Carlson99 compared the effect of a traditional phase III 
rehabilitation programme, involving three supervised exercise sessions per week for 
6 months, with a modified phase III programme that was designed to enhance 
patients' self-efficacy for independent exercise. At the start of the modified 
programme, participants attended three supervised exercise sessions a week, 
however the frequency of supervised sessions was gradually reduced to one 
supervised session every two weeks at 6 months to facilitate independent exercise. 
Participants of both programmes were encouraged to exercise for 30 minutes five 
times per week (either supervised or independently). At 6 months, both interventions 
produced significant and comparable improvements in body weight, exercise 
capacity, and blood lipids. However, adherence to the exercise recommendations 
(Le. 5 x 30-minute sessions/week) was significantly greater for modified programme 
participants compared to participants of the traditional programme. These results 
52 
suggest that enhancing a participant's self-efficacy for independent exercise 
improves exercise adherence in phase III. It would have been interesting to assess 
exercise behaviour during phase IV to determine whether the modified phase III 
programme was superior to traditional rehabilitation for improving maintenance of 
exercise after phase III. 
Debusk47 reported a significant improvement in exercise capacity after a six-month 
home-based rehabilitation programme, which used SCT techniques to modify CHD 
risk factors (e.g. smoking, diet and exercise). The strategies used were self-
monitoring, feedback, goal setting, relapse prevention training, problem-solving 
barriers, behavioural contracting and social support. However, as physical activity 
and exercise capacity were not assessed in the long-term after programme 
completion, it is not possible to tell if this programme was effective in maintaining 
changes in activity and fitness. Lisspers62 reported that a 12-month rehabilitation 
programme following PTCA, which used health education and behavioural strategies 
derived from SC"'f to modify CHD risk factors was more effective than usual care in 
improving exercise capacity and exercise habits at 12 months. Furthermore, these 
improvements in fitness and exercise participation were maintained 12 months after 
the end of the intervention period.63 In contrast, other studies have shown that short-
term comprehensive programmes based on the SCT had no lasting effect on 
physical activity habits at 12 months.59;79 
Relapse Prevention Model 
Relapse is a breakdown or set back in a person's attempt to change or modify a target 
behaviour. The relapse prevention model was developed to treat addictive behaviours 
such as alcoholism and smoking.153 The model proposes that relapse may result from 
an individual's inability to cope with situations that pose a risk of return to the previous 
behaviour. For example, a former smoker finds himself or herself in a social situation 
with lots of smokers. Thus, helping the individual to acquire strategies to cope with 
high-risk situations will both reduce the risk of an initial lapse, and prevent any lapse 
from escalating into a total relapse. Simkin 154 assessed coping responses to high risk 
situations for exercise relapse (e.g. negative mood, boredom, lack of time) in 29 
healthy women who had adopted exercise without formal intervention. The womens' 
activity levels were measured weekly for 14 weeks. The study found that 66% of 
participants experienced a lapse (defined as not exercising for 1 week) and 41 % 
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experienced a relapse (defined a not exercising for 3 or more consecutive weeks) over 
the 14 monitored weeks. Participants who experienced a relapse reported significantly 
fewer behavioural and cognitive strategies to cope with high-risk situations compared 
to participants who did not relapse. These findings suggest that acquiring effective 
strategies to cope with exercise barriers may prevent relapse. 
The relapse prevention model has been used to improve exercise adherence in the 
I I t· 147;150;155 B I' genera popu a Ion. e Isle reported that relapse prevention training increased 
attendance at a ten week exercise programme and improved maintenance of exercise 
for 12 weeks following programme completion.150 King 155 evaluated the effect of self-
monitoring and relapse prevention techniques on maintenance of physical activity for 6 
months in a group of healthy subjects who had completed a six month programme of 
moderate intensity home-based exercise. Fifty-one subjects were randomised to 
receive strategies for maintaining exercise adherence, including daily self-monitoring 
of activity and relapse prevention or a comparison group who underwent weekly self-
monitoring of activity. The results revealed that the intervention group engaged in 
significantly more exercise sessions over the 6-month period compared to the 
comparison group. Therefore, daily self-monitoring of activity levels and relapse 
prevention training improved exercise adherence. 
The research suggests that relapse prevention training is an effective strategy for 
improving exercise adherence in the general population. Despite the high dropout 
rates from cardiac rehabilitation exercise programmes and poor long-term 
maintenance of physical activity following programme completion, there is limited 
research on the effect of relapse prevention training on exercise adherence in cardiac 
rehabilitation settings. Relapse prevention training 154 involves teaching individuals that 
a lapse from exercising (e.g. missing an exercise session) need not lead to a relapse 
(e.g. missing a week without exercising) and a lapse can be prevented from escalating 
into a complete relapse (e.g. return to a sedentary lifestyle). The individual is 
encouraged to identify situations that are likely to lead to a lapse. Potential high-risk 
situations relevant to exercise include bad weather, an increase in work commitments, 
change in routine, injury or illness. Individuals are encouraged to develop a plan to 
cope with these high risk situations; for example the plan for coping with bad weather 
could be using exercise video tapes, increased work commitments could be overcome 
by rescheduling an activity session or engaging in a shorter bout of activity. Such 
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coping is believed to prevent escalation of a lapse into a relapse. 
Transtheoretical Model (TTM) 
The Transtheoretical Model (TIM) proposes that individuals attempting to change their 
physical activity behaviour progress through five stages of change. 156 The stages differ 
according to an individual's intention and behaviour, and have been labelled; 
Precontemplation (inactive and no intention to change), Contemplation (inactive, but 
intending to change in the next 6 months), Preparation (engaging in some activity, but 
not regularly), Action (regularly physically active, but only began in the past 6 months), 
Maintenance (regularly active for more than six months). Thus, according to this 
model, maintenance of physical activity is defined as being regularly active for at least 
6 months. Movement through these stages often occurs in a cyclic pattern because 
many individuals relapse back to an earlier stage when attempting behaviour change. 
In fact, many individuals progress and regress through the stages of change several 
times before reaching maintenance. Action is an unstable stage during which 
individuals are at high risk of relapse. 
Studies have reported an increase in self-reported physical activity and 
cardiorespiratory fitness with advancing stage of change in healthy adults and cardiac 
rehabilitation participants.96;144;157-159 A recent meta-analysis found an increase in 
physical activity as individuals moved to a higher stage of change. 159 The largest 
increase in physical activity occurred as subjects moved from preparation to action, 
this is the point at which individuals engage in regular physical activity. 
Three components of the TIM are hypothesised to mediate the behaviour change 
process. These are the processes of change, the decisional balance and self-efficacy. 
The processes of change are strategies that people use when changing their exercise 
behaviour. 16o There are ten processes, which have been grouped into five experiential 
and five behavioural processes and a description of each is provided in Table 6. In 
1992, Marcus developed a questionnaire to measure the use of each process of 
change for individuals who were in different stages of change for exercise 
behaviour. 16o 
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Table 6: Processes of Exercise Behaviour Change 160 
Process of Change Definition 
Experiential 
Consciousness raising Efforts by the individual to seek information and gain 
understanding and feedback about physical activity (e.g. 
reading articles about exercise to learn more on it). 
Dramatic relief Emotional experiences related to physical inactivity and its 
consequences (e.g. warnings about the health hazards of 
inactivity emotionally affect the person). 
Environmental 
reevaluation 
Self-reevaluation 
Social liberation 
Behavioural 
Counterconditioning 
Helping relationships 
Reinforcement 
management 
Self-liberation 
Stimulus control 
Evaluation by the individual of how inactivity affects the 
physical and social environment (e.g. the person wonders 
how their inactivity affects others). 
Emotional and cognitive reevaluation by the individual of the 
values of physical activity (e.g. what are the benefits of 
physical activity to me?). 
The individual's awareness, availability and acceptance of 
physical activity in society (e.g. awareness of changes in 
society that make it easier for the exerciser). 
Substituting situations of inactivity for physical activity (e.g. 
taking the stairs instead of the lift). 
Trusting and using the support of others during attempts to 
change physical activity behaviour (e.g. having a friend who 
encourages the person to exercise). 
Changing the contingencies that control or maintain 
inactivity (e.g. the person rewards himself or herself when 
they exercise). 
The individual's commitment to physical activity (e.g. the 
individual makes commitments to exercise). 
Control of situations that trigger inactivity (e.g. individual 
removes things that contribute to inactivity). 
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A recent meta-analysis 159 found that use of the processes of change vary across the 
five stages of change, as depicted in Figure 1. The use of experiential and behavioural 
processes increases with advancing stage, with the largest increase occurring from 
precontemplation to contemplation and preparation to action. Furthermore, the use of 
behavioural processes is more important than experiential processes from the 
contemplation stage onwards. There is little change in process use from the action to 
maintenance stages, implying that maintenance of physical activity does not require 
further changes in experiential and behavioural strategies, or that individuals use 
additional strategies to those proposed by the processes of change. Similarly, an 
observational study of patients who had previously attended a cardiac rehabilitation 
programme found that the experiential and behavioural processes were used more 
frequently with advancing stage of exercise behaviour change. 144 In contrast, Jue 
reported no significant difference in process use among the five stages of exercise 
behaviour change in a group of elderly patients after CABG. 161 However, the process 
of change questionnaire was developed for a younger, working population, and 
therefore may not be valid for an elderly, retired population. 
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Figure 1 Relationship between the stages and processes of exercise 
behaviour change 159 
PC = Precontempl~tion, C = Contemplation, P = Preparation, A = Action, M = 
Maintenance. 
A longitudinal study measured changes in the stages and processes of change for 
exercise behaviour from baseline to 6 months in a group of healthy subjects. 162 At 6 
months, subjects were categorised into four groups; stable sedentary (remained in 
either precontemplation or contemplation at both assessments), stable active 
(remained in preparation, action or maintenance at both assessments), adopters 
(progression from precontemplation, or contemplation to preparation, action or 
maintenance), and relapsers (regression from preparation, action or maintenance to 
either contemplation or precontemplation). This study found that process use did not 
change for subjects in the stable active or stable sedentary categories. However 
process use was significantly greater for subjects who remained active compared to 
those who stayed inactive over the study period. Subjects in the adoption group 
reported a significant increase in the use of experiential and behavioural processes, 
whereas those in the relapse group reported a significant decline in the use of all 
behavioural processes and 1 experiential process (dramatic relief) . These findings 
suggest that continued use of behavioural strategies may be important to prevent 
relapse. Furthermore, a significant decline in dramatic relief among relapsers suggests 
that belief in the health benefits of physical activity may decrease considerably when 
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individuals are no longer physically active or that inactivity is no longer seen as an 
emotional issue. 
Decisional balance involves a comparison of the perceived costs (cons) and benefits 
(pros) of engaging in a behaviour. As previously described, studies have demonstrated 
a significant relationship between exercise adherence and perceived benefits and 
barriers to exercise in patients with CHD.142-144 Decisional balance is also related to the 
t f . b h' h 144'159'163'164 159 sage 0 exercise e aVlour c ange. ' , , The meta-analysis reported that the 
pros of exercise increase with advancing stage of change, with the largest increase 
evident from the precontemplation to the contemplation stage (see Figure 2). The 
perceived cons of change decreased across the stages, with the most pronounced 
decline occurring from precontemplation to contemplation. Therefore, it seems that 
increasing the pros of exercise and decreasing the cons to exercise are important to 
enhance behaviour change. Similarly, Hellman reported a decline in the perceived 
barriers to exercise and an increase in the perceived benefits of exercise with 
advancing stage of change in a group of patients who had previously attended in-
patient cardiac rehabilitation.144 
Self-efficacy was integrated into the TIM from Bandura's Self-Efficacy Theory,145 and 
is defined as an individual's confidence in his or her ability to perform a specific 
behaviour. As previously discussed, self-efficacy is an important determinant of 
exercise compliance in cardiac rehabilitation. 95;142 Findings from a recent meta-
analysis demonstrated a significant relationship between exercise self-efficacy and 
stage of change, as illustrated in Figure 3. The graph shows that exercise self-efficacy 
increases with each forward movement in stage of change. Individuals in the 
precontemplation stage demonstrate the lowest self-efficacy, whereas those in 
maintenance have the highest self-efficacy. Furthermore, the relationship between 
exercise self-efficacy and stage of change is nonlinear, and self-efficacy seems to be 
especially important when moving from action to maintenance. Similarly, Hellman 144 
reported that exercise self-efficacy is significantly related to stage of exercise 
behaviour change in cardiac rehabilitation participants. 
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behaviour change.159 
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change.159 
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Application of the Transtheoretical Model 
Cardiac Rehabilitation 
Recently, Bock
96 
measured the components of the TIM and physical activity by self-
report in 62 cardiac patients at the beginning and end of a 12 week phase II 
supervised exercise programme and at three months follow up. At the beginning of 
phase II, 43% of participants were in the action and maintenance stages (i.e. 
accumulating a weekly minimum of 30 minutes of moderate activity on most days). At 
the end of the programme, 96% of participants were in the action and maintenance 
stages and self-reported physical activity had significantly increased. Moreover, there 
were significant increases in exercise self-efficacy, the use of behavioural processes, 
and a significant reduction in the perceived barriers to exercise, with no change in the 
use of experiential processes or perceived benefits of exercise. Three months after 
programme completion, the proportion of patients in the action and maintenance 
stages had decreased to 80% and nearly 50% of participants had reduced their 
physical activity compared to the end of the programme. Individuals who had 
regressed at the ~ month follow-up had significantly lower scores for self-efficacy, use 
of behavioural processes, and more negative decisional balance scores at the end of 
the programme compared to participants who remained physically active at 3 months. 
Thus, maintenance of exercise behaviour after completion of a cardiac rehabilitation 
exercise programme appears to be associated with changes in self-efficacy, decisional 
balance and behavioural processes. The findings suggest that enhancing these 
components of the TIM may promote maintenance of physical activity after 
programme completion. However, there is limited research investigating the effect of 
interventions based on this model to improve maintenance of physical activity in 
cardiac rehabilitation. 
General Population 
Interventions based on the TIM have been shown to be effective in improving 
adoption and maintenance of physical activity In the general 
population. 60;74;77;165;166;166;167;167;168;168 These Interventions use the concept of matching 
treatment to the individual's stage of change for exercise behaviour. Marcus 
randomised 194 sedentary adults to receive either an individualised, stage-matched 
intervention or a standard intervention over a 6-month period. 167 The stage-matched 
intervention involved providing participants with individualised feedback about their 
physical activity behaviour and stage-matched self-help manuals, which were designed 
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to enhance the components of the TIM. The standard intervention involved providing 
participants with standard self-help booklets to promote physical activity, developed by 
the American Heart Association. A significantly greater proportion of participants in the 
stage-matched group were regularly active and had reached the action stage 
compared to individuals receiving standard treatment at 6 months. In addition self-, 
reported physical activity had increased significantly more in the stage-matched group 
compared to the standard group at 6 months. In a follow-up to this study, a 
significantly greater proportion of participants who had received the stage-matched 
intervention were regularly active and were in the action or maintenance stages 6 
months after the intervention period compared to subjects who received the standard 
intervention.168 These findings suggest that an intervention tailored to an individual's 
stage of exercise behaviour change was more effective than a standard intervention in 
improving adoption and maintenance of physical activity in a group of sedentary 
healthy adults. 
In summary, the transtheoretical model proposes that by identifying an individual's 
stage of exercise behaviour change, key components such as the processes of 
change, exercise self-efficacy and decisional balance can be influenced to encourage 
stage progression and relapse prevention. For example, maintaining physical activity 
and preventing relapse may require continued use of behavioural processes and 
enhancing self-efficacy. 
Overall, several theories have been used to understand and explain adherence to 
exercise in healthy subjects and in cardiac rehabilitation settings. These theories have 
identified a number of factors influencing participation in physical activity including: 
social support, exercise self-efficacy, perceived behavioural control, perceived benefits 
of exercise, perceived barriers to exercise, ability to cope with high risk situations, and 
use of cognitive and behavioural processes. In addition, the evidence suggests that 
interventions based on theoretical models of behaviour change such as social 
cognitive theory, the relapse prevention model and the transtheoretical model are 
effective in increasing and maintaining physical activity in the general population. 
Effective compliance enhancing strategies include; goal setting, decision balance 
sheets, enhancing exercise self-efficacy and social support, self-monitoring, written 
agreements, relapse prevention training, and enhancing the use of cognitive and 
behavioural processes. In contrast, there is little research on the effect of theory-based 
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interventions to encourage maintenance of physical activity after completion of formal 
cardiac rehabilitation. 
Physical Activity Counselling 
Recent cardiac rehabilitation guidelines9 by the American Heart Association and the 
American Association of Cardiovascular and Pulmonary Rehabilitation recommend 
that physical activity counseling should be a core component of cardiac rehabilitation 
programmes to promote an active lifestyle for patients with CHD. Physical activity 
counselling should include an evaluation of the individual's current physical activity 
level, stage of change, self-efficacy, barriers to increasing physical activity and social 
support in making positive changes. Interventions should include providing support, 
advice and counselling about physical activity needs, and set goals to increase 
physical activity that include 30 minutes per day of moderate physical activity on ~5 
days a week. In addition, patients' daily schedules should be explored in order to 
suggest how to incorporate physical activity into their daily routine; e.g. parking 
farther away from. entrances, walking up 2 or more flights of stairs and walking for 15 
minutes during lunch breaks. 
Physical activity counselling is based on the transtheoretical model of behaviour 
change and social cognitive theory. In addition, this approach is closely linked with the 
1995 physical activity recommendations of accumulating 30 minutes of moderate 
intensity physical activity on most days of the week. Thus, these interventions use 
stage-matched strategies to encourage participants to integrate moderate intensity 
physical activity into their daily lives. Physical activity counselling has produced 
improvements in stage of exercise behaviour change and physical activity levels in 
initially sedentary healthy adults.169-173 
Exercise Consultation 
In 1995, Loughlan and Mutrie 174 developed a set of guidelines on exercise 
counselling of sedentary adults. This intervention, known as the exercise 
consultation is a client-centred one to one counselling approach. It is based on the , 
transtheoretical model and social cognitive theory and comprises strategies to 
increase and maintain physical activity. Several randomised-controlled trials have 
investigated the effect of the exercise consultation on physical activity adoption and 
adherence. Loughlan and Mutrie 175 showed that the exercise consultation was as 
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effective as standard fitness assessments in increasing physical activity at 3 months. 
Though these initial increases in activity were not maintained at 6 months in the 
fitness assessment group, the exercise consultation group were significantly more 
active at 6 months compared to baseline. In a similar study, Lowther and Mutrie 
reported that participants who had received an exercise consultation remained more 
active compared to participants receiving the fitness assessment, who had 
regressed to baseline values at 1-year fo"ow_up.176 Kirk et al found in a group of 
sedentary people with type 2 diabetes that an exercise consultation significantly 
increased physical activity assessed by self-report and accelerometry from baseline 
to six months compared to standard exercise information. 177 In addition, these 
improvements were maintained from six to 12 months in the exercise consultation 
group. Results from these trials suggest that the exercise consultation may be a 
successful intervention for long-term maintenance of physical activity.17s;176 
The exercise consultation intervention was initially aimed at sedentary individuals, 
however recently strategies to prevent relapse were incorporated into the 
consultation procedure to enhance maintenance of physical activity. A pilot study178 
demonstrated that the exercise consultation significantly improved short-term 
exercise adherence during phase IV cardiac rehabilitation in a group of patients who 
had completed a phase "I supervised exercise programme. 
SUMMARY OF SECTION TWO 
In summary, theoretical models of behaviour change have identified a number of 
factors that influence participation in physical activity in the general population and 
cardiac rehabilitation settings. Furthermore, interventions based on theoretical models 
such as the TIM, SCT and relapse prevention are effective in increasing and 
maintaining physical activity. Current traditional phase III rehabilitation programmes do 
not facilitate independent exercise after programme completion. However, the 
research is limited on effective interventions to encourage long-term maintenance of 
physical activity after completion of cardiac rehabilitation exercise programmes. 
Physical activity counselling and exercise consultation, based on the TIM, SCT and 
relapse prevention training, use evidence-based strategies to increase and maintain 
physical activity. In addition, these intervention are closely linked to the 1995 physical 
activity guidelines, thus encourage individuals to integrate moderate intensity activity 
into their daily lives, which may overcome the many barriers associated with 
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supervised exercise programmes. A pilot study found that the exercise consultation 
improved short-term maintenance of physical activity following completion of a phase 
III exercise programme. 178 However, the long-term effect of the exercise consultation 
on maintenance of physical activity after programme completion has not been studied. 
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SECTION THREE 
MEASUREMENT OF PHYSICAL ACTIVITY 
The primary aim of this study is to evaluate the effect of an exercise consultation on 
maintenance of physical activity following completion of a phase III cardiac 
rehabilitation exercise programme. Therefore, to detect changes in this variable it is 
important to accurately measure physical activity. This section reviews the methods 
that have been commonly used to measure physical activity. This review was then 
used to select the most appropriate methods to measure these outcomes based on 
the requirements of the study. 
Components of Physical Activity 
Physical activity is a complex, multidimensional behaviour, which is difficult to 
measure. Physical activity has been defined as "any bodily movement produced 
skeletal muscles that results in energy expenditure.,,182 Therefore, physical activity can 
be quantified by measuring energy expenditure, either directly (e.g. using doubly 
labelled water) or indirectly (e.g. measuring bodily movement using motion sensors). 
Physical activity has three dimensions; frequency, intensity (light, moderate or 
vigorous) and duration, which are associated with health and fitness.? Physical activity 
can be performed in a number of different settings including leisure-time, housework, 
and occupation. 182 Although exercise is often used interchangeably with physical 
activity, it is actually a subcategory of physical activity. Exercise is physical activity, 
which is planned, structured and undertaken to improve or maintain one or more 
components of physical fitness. Physical fitness has been defined as a set of attributes 
(e.g. cardiorespiratory fitness, muscle strength and flexibility) that people have or 
achieve that relates to the ability to perform physical activity. Although, more active 
people tend to be fitter, physical fitness and the ability to improve fitness with training 
have a sizeable hereditary component and are affected by gender, ageing and habits 
other than physical activity.183 Therefore, measuring fitness to quantify an individual's 
physical activity has its limitations. Overall, physical activity involves various 
components, most or all of which may need to be recorded to accurately quantify an 
individual's physical activity behaviour. Accurate measurement of physical activity is 
required to determine the proportion of a study population meeting current physical 
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activity recommendations6;8 and to examine the effectiveness of physical activity 
interventions. 
Methods to Measure Physical Activity 
There are numerous methods available to measure physical activity, making it difficult 
for researchers to select the most appropriate method(s). Physical activity measures 
can be divided into subjective (e.g. recall questionnaires, and activity diaries) and 
objective methods (e.g., doubly labelled water, indirect calorimetry, pedometers, 
accelerometers and heart rate monitoring). The method selected to measure physical 
activity in intervention studies needs to be valid, reliable, and responsive to change, 
without influencing an individual's behaviour. 
Validity is the extent to which a method measures what it is designed to measure. 184 
Testing the validity of a method involves comparing it with another physical activity 
measure, known as the criterion method. In addition, the method has to demonstrate 
good reliability.184 A reliable method consistently provides the same results under the 
same conditions. Reliability of a method can be tested by repeatedly measuring a 
physical activity bout on the same subjects, this is known as test-retest reliability. High 
reliability is important in intervention studies to ensure that changes in physical activity 
are caused by the intervention, and not because of variation in activity scores due to 
low reliability.185 Finally, to obtain a good estimate of an individual's physical activity 
habits, a minimum of 5 or 6 days of recordings are required. 186 This is because 
physical activity varies from day to day, and measuring physical activity over several 
days reduces this variability. Furthermore, if the study population includes subjects that 
are working, then both week and weekend days must be sampled.186 
A number of methods can be used to measure physical activity, which are discussed 
below. 
Indirect Calorimetry 
I ndirect calorimetry estimates energy expenditure by directly measuring oxygen uptake 
(V02) and carbon dioxide production (VC02).183 This method can be conducted in two 
ways; using a whole room calorimeter or a metabolic cart. Whole room indirect 
calorimeter is an airtight room, which is usually equipped with a desk, chair, toilet, sink, 
TV, a bed and a stationary bike etc. Oxygen uptake and carbon dioxide production are 
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measured from expired gas and used to calculate energy expenditure. A whole room 
calorimetry accurately measures energy expenditure,187 however these rooms are 
expensive to build and operate, they are confining, and some types of activity cannot 
be performed, such as gardening or sports. Thus, whole room calorimeters cannot be 
used to measure physical activity habits under free living conditions. 
Energy expenditure can also be estimated by measuring oxygen uptake and carbon 
dioxide production in expired air using a metabolic cart. 183 With this procedure, the 
subject wears a face mask or nose clip and mouthpiece. Stationary metabolic carts are 
used in the laboratory to estimate energy expenditure at rest, during treadmill or cycle 
exercise, and other laboratory-based activities. Portable metabolic carts can be used 
to estimate the energy cost of field-based activities. However, portable systems cannot 
be used to measure habitual physical activity in free-living conditions due to the 
limitations of the equipment. 
Doubly Labelled Water (DLW) 
Doubly labelled water (DLW) can be used to measure total energy expenditure (TEE) 
for 1 to 3 weeks under free living conditions. 188 DLW consists of the stable isotopes of 
water 2H20 and H2180, which is ingested by the subject as a liquid. Elimination of these 
isotopes in water (e.g. urine, sweat or saliva) and CO2 is analysed using mass 
spectrometry over several days, and energy expenditure and oxygen uptake can be 
estimated from CO2 production using established equations. Physical activity related 
energy expenditure is calculated by subtracting the resting metabolic rate and the 
thermic effect of food from total energy expenditure. The DLW method accurately 
measures energy expenditure, therefore it is considered to be the "gold standard" for 
measuring energy expenditure under free-living conditions. 188 However, this method 
has limited applicability for measurement of physical activity in intervention studies and 
epidemiology based trials of large populations because the stable isotope of water is 
expensive, and the analysis of samples using the mass spectrometer is costly and 
complex. Moreover, as DLW measures energy expenditure, it does not provide 
information on physical activity patterns (i.e. intensity, duration or frequency). However, 
DLW has been used to validate other instruments because it accurately measures 
energy expenditure. 
Overall, indirect calorimetry and doubly labelled water are frequently used as criterion 
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methods to validate other physical activity measures, such as motion sensors 
, 
questionnaires and heart rate monitors. 
Motion Sensors 
Motion sensors, such as pedometers and accelerometers are devices that measure 
physical activity by detecting motion or acceleration of a limb or trunk, depending on 
the placement of the monitor on the body.189 
Accelerometers 
When a person moves, the limbs and body are accelerated, theoretically in proportion 
to the muscular forces responsible for the accelerations and thus to energy 
expenditure. 189 Portable accelerometers measure these accelerations caused by bodily 
movement in either one (uniaxial) or three (triaxial) directions. A number of 
accelerometers, varying in size, cost and weight are commercially available, such as 
the Caltrac, Computer Science and Applications and the Tritrac. Accelerometers 
record activity counts, which are the product of the frequency and intensity of 
movement, sampled at set intervals. They have a large memory capacity, thus are 
able to store minute by minute data for several weeks. In addition, the accelerometer 
recordings can be used to estimate oxygen uptake, energy expenditure, and the time 
spent engaging in light, moderate and vigorous physical activity using established 
regression equations. 
Uniaxial accelerometers 
Uniaxial accelerometers detect bodily accelerations in the vertical (z) direction, and 
have been widely used in research to assess physical activity.190 The Computer 
Science and Applications (CSA) is a uniaxial accelerometer, which has been frequently 
used in physical activity studies due to its small size, lightweight, ease of use, 
durability, large memory capacity and can be worn on the ankle, wrist or waist. Studies 
have found that the CSA accelerometer is very reliable for measuring physical activity. 
Melanson assessed the test-retest reliability (r=0.93 to 0.99) of the CSA accelerometer 
worn on the waist, ankle and wrist by colleding CSA recordings during treadmill 
walking and jogging on two separate occasions in a group of healthy subjects. High 
correlation coefficients, ranging from 0.93 to 0.99 between CSA recordings collected 
during repeat testing were reported in this study. In addition, no significant differences 
were observed between CSA activity counts recorded during repeat testing of field-
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based activities. 191 Fairweather tested the inter-instrument reliability of the CSA 
accelerometer by attaching CSAs to a mechanical accelerometry system, which 
simulated body movement. A minimal difference (3%) was observed between CSA 
accelerometers attached to this system. 192 
The validity of the CSA accelerometers to measure physical activity and estimate 
energy expenditure has been studied under laboratory conditions in adults and 
h'ld 193-195 M I 193 .. C I reno e anson assessed the validity of the CSA accelerometer worn at all 
three attachment sites against direct measurement of V02 during treadmill walking and 
jogging in a group of young adults. The study found a significant increase in activity 
counts from the monitors attached to all sites with increaSing treadmill speed. 
Furthermore, significant linear correlations (r > 0.80) were observed between activity 
counts and measured V02 and energy expenditure during walking and jogging. In 
contrast, there was no significant relationship between activity counts and measured 
V02 or energy expenditure for changes in the gradient of the treadmill at a constant 
speed. Therefore, the CSA accelerometer detected changes in treadmill speed but not 
gradient. Other studies have demonstrated that the CSA accelerometer is a valid 
instrument for estimating energy expenditure during treadmill walking and jogging 
under controlled laboratory conditions. 190;193-195 Freedson developed a regression 
equation to estimate energy expenditure from activity counts recorded during treadmill 
walking and jogging in a group of young adults. 195 The study found no significant 
difference between estimated and measured energy expenditure during treadmill 
exercise. Similarly, Trost found that the CSA accurately estimated energy expenditure 
during treadmill exercise in a group of children. 194 
The validity of the CSA to measure physical activity and estimate energy expenditure 
has also been examined in field settings. 191 ;196-199 Hendleman 191 reported a significant 
correlation (r = 0.77) between accelerometer recordings and oxygen uptake measured 
by indirect calorimetry during overground walking at a range of self-paced speeds. 
These accelerometer recordings measured during overground walking were used to 
develop individual regression equations to estimate oxygen uptake. These equations 
were used to estimate V02 from activity counts recorded during golf, washing 
windows, vacuuming, lawn mowing, dusting and planting shrubs. The V02 estimated 
from activity counts was significantly lower than measured V02 for all activities. The 
difference between measured and predicted V02 ranged from 30.5% for golf to 56.4% 
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for planting shrubs. Other studies have found that the CSA significantly overestimated 
the energy cost (METs) of walking 196 and significantly underestimated the metabolic 
cost of leisure, recreational and household activities. 191 ;196;197 
The CSA has been compared with DLW to measure total and physical activity related 
d't 198;199 L 198 
energy expen lure. eenders found that total daily energy expenditure 
estimated from CSA recordings was significantly lower by 59%, compared to energy 
expenditure measured using the DLW method in a group of 13 healthy women. 
Furthermore, a modest correlation (r = 0.45) between measured energy expenditure 
and activity counts was reported. In contrast, Ekelund199 documented that the CSA 
accurately estimated total and physical activity related energy expenditure in a group 
of children. However, a significant proportion (40% to 55%) of the variation in energy 
expenditure was not explained by activity counts. 199 
In summary, strong linear correlations have been observed between activity counts 
collected at the t~ree attachment sites and measured V02 and energy expenditure 
during level walking and jogging on a treadmill and overground walking.193-195 However, 
poor to modest correlations have been observed between activity counts and 
measured V02 and energy expenditure during uphill walking on a treadmill and field-
based activities. 191 ;196 Furthermore, the CSA accelerometers substantially 
underestimated the energy cost of household, gardening and leisure activities and 
d· d f I" d't' 191'196-198 energy expen Iture un er ree- Ivmg con I Ions. ' 
Triaxial accelerometers 
Human movement is multi-directional, thus measuring accelerations in three planes 
may provide a more accurate assessment of physical activity and energy expenditure 
compared to measuring movement in one direction.189 The Tritrac is the most 
commonly used triaxial accelerometer and measures accelerations in the anterior-
posterior (x), medio-Iateral (y), and vertical (z) direction. The test-retest reliability of the 
200' . . 200-203 t . 202 Tritrac has been demonstrated at rest, dUring treadmill exerCise, s epping, 
and stationary cycling.202 However, a study assessing the inter-instrument reliability of 
the Tritrac, found a 220/0 difference in activity counts between two monitors during 
treadmill walking. 204 
Similar to the CSA, the Tritrac is able to detect changes in treadmill speed,201;205 but 
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not gradient. 201 ;206 Studies . h assessing t e validity of the Tritrac to estimate energy 
expenditure during laboratory-based activities have reported inconsistent 
f d' 201'202'205'206 207 In Ings. ' , , Sherman found that compared to measured energy expenditure, 
the Tritrac accurately estimated energy expenditure at rest and during treadmill 
exercise at 3 different speeds at 0% gradient in a group of young adults, In contrast 
, 
other researchers observed that the Tritrac Significantly overestimated energy 
expenditure during treadmill walking at 0% gradient,201;202 and significantly 
underestimated energy expenditure during treadmill walking at an incline, stepping, 
t t· I' d I' . 201'202'206 S a lonary cyc lng, an s Ideboardlng. ' , These conflicting findings indicate that 
estimating energy expenditure with the Tritrac may depend upon the activity 
performed, or the placement of the Tritrac; on the hip201;202 compared to the lower 
back.205 
Chen 187 evaluated the validity of the Tritrac to estimate energy expenditure using a 
whole room calorimeter, thus simulating conditions that were close to free living. 
Compared to measured energy expenditure, the Tritrac significantly underestimated 
total and physical activity energy expenditure. The Tritrac manufacturer's prediction 
equation was used to estimate energy expenditure from accelerometer recordings, 
However, Chen discovered that the estimations of total and physical activity energy 
expenditure were significantly improved when their own prediction equation was used. 
The investigators concluded that the inaccurate estimates of energy expenditure from 
the Tritrac were due to the equation used to predict energy expenditure. 
The validity of the Tritrac to measure physical activity and estimate energy expenditure 
has been tested in under free-living conditions. 191 ;198 Compared to DLW, the Tritrac 
significantly underestimate energy expenditure by 35%.198 Furthermore, only a modest 
correlation was found between measured energy expenditure and Tritrac recordings (r 
= 0.54). Similarly, Hendelman 191 reported that the Tritrac significantly underestimated 
the energy cost of various household and leisure activities, The difference between 
measured and predicted METs ranged from 32.1 % for golf to 53.1 % for planting 
shrubs. 
Limitations of accelerometers 
There are limitations of accelerometers for measuring physical activity. Firstly, these 
devices are designed to measure acceleration during bodily movement, thus static 
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work such as lifting objects cannot be accurately quantified by accelerometers, In 
addition, activities that increase energy expenditure without a proportional increase in 
bodily acceleration such as walking uphill will not be detected by accelerometers,193 
These instruments cannot be worn in water, thus will not be able to record swimming 
or other water activities. Additionally, accelerometers may not record upper body 
movement, unless they are worn on the wrist. Overall, as accelerometers cannot 
detect all types of physical activity, they will be unable to accurately estimate energy 
expenditure in free-living conditions. Additionally, the inaccurate estimations of oxygen 
uptake and energy expenditure from accelerometers may be due to the equations 
used to predict these parameters from accelerometer recordings. The equations were 
developed from accelerometer readings and oxygen uptake recorded during walking 
and jogging under controlled laboratory conditions. However, the relationship between 
activity counts and oxygen uptake under laboratory conditions differs from the 
relationship in field settings. For example, a lower correlation between oxygen uptake 
and activity counts was observed for overground walking compared to treadmill 
walking. 191 Furthermore, the relationship between accelerometer counts and oxygen 
uptake or energy expenditure may be specific to a given type of activity. For example, 
a stronger relationship between activity counts and V02 was observed for walking 193-195 
d th t· 't' ( d' d h k) 191'196'198 I dd't' compare to 0 er ac IVIles e.g. gar emng an ousewor.'" n a lion, 
Hendelman 191 found that the GSA and Tritrac did not accurately estimate the energy 
cost of various household, gardening and leisure activities using regression equations 
developed during overground walking. Thus, researchers have recommended using 
the raw output from accelerometers (i.e. activity counts) to quantify physical activity 
rather than converting the accelerometer readings to energy expenditure. 
Comparison of the CSA and the Tritrac 
It has been proposed that measurement of bodily movement in 3 directions is better 
than measuring acceleration in one direction. Therefore, studies have compared 
triaxial and uniaxial accelerometers to determine whether one instrument is superior 
for measuring physical activity.191;198;203;208 A slight improvement in the estimation of 
V02 and energy expenditure was observed with the Tritrac compared to the GSA, 
. 198;208 I 
although both monitors still significantly underestimated energy expenditure, n 
contrast, Welk203 found that the GSA accurately estimated METs during treadmill 
walking at 3 different speeds on the level, whereas the Tritrac did not. Finally, another 
study found that the Tritrac and the GSA underestimated the energy cost of various 
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leisure and household tasks by a comparable amount. 191 Although there is some 
evidence to suggest that the Triaxial accelerometer may provide a better estimate of 
energy expenditure, these findings are inconsistent and both types of accelerometer 
do not accurately estimate V02 and energy expenditure under free-livin 
d' . 191'198'208 g 
con Itlons. " Furthermore, the CSA accelerometer has some advantages 
compared to the Tritrac for measuring physical activity under free-living conditions. 
The CSA is smaller, lighter, less expensive and more compact than the Tritrac, and 
can be worn on the waist, ankle or wrist, whereas the Tritac can be positioned on the 
waist or lower back. One study found that 20% of elderly subjects did not comply with 
wearing the Tritrac for at least 3 days.20o Therefore, the CSA may allow for less 
obtrusive data collection and better compliance. 
Pedometers 
Pedometers are small, inexpensive and are designed to count steps during 
locomotion.189 They contain a horizontal, spring-suspended lever arm that moves up 
and down with vertical acceleration of the body during locomotion. With each step, the 
lever arm makes mechanical contact and one step is recorded. The output from the 
pedometer is in total steps. Although, some pedometers can estimate total distance 
walked, if stride length is provided, or they can estimate energy expenditure.189 
Bassetf09 reported that the Yamax Digi-walker was very accurate for counting steps 
and estimating total distance during self-paced overground walking. Hendelman 191 also 
tested the utility of the Digi-walker to assess moderate intensity overground walking. 
Pedometer recordings were highly correlated with actual steps counted (r=0.84), 
walking speed (r=0.86) and V02 (r = 0.75). However, pedometers underestimate step 
frequency at slow walking speeds, as the vertical acceleration of the body during slow 
walking may be too low to be captured by the instrument. 191;209 In addition, 
pedometers underestimate the total distance walked at fast walking speeds, despite 
accurately counting step frequency.209 This is because stride length tends to increase 
at fast walking speeds. Therefore, estimating total distance walked from pedometry 
recordings introduces measurement error. In addition, pedometers cannot differentiate 
. 't f t 189 between walking and running, therefore do not reflect the Intensl y 0 movemen. 
Furthermore, pedometers do not accurately assess energy expenditure under free-
living conditions.196-198 Leenders 198 found that the Digi-walker significantly 
underestimated physical activity energy expenditure by 59% when compared to energy 
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expenditure assessed by DLW. Additionally, other studies reported that pedometers 
significantly overestimated the energy cost of walkl'ng 196 d . 'fi 
an slgnl Icantly 
underestimated the energy cost of various moderate intensity activities.196;197 
Montoye 189 stated that "pedometers were designed to count steps in locomotion and 
should not be expected to measure other kinds of activities or estimate energy 
expenditure." In agreement, the literature suggests that pedometers may be useful for 
measuring walking behaviour by counting steps. However, they can be inaccurate at 
very slow walking speeds, may not accurately measure total distance walked at very 
fast walking speeds, and provide inaccurate estimates of energy expenditure under 
free-living conditions. These limitations of the pedometer make it less suitable for 
measuring habitual physical activity, unless walking is the predominant form of activity. 
Heart Rate Monitoring 
There is a linear relationship between heart rate and oxygen uptake during exercise 
under laboratory ,conditions.21o Therefore, monitoring heart rate has been used to 
assess physical activity by estimating V02 and energy expenditure. Advantages of 
heart rate monitoring include their ability to measure the frequency, intensity and 
duration of physical activity. In addition, they are relatively inexpensive, simple to use, 
robust, and versatile in a wide variety of field settings, non-intrusive and well tolerated 
by subjects.21o However, there are limitations of assessing physical activity by 
monitoring heart rate. Factors such as emotional stress, high ambient temperature and 
high humidity will raise the heart rate with little effect on oxygen uptake.211 In addition, 
arm exercise elicits a higher heart rate than leg exercise even though the oxygen cost 
is the same, because of the smaller muscle mass involved with arm only activity.197 
Individual variations in age, medication (e.g. beta-blockers), fitness level and gender 
can also affect the relationship between heart rate and oxygen uptake (HR_V02).211 
These individual differences in the HR-V02 relationship resulting from variations in 
age, medication, gender and fitness can be overcome by establishing a HR-V02 
calibration curve for each individual. 211 This involves simultaneously recording an 
individual's heart rate and V02 responses to exercise at different intensities under 
laboratory conditions. A HR-V02 calibration curve is established for each individual, 
which is then used to estimate V02 and energy expenditure from heart rates recorded 
under free living conditions. 197 Using this method, Racette212 found that heart rate 
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monitoring produced similar estimates for total and physical activity related energy 
expenditure compared to DLW. However, other investigators have reported that heart 
rate monitoring significantly overestimated the oxygen cost of various field-based 
activities. 197;213 
The relationship between heart rate and V02 is poor at low levels of exercise 204 thus , , 
the HR FLEX method was developed to overcome this limitation.214;215 This technique 
involves monitoring each subject simultaneously for heart rate and V02 at rest, during 
sedentary activity and exercise, resting metabolic rate is also obtained. This 
information is then used to develop the individual's HR-V02 calibration curve. The 
FLEX HR is determined by taking the highest heart rate recorded from rest and 
sedentary activity and the lowest heart rate recorded during light exercise. Above the 
FLEX HR value, there is a strong relationship between HR and V02, below it they are 
poorly correlated. During heart rate monitoring of physical activity in the field, if a given 
heart rate is below the FLEX HR then energy expenditure is determined from resting 
metabolic rate. Whereas, if a given heart rate is above the FLEX HR then energy 
expenditure is estimated using the calibration curve. 216 Studies have reported no 
significant difference between measured and estimated energy expenditure using the 
FLEX HR method in a group of children215 and adults.214 However, there are some 
drawbacks of the FLEX HR method to estimate energy expenditure. Firstly, the 
calibration test and the data analysis is time consuming and costly. Secondly, the HR-
V02 relationship derived from activities in a controlled laboratory setting may not 
accurately represent the relationship in free-living activity.211 Finally, heart rate can be 
affected by factors other than physical activity, as previously discussed. 
Simultaneous use of heart rate monitoring and accelerometers 
Heart rate monitoring and accelerometers have limitations for measuring physical 
activity and estimating energy expenditure. However, Strath 197 found that the 
simultaneous use of heart rate and motion sensors improved the estimation of V02 of 
selected field-based activities, compared with heart rate monitoring and 
accelerometers independently. This study established an individual calibration curve 
between HR and V02 for both arm and leg exercise in the laboratory. In the field 
setting, the activity monitor was used to differentiate between arm and leg movement 
and heart rate was used to estimate V02 from the corresponding calibration curve. 
This differentiation allowed the investigator to predict V02 from an individualised arm 
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or leg HR-V02 calibration curve, as the relationship between HR and V0
2 
differs for 
d I . 211 arm an eg exercise. Another advantage of this technique is that the 
accelerometers can differentiate between an increase in heart rate caused by physical 
activity and that caused by other factors. The simultaneous use of heart rate and 
accelerometers to measure physical activity could be a promising method to measure 
physical activity, however this method is very time-consuming. 
In summary, the objective methods that could be used to measure physical activity in 
this study were reviewed. Although motion sensors and heart rate monitors have 
limitations, an objective method was selected because they eliminate the subjectivity 
associated with self-report methods. An accelerometer seemed to be the most 
appropriate instrument to use in this study for the following reasons. Firstly, 
accelerometers have a large memory capacity, which is important because at least 5 
days of physical activity should be recorded to obtain a good estimate of an individual's 
physical activity behaviour. 186 Heart rate monitoring was not selected, as it requires the 
development of individual calibration curves, which is very time-consuming, whereas 
analysing accelerometer recordings is relatively quick and simple. Additionally, 
accelerometers are reliable, which is important in an intervention study to ensure that 
changes in physical activity are a result of the intervention, and not because of 
variation in activity scores due to low reliability. As previously discussed, 
accelerometers cannot record all types of activity under free-living conditions, however 
there were limitations to all other objective methods that could have been used in this 
study. The GSA accelerometer was chosen instead of the Tritrac because it is smaller, 
lighter, and more compact than the Tritrac, which may allow for less obtrusive data 
collection and better compliance. One study reported that 20% of the study sample did 
not comply with wearing the Tritrac for at least 3 days.39 In addition, the GSA is less 
expensive than the Tritrac. Finally, the GSA is similar to the Tritrac for measuring 
physical activity. Schutz recommended using multiple methods to measure physical 
activity as no single current technique is able to quantify all aspects of physical activity 
under free living conditions.217 Thus, a self-report method was selected to gain 
additional information on patterns of physical activity. 
Self Report 
Numerous self-report instruments have been developed to assess physical activity. 
Self-reports include self-administered or interviewer-administered recall 
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questionnaires, activity logs or diaries. They are practical for use in field studies as 
they are relatively inexpensive and require less equipment compared to objective 
218 
measures. Furthermore, some self-reports measure the dimensions of physical 
activity (type, frequency, intensity, and duration), therefore an individual's pattern of 
physical activity can be examined. This information can also be used to determine if 
individuals are meeting current physical activity recommendations. 219 However, there 
are limitations to self-report methods. They are subjective, therefore can be influenced 
by the subject's perceptions and emotions. In addition, subjects may not recall their 
activities accurately, and social desirability bias can lead to over-estimation of the 
duration or intensity of activities. Recall questionnaires have an advantage over activity 
diaries and activity logs, as they are less time consuming and do not affect physical 
activity behaviour (unless subjects know in advance that they will be completing one). 
Recall Questionnaires 
Recently, Sallis reviewed the validity, reliability and content of numerous self-report 
questionnaires th.at have been frequently used over the past decade to measure 
physical activity in adults. 219 The components of physical activity measured by the 
questionnaires varied widely. The majority of self-reports measured the dimensions of 
physical activity (Le. duration, frequency, and intensity); some assessed both 
moderate and vigorous intensity activities. Leisure physical activity was included in all 
self-reports, whereas, assessment of household and occupational activity was less 
common. A few questionnaires measured long-term habitual physical activity over the 
previous year, whereas others assessed recent or usual activity. All of the self-report 
questionnaires reviewed demonstrated modest to high levels of test-retest reliability.219 
However, the test-retest correlation coefficients tended to be higher for total and 
vigorous physical activity compared to moderate physical activity. The validity of the 
questionnaires for measuring physical activity was evaluated by comparing them with 
motion sensors and heart rate monitoring. In general, low to moderate correlation 
coefficients were observed between self-report measures and objective methods, 
ranging from 0.14 to 0.50. However, motion sensors and heart rate monitoring have 
limitations for measuring physical activity, therefore they are inadequate for use as a 
criterion method. Doubly labelled water accurately measures total and physical activity 
related energy expenditure, thus has been used to validate questionnaires. However, 
DLW does not measure the intensity, frequency and duration of physical activity, 
therefore this method cannot be used to validate the various components of physical 
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activity measured by self-report questionnaires. In general, determining the validity of 
self-report questionnaires is difficult due to the lack of an acceptable criterion method. 
In summary, there are numerous questionnaires that can be used to measure physical 
activity, each demonstrating varying levels of reliability and validity. Recall 
questionnaires are useful in assessing habitual physical activity, as they are 
inexpensive, easy to use and do not alter physical activity behaviour. In addition, unlike 
accelerometers, they can provide information on mode, intensity, duration and 
frequency of physical activity and whether an individual is meeting current physical 
activity recommendations. For these reasons, it was appropriate to use a recall 
questionnaire to assess physical activity in this study. The seven-day physical activity 
recall220 was selected, as it measures all dimensions of physical activity (i.e. type, 
frequency, duration and intensity), and measures physical activity during both 
occupation and leisure time. In addition, the questionnaire measures recent, instead of 
usual activity, which is important in an intervention study to assess changes in physical 
activity. Physical activity patterns vary from day to day and from weekday to weekend, 
therefore the questionnaire assesses physical activity behaviour for seven days. 
Finally, the instrument is administered in an interview format, which may generate 
more accurate and reliable information than self-administered questionnaires.221 This 
is because some subjects find it difficult to recall physical activity or classify the 
intensity level of various activities. Furthermore, individuals may not always define 
what they are doing as physical activity, for example housework. Therefore, the 
interviewer can advise the subject and use prompts to facilitate recall. 220 
Stanford Seven-Day Physical Activity Recall 
The Stanford Seven-Day Physical Activity Recall (7DPAR)220 has been widely used in 
research to quantify physical activity. This instrument is an interview administered 
questionnaire that measures the time spent in sleep and light, moderate, hard and 
very hard intensity physical activity for seven days. An estimate of energy expenditure 
can be calculated from the time spent in various intensities of physical activity, using 
established MET values for each intensity category. The reliability and validity of the 
seven-day recall has been reviewed by various investigators.218;219;222;223 The seven-day 
recall demonstrated high test-retest reliability (r-0.7 to 0.9) for estimating energy 
. 223-225 
expenditure when the questionnaire was administered over a two-week period. 
Other studies have observed modest test-retest correlation coefficients for the recall of 
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moderate, hard, very hard and total physical activity.219;222;226-228 However, the time 
interval between questionnaire administrations ranged from 2 weeks to 1 th mon , 
therefore the reliability estimates reflect both the ability of the individual to recall their 
activity and actual changes in physical activity. Studies have reported poorer test-
retest reliability for the recall of moderate intensity physical activity compared to recall 
of total, hard, very hard and occupational physical activity.219;222;226;227 Vigorous 
activities tend to be planned or structured, thus individuals are more likely to accurately 
recall these types of activity. Whereas, it is more difficult to accurately recall and 
categorise the intensity of moderate activities that are part of normal daily life. 229 
The validity of Stanford Seven-Day Recall (7DPAR) to measure physical activity and 
estimate energy expenditure has been tested. Studies have found that energy 
expenditure estimated by the 7DPAR was similar to energy expenditure measured by 
DLW in a group of obese212 and normal weight women. 198 In contrast, other studies 
have found that energy expenditure estimated by the 7DPAR was significantly 
overestimated by. 11 0/0230 to 30%231;232 compared to DLW. Leenders reported high 
correlation coefficients (r=0.82 - 0.94) between energy expenditure estimated from the 
7DPAR and accelerometers recordings (CSA and Tritrac).233 Furthermore, the 
questionnaire and accelerometers similarly estimated the time spent in light, moderate, 
hard, very hard and total physical activity. In contrast, Duncan found that sedentary, 
middle aged subjects significantly overestimated the time spent in moderate intensity 
activity measured by the questionnaire compared with actual moderate activity 
determined by heart rate monitoring.223 Other studies have observed lower correlations 
for moderate intensity activity compared to hard, very hard intensity and total activity 
between the 7DPAR and accelerometers.219;222;227;228;234 The 7DPAR has been used to 
assess physical activity levels of individuals participating in exercise-based cardiac 
rehabilitation. These studies found a significant increase in physical activity measured 
by the questionnaire after cardiac rehabilitation. 89;93;96 In addition, these changes were 
confirmed by a concomitant increase in exercise capacity.89;93 In addition, physical 
activity intervention trials in the general population have found Significant increases in 
physical activity measured by the questionnaire and accelerometers. Thus, the seven-
day physical activity recall seems to be responsive to the effect of interventions to 
increase physical activity. 
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Cardiorespiratory Fitness 
Cardiorespiratory fitness and the ability to improve fitness with exercise training has a 
sizeable hereditary component and can be affected by factors other than physical 
activity. Therefore, using fitness as an indicator of an individual's physical activity 
behaviour has its limitations. On the other hand, the improvement in aerobic capacity 
and submaximal endurance capacity with cardiac rehabilitation exercise training has 
been well documented. Furthermore, studies have shown that both physical activity 
and exercise capacity tend to decline in the long-term following completion of exercise-
based cardiac rehabilitation. The aim of this study was to investigate the effect of an 
exercise consultation on maintenance of physical activity following completion of phase 
III exercise training, thus it was appropriate to assess cardiorespiratory fitness. 
Exercise Capacity 
Maximal oxygen uptake (V02max) is the criterion measure of exercise capacity.83;235 
V02max is the highest oxygen uptake attainable during a progressively increasing 
exercise test, as demonstrated by a plateau in oxygen uptake despite further 
increases in work rate. V02 max is equal to maximal cardiac output and maximal 
arteriovenous oxygen difference, thus represents the capacity of the cardiovascular 
system to supply oxygen to exercising skeletal muscles and the potential for oxygen 
extraction by the exercising muscle. However, most cardiac patients fail to achieve a 
"true" V02max as they are often limited by cardiac symptoms and may be reluctant 
to push themselves to their maximal capacity.236 Thus, peak V02, the rate of oxygen 
uptake at the highest level of exercise, is more relevant when discussing the 
exercise capacity of individuals with CHD. 
Accurate assessment of exercise capacity (i.e. peak V02) is achieved with direct 
analysis of expired gases during a progressively increasing exercise test. The type 
of exercise testing protocol used influences the measurement of peak oxygen 
uptake.237 In clinical practice, the Bruce protocol (or modified Bruce) is the most 
d· t' t 83;236;237 commonly used exercise testing treadmill protocol for car lac pa len s. 
However, this protocol has been criticised because of its large and unequal 
increases in work rate every three minutes. It is thought that some patients will be 
unable to tolerate these large and unequal increases in exercise intensity, thus will 
83'236'237 dd't' I d nequal terminate the exercise test prematurely. " In a I lon, arge an u 
increments in work rate leads to difficulties in interpreting gas-exchange 
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measurements (e.g. lactate threshold) and causes inaccurate estimates of exercise 
capacity.83 Protocols with smaller, more frequent uniform work rate increments are 
recommended, which are preferred and better tolerated by patients and produce an 
accurate assessment of peak V02.83;236;237 The exercise testing protocol should also 
be individualised, as cardiac patients exhibit a wide range of exercise capacities.237 
For example, exercise testing protocols with small work rate increments to 
accommodate patients with poor exercise capacity result in very long tests for fitter 
patients, which may produce unrepresentative values for peak V02 as subjects may 
terminate the test prematurely due to boredom. The optimal exercise test duration is 
8 to 12 minutes, thus the work load increments should be adjusted for each patient's 
capabilities to achieve this test duration. 83;236;237 
Submaximal Endurance Capacity 
Estimating the lactate threshold, the exercise V02 at which the concentration of 
lactate in arterial blood increases above the resting value,83 during a progressive 
exercise test can be used as an indicator of submaximal endurance capacity. A 
range of techniques have been used to estimate the lactate threshold, including both 
direct measurements and indirect estimation. Direct measurement of lactate requires 
serial blood sampling during exercise testing, which is invasive and uncomfortable 
for patients. 83 However, the lactate threshold can be estimated noninvasively as the 
increase in lactate during exercise causes profound alterations in ventilation and gas 
exchange. The V-slope and ventilatory equivalent techniques are common and 
reliable methods for indirectly detecting the lactate threshold. 83 
The V-slope method for estimating the lactate threshold is illustrated in Figure 4. As 
work rate increases during an incremental exercise test, there is a linear increase in 
oxygen uptake (V02) and carbon dioxide output (VC02). Above the lactate threshold, 
the increase in lactic acid production causes carbon dioxide output to increase more 
rapidly than oxygen uptake. When these V02 and VC02 are plotted against each 
other, the relationship is composed of two linear components, the lower of which has 
a slope slightly less than 1.0, whereas the upper component has a slope steeper 
than 1.0. The intercept of these two slopes defines the oxygen uptake above which 
VC02 increases faster than V02 and signals the increased concentration of lactic 
acid. The increase in VC02 in excess of that derived from aerobic metabolism is 
generated from the buffering of lactic acid. 
82 
The ventilatory equivalent method is illustrated in Figure 5 Above the lactate 
threshold, minute ventilation (VE) increases proportionally with the increased CO2 
output. Thus, VE retains a constant relationship with VC02 (VENC02 appears 
constant or decreases slightly), whereas VE increases relative to V02 (VEN02 
increases). Similarly, the end tidal pressure of oxygen (PET02) increases, whereas 
the end tidal pressure of carbon dioxide (PETC02) remains constant at the lactate 
threshold. This method is frequently used to verify estimation of the lactate threshold 
by the V-Slope method. Beaver found that the values obtained by the V-slope 
method agreed closely with those obtained by direct measurement of the lactate 
threshold. 238 
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Figure 4 The V-Slope technique to estimate the lactate threshold. 
Below the lactate threshold, there is a linear increase in V02 and VC02· Above the 
lactate threshold, VC02 increases more rapidly than V02 due to increased lactic acid. 
V02 = Oxygen uptake. VC02 = Carbon dioxide production. 
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Figure 5 Ventilatory equivalent method to estimate the lactate threshold. 
At the lactate threshold, VEN02 and PET02 increase, whereas VENC02 and PETC02 
remain constant or decreases slightly. 
VEN02 = ventilatory equivalent for oxygen uptake, VENC02 = ventilatory equivalent for 
carbon dioxide output. PET02 = End tidal O2 partial pressure, PETC02 = End tidal VC02 
partial pressure. 
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SECTION FOUR 
MEASURING ANXIETY, DEPRESSION AND QUALITY OF LIFE 
Anxiety and depression are commonly experienced psychological problems 
encountered by patients following cardiac events.2 Evidence shows that moderate to 
severe depression following an MI is a significant predictor of cardiac mortality over the 
subsequent 6 to 18 months. 1oo;101 In addition, patients suffering from psychological 
distress have demonstrated poorer quality of life, increased severity of chest pain, poor 
compliance to lifestyle changes and increased use of health services compared to 
non-distressed patients. 102 Therefore, a goal of cardiac rehabilitation is to limit the 
psychological effects of cardiac illness and to enhance quality of life. 1 Beneficial effects 
of exercise-based cardiac rehabilitation on quality of life, anxiety and depression have 
been reported. However, some studies have found that improvements in quality of life 
achieved during cardiac rehabilitation diminish after programme completion, which 
may be a result of poor compliance to lifestyle changes in the long-term. Thus, 
measurement of quality of life, anxiety and depression were important secondary 
outcomes of this study. 
Anxiety and Depression 
National guidelines for cardiac rehabilitation2 have recommended using the Hospital 
Anxiety and Depression Scale (HADS) to measure anxiety and depression. This 
instrument is easy to administer, simple to score and has been widely used in cardiac 
rehabilitation settings to screen patients for symptoms of psychological distress, and to 
evaluate psychological outcomes of cardiac rehabilitation. 
The Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale is a self-report instrument developed by 
Zigmond and Snaith (1983) to measure states of anxiety and depression in medical 
patients.239 Symptoms relating to serious mental disorders were excluded from the 
instrument, which is thought to make the scale more sensitive to mild forms of 
psychological distress. Furthermore, the investigators omitted physical symptoms of 
psychological distress such as insomnia, loss of energy or weight loss, which may be a 
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direct consequence of a medical illness (e.g. MI) rather than related to depression or 
. t 240 Th . 
anxle y. e Instrument measures states of anxiety and depression over the past 
week, therefore it is sensitive to change but is not limited to an immediate stressful 
situation.240 
The HADS is a reliable and valid instrument for measuring anxiety and depression in 
medical patients and patients with CHD.241 Visser found that the anxiety and 
depression scales were very reliable over a two week period in a group of patients who 
had suffered an MI in the previous 6 to 24 months.242 It is fundamental that the 
questionnaire items that compose a scale are related to one another, known as 
internal consistency. A Cronbach's alpha coefficient of 0.7 or above is taken as 
evidence of internal consistency. Johnston reported cronbach's alpha coefficients 
exceeding 0.80 for the HADS anxiety and depression scales at three time periods over 
12 months following myocardial infarction.243 The validity of a psychological instrument 
can be examined by comparing the questionnaire with relevant psychometric 
properties of oth~r instruments (i.e. concurrent validity). A recent review observed 
moderate to high correlations ranging from 0.6 to 0.8 between the HADS anxiety and 
depression subscales and other self-assessment instruments.244 The HADS is able to 
detect anxiety disorders and depression in medical populations compared to gold 
standard diagnostic instruments.241 ;244 In addition, the prevalence of moderate anxiety 
and depression estimated using the HADS in a sample of the general adult UK 
population was similar to findings from epidemiology studies that employed well-
validated classification systems. 245 Finally, it is expected that patients who have 
experienced a myocardial infarction will have higher levels of anxiety and depression 
compared to the general healthy population. Visse(42 reported higher scores on HADS 
anxiety and depression subscales for a group of post MI patients compared to healthy 
controls. Studies have shown that the HADS is responsive to the effects of cardiac 
b I· t 246;243;110;247 rehabilitation for up to one year after the ase me assessmen . 
Quality of Life 
Evaluating the effect of cardiac rehabilitation on quality of life should include the 
assessment of physical function, psychological well-being and social functioning.
248 
Instruments designed to measure quality of life can be divided into two categories: 
generic and disease-specific. Generic questionnaires provide a broad assessment of 
the health status of an individual and allow comparisons between groups of patients 
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with different conditions and general populations, however a main concern of these 
instruments is their lack of sensitivity to measure change over time.248 In contrast, 
disease-specific instruments assess the effects of a particular disease on health 
status, which may improve the sensitivity of the measurement. However a 
I 
disadvantage of disease-specific instruments is that they may be less comprehensive 
in covering the multiple dimensions of health status. Due to the advantages and 
disadvantages of both types of questionnaire, ideally both disease-specific and generic 
instruments should be used to measure quality of Iife.246 However, a number of 
methods were being used to measure the primary outcomes of this study I thus the 
addition of two quality of life questionnaires may have burdened the patients potentially 
affecting patient recruitment and compliance to the study. A generic questionnaire was 
selected to measure quality of life in this study for the reasons discussed below. 
A variety of valid and reliable generic and disease-specific instruments have been 
used to measure quality of life in cardiac rehabilitation. In addition, a systematic review 
identified a number of instruments that were responsive to cardiac rehabilitation. 246 
Thus, no agreement has been reached regarding the most appropriate questionnaire 
to measure quality of life in cardiac rehabilitation settings.2 Recently, Hevey247 
examined the responsiveness of nine disease-specific and generic instruments, which 
are commonly used to assess quality of life in cardiac rehabilitation. The study sample 
was comprised of patients who had experienced aMI, CABG or PTCA. Results 
showed that most of the disease-specific questionnaires (i.e. Quality of Life after 
Myocardial Infarction, Quality of Life Index Cardiac Version III, and Cardiac Depression 
Scale) were not responsive to the effects cardiac rehabilitation. The exceptions were 
two subscales of the Heart Patient's Psychological Questionnaire: feelings of disability 
and despondency. However, the English version of this questionnaire has not been 
validated. 247 In contrast, a number of generic questionnaires were responsive to 
cardiac rehabilitation. These included the Global Mood Scale, the depression scale of 
the HADS and five out of eight subscales of the Short-Form 36. 
Similarly, Smith249 showed that the Short-Form 36 was more responsive to 6 weeks of 
cardiac rehabilitation than two disease-specific measures; the Quality of Life after 
Myocardial Infarction and the Quality of Life Cardiac Version III. There are other valid 
and reliable disease-specific instruments available, such as the Cardiac Quality of Life 
Inventory, and the Multidimensional Index to Life Quality, however their 
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responsiveness to cardiac rehabilitation has not been assessed. In contrast, the 
Seattle Angina Questionnaire is more responsive than the Short-Form 36,250 however 
this disease-specific instrument does not provide a broad measure of quality of life. 
Another reason for choosing a generic questionnaire was the fact that many of the 
disease-specific questionnaires tend to focus on a specific cardiac condition (e.g. 
Quality of Life after MI, Angina Pectoris Quality of Life Questionnaire), and would not 
be appropriate for the heterogeneous population (i.e. MI, CABG and PTCA) included 
in this study. In addition, McGhee246 suggested that if both a disease-specific and 
generic measure were shown to have equal responsiveness, then it may be 
preferential to use a generic measure as this allows comparison with other patient 
groups and normative data for the general population. 
The most commonly used generic instruments to measure quality of life in coronary 
heart disease are the Nottingham Health Profile, the Short-Form 36 and the Sickness 
Impact Profile.251 The Sickness Impact Profile was not feasible for use in this study 
because it takes patients approximately 20 minutes to complete the 136 questionnaire 
items.242 Although, the Nottingham Health Profile has demonstrated acceptable 
reliability and validity in patients with heart disease,252 major ceiling effects (maximum 
possible score) have been reported. 251 ;253 Dempste~51 found that 16% to 62% of MI 
patients achieved the maximum possible score on all NHP domains at the beginning of 
a cardiac rehabilitation programme. Thus, the Short-Form 36 (SF-36) was selected to 
measure quality of life in this study for the following reasons. 
The Short-Form 36 (SF-36) 
The SF-36 demonstrates good content validity, as it measures quality of life 
dimensions that are important in cardiac rehabilitation, for example physical function, 
social function and psychological wellbeing.248 Secondly, the validity, internal 
consistency and test-retest reliability of the instrument has been established among 
patients with CHD. An acceptable level of internal consistency has been found for all 
SF-36 subscales in cardiac rehabilitation participants,249;254 patients with stable 
coronary heart disease,255 and patients who had suffered an MI in the previous 4 
years,z53 In addition, Jette found that all SF-36 scales, except Role Emotional, were 
very reliable over a two week time interval in a group of cardiac rehabilitation 
participants.254 High levels of agreement have been observed between SF-36 domains 
253 S I A . 
and relevant scales on the Nottingham Health Profile, the eatt e nglna 
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Questionnaire, and the Chronic Heart Failure Questionnaire. 256 Dougherty reported a 
significant correlation between the physical limitations scale of the Seattle Angina 
Questionnaire and the physical function domain of the SF-36 in a sample of stable 
angina patients.
257 
Furthermore, the disease perception scale of the Seattle Angina 
Questionnaire correlated significantly with both the energy and general health scales 
of the SF-36 in this group. 
Studies have reported significantly poorer scores on all SF-36 subscales for post MI 
patients258 and patients with stable coronary heart disease256 compared to age and sex 
adjusted normative data for the general population. In addition, scores on all of the SF-
36 scales were significantly poorer for cardiac patients who were experiencing 
symptoms of angina or breathlessness compared to those who were 
asymptomatic.253;255 Among post MI patients, increasing frequency of chest pain was 
significantly associated with lower scores on all physical health domains, with no 
differences for role emotional or mental health. On the other hand, some studies have 
reported that all of the SF-36 subscales, except bodily pain255 were unable to detect 
differences in the severit/55;257 and frequenc/55 of angina in patients with stable 
coronary artery disease. However, similar findings were observed for two disease-
specific instruments. In addition, floor and ceiling effects were reported for the Role 
Physical and Role Emotional SF-36 subscales among patients with stable coronary 
artery disease, post MI, and those at the beginning of cardiac rehabilitation?53;255 
Consequently, the SF-36 was revised to reduce the floor and ceiling effects of these 
subscales.259 The authors reported that the Role Physical and Role Emotional 
subscales of the SF-36 version II demonstrated greater internal consistency and fewer 
floor and ceiling effects compared to the original questionnaire, which may improve the 
instrument's responsiveness.259 Normative values for the SF-36 version II are available 
for a UK general population.259 
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CHAPTER TWO 
AIMS 
The benefits of exercise-based cardiac rehabilitation are well documented. However , 
evidence suggests that physical activity is not maintained in the long-term following 
completion of these programmes. Therefore, interventions are required to improve 
maintenance of physical activity after programme completion. Exercise consultation , 
based on the established behaviour change theories is effective in encouraging 
promotion and maintenance of physical activity in patients with Type II diabetes and 
the general population for 6 to 24 months. In a pilot study, the exercise consultation 
improved short-term maintenance of physical activity after completion of a phase III 
exercise programme. 
Primary Aim 
The primary aim 'of this randomised-controlled trial was to evaluate the effect of an 
exercise consultation (experimental condition) compared with standard exercise 
information (control condition) on maintenance of physical activity six and 12 months 
following completion of a phase III cardiac rehabilitation exercise programme. 
Secondary Aim 
The secondary aim was to determine the effect of an exercise consultation 
(experimental) compared with standard exercise information (control) on maintenance 
of cardiorespiratory fitness, the use of processes of exercise behaviour change, quality 
of life, anxiety and depression, blood lipids and clinical outcomes at six and 12 months 
in phase IV cardiac rehabilitation. 
The Research Objectives are: 
1) To describe the baseline demographic and clinical characteristics of the 
experimental and control group. 
2) To describe the baseline physical activity behaviour of the study sample (n=70) 
using the CSA accelerometer, 190 the Stanford Seven-Day Physical Activity 
Recall220 and the Stage of Exercise Behaviour Change.26o As subjects had recently 
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completed a phase III exercise programme, it was hypothesised that they would be 
physically active at baseline. 
3) To determine the effect of the exercise consultation (experimental) compared with 
standard exercise information (control) on the following: 
a) Maintenance of physical activity measured using the Stage of Exercise 
Behaviour Change,260 the CSA accelerometer190 and the Stanford Seven-Day 
Physical Activity Recall. 220 
b) Maintenance of cardiorespiratory fitness,83 including exercise capacity and 
submaximal endurance capacity. 
c) The use of the experiential and behavioural processes of exercise behaviour 
change. 16o 
d) Anthropometric variables including weight, body mass index and the proportion 
of patients who were overweight and obese. 
e) Blood lipids including total cholesterol, triglycerides, LDL cholesterol, HDL 
cholesterol and the ratio of total cholesterol to HDL cholesterol. 
f) Psychological functioning including anxiety and depression, and quality of life 
measured using the Hospital Anxiety and Depression Scale240 and the Short-
Form 36 version 2,261 respectively. 
4) To report the incidence of total and cardiovascular mortality, and the number of 
cardiac hospital readmissions (e.g. MI, UAP, CABG and PTCA) in the experimental 
and control group. 
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CHAPTER THREE 
METHODS 
Participants 
Men and women who had experienced a myocardial infarction (MI), unstable angina 
(UAP) or had undergone coronary artery bypass grafting (CABG) or percutaneous 
transluminal coronary angioplasty (PTCA) and were attending a phase III hospital-
based cardiac rehabilitation exercise programme were candidates for inclusion in the 
study. Patients were excluded if any of the following criteria were present: (1) on 
waiting list for cardiac investigation (Le. angiography), (2) on waiting list for coronary 
artery bypass surgery (CABG) or percutaneous transluminal coronary angioplasty 
(PTCA), (3) attended less than 70% of the phase III exercise programme. Subjects 
were recruited from the phase III exercise programme from August 2000 to August 
2001. Eligible subjects who were attending weeks 6 to 11 of the exercise programme 
were given information on the study. Subjects who agreed to participate in the trial 
received an appointment for a baseline assessment. Baseline assessments were 
carried out within one month of patients completing the phase III exercise programme. 
All assessments were conducted in the cardiology department at the Royal Alexandra 
Hospital. The study was approved by the Argyll and Clyde Research Ethics Committee 
(Appendix A) and all patients provided written informed consent before participation in 
the study (Appendix B). 
Phase III Cardiac Rehabilitation Programme 
The phase III cardiac rehabilitation programme was based at a district general hospital 
(Royal Alexandra Hospital) in the West of Scotland. The programme involved 
supervised exercise training, education sessions, medical evaluation, psychological 
support from specialist nurses and access to a clinical psychologist. The exercise 
programme involved two exercise classes each week for 11 weeks. Each class 
included a 15 minute warm-up with flexibility exercises, 20 minutes of circuit training, 
and a 10 minute cool down period with flexibility exercises. Participants were also 
encouraged to participate in physical activity at home on days they were not attending 
the exercise programme. Information booklets on physical activity and CHD were 
available in the gymnasium where the phase III classes took place. 
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Sample size 
Physical activity measured using the CSA accelerometer190 was used to estimate the 
number of participants needed to detect a true difference in this variable between the 
experimental and control groups. The following equation was used n = 2(a+ p)2 s2/d2, s 
= standard deviation and d = difference between the groups, and the values selected 
for alpha (a) and beta (p) were 5% and 10% respectively.262 
No randomised controlled trials have evaluated the effect of exercise-based cardiac 
rehabilitation on physical activity measured objectively using accelerometers. However, 
a pilot study compared the effect of an exercise consultation with standard care on 
physical activity measured using CSA accelerometers in a group of people with type II 
diabetes.263 Thus, the difference between the experimental and control group for the 
mean change in total activity counts/week measured with the CSA accelerometer was 
used to calculate the sample size (baseline mean = 1813893, mean difference 
between groups .= 409780, SO = 444779). A minimum of 25 patients in each group 
was required to have a 90% power of detecting a true difference of 409780 
counts/week (22%» with a Significance level of 5%. However, 70 patients were 
recruited to allow for potential dropout from the study. 
Baseline Assessment 
Visit One: Total duration 60 minutes 
Patients attended the first visit within one month of completing the phase III exercise 
programme. Written informed consent was obtained from participants. The following 
data were collected by self-report and reviewing medical records: demographics, 
socio-economic status264 and occupation, medical history, medication and smoking 
261 Th 
status. Quality of life was measured using version 2 of the UK Short Form 36. e 
Hospital Anxiety and Depression scale240 was used to assess psychological distress. 
Weight (kg) and height (m) were recorded and used to determine body mass index 
(8MI). An incremental exercise test with expired gas analysis was performed to 
assess cardiorespiratory fitness. 83 Patients were given a Computer and Science 
Applications (CSA) accelerometer190 to objectively measure their physical activity 
behaviour for a minimum of seven days. The monitor was attached to the subject's 
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right ankle. Individuals wore the accelerometer during all waking hours and recorded 
the time (see Appendix D) that the monitor was attached and removed each day 
until they returned for the second visit. Additionally, subjects were asked to record 
the activities they engaged in over the following week that were at least of a 
moderate intensity, defined as effort similar to a brisk walk. The physical activity 
recording sheet is shown in Appendix E. 
Visit 2: Total duration 45 minutes 
Approximately eight days after visit one, subjects returned for visit two. Patients were 
asked to fast for 12 hours prior to the visit and a blood sample was obtained to 
measure total cholesterol, triglycerides, HDL cholesterol and LDL cholesterol. The 
CSA accelerometer was returned and the Stanford Seven-Day Physical Activity 
Recall,220 and the t d f' 260 S ages an processes 0 exercise behaviour change 
questionnaires were completed. Thus, data collected with the accelerometer 
corresponded with information obtained from the seven-day physical activity recall. 
Participants wererandomised (refer to randomisation procedure) to the experimental 
or control group. All participants received standard exercise information. Patients in the 
experimental group received an exercise consultation,174 which was delivered either 
during the second visit or in a third visit depending on what was convenient for the 
patient and the researcher. 
Six and 12 Month Assessment 
All outcome measures recorded at baseline were repeated at six and 12 months. The 
experimental group received a further exercise consultation 174 at six months. 
Randomisation 
Participants were randomly allocated to the experimental or control group following the 
baseline assessment. Patients remained in the same allocation group throughout the 
study period. A blocked randomisation procedure was used to ensure two groups of 
equal size. Block sizes of 10 and 20 were used with an allocation ratio of one 
experimental to one control. For each block, a blinded research assistant generated a 
random sequence of numbers. This same individual then marked cards with "control" 
or "experimental" by allocating odd numbers to the control condition and even numbers 
to the experimental condition. These cards were placed in sequentially numbered 
opaque envelopes, which were then sealed. These envelopes were then allocated to 
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participant t'"t 
s a VISI two and were opened by the principal researcher after the baseline 
measures had been recorded. 
Experimental Group 
Patients in the experimental group received an exercise consultation 174 delivered after 
the baseline and 6 month assessments. In addition, patients received a support phone 
call three months and nine months after the baseline assessment. 
Exercise Consultation at Baseline 
All exercise consultations were conducted in accordance with guidelines published by 
Loughlan and Mutrie. 174 The researcher was trained in the exercise consultation 
process in a one-day course (BASES workshop, Dr Nanette Mutrie, 30th November 
1998) and through the use of an Exercise Consultation video. 265 In addition, the 
researcher had previously conducted a pilot study to tailor the exercise consultation to 
cardiac patients who had recently completed a phase III exercise programme. 178 The 
consultation involved an individualised, one to one counselling session lasting between 
20 and 30 minutes. Consultations were conducted in a private room containing two 
comfortable chairs. Excellent communication and counselling skills are required to 
effectively conduct a consultation. The researcher achieved this through an open 
posture (e.g. avoid crossing arms or legs), leaning towards the client, appropriate eye 
contact and a relaxed style to put the participant at ease and convey interest and 
attention. Counselling skills, including empathy (Le. understanding the client's goals 
and needs), parroting (i.e. repeating the key words and phrases that the client used) 
and paraphrasing (i.e. summarising what the participant has said) were used to show 
the participant that the researcher had listened carefully and had understood what he 
or she had said. The exercise consultation is a client-centred approach, thus the 
researcher avoided preaching, lecturing or providing solutions for the client. However, 
the researcher could offer suggestions, such as how to overcome a certain barrier to 
activity, but watched for reactions to them, such as non-verbal clues. 
As the participants had recently completed a phase III exercise programme, it was 
thought that participants would be either regularly physically active (Le. in the action or 
maintenance stage of change) or doing some activity but not enough to meet current 
physical activity guidelines (i.e. preparation stage). Physical activity guidelines included 
accumulating at least 30 minutes of moderate intensity activity on most days of the 
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week
8 
or engaging in a minimum of three 20 minute sessions of moderate to vigorous 
intensity exercise per week. 6 The aim of the consultation was to ensure that patients 
were regularly physically active and to encourage them to remain regularly active by 
preventing relapse. 
The strategies used to increase and maintain physical activity were; previous activity 
history, decisional balance, problem solving barriers to physical activity, social support, 
goal setting and preventing relapse. A copy of the sheet that was used to guide the 
exercise consultation is included in Appendix C. 
The consultation began by reviewing the participant's stage of exercise behaviour 
change and current physical activity behaviour using information collected during the 
baseline assessment (Le. from the Stanford Seven-Day Physical Activity Recall and 
the Stage of Exercise Behaviour Change questionnaire). This was followed by a 
discussion on the participant's past and present activities to discover their likes and 
dislikes (e.g. if t~e patient enjoyed exercising in a group setting then they were 
encouraged to attend exercise classes in the community). Clients completed a 
decisional balance sheet, which involved comparing the perceived pros and cons of 
participating in physical activity. Patients were encouraged to identify the benefits they 
had gained by attending the phase III exercise programme. Examples of benefits 
included increased fitness, improved wellbeing, increased confidence and weight 
management. The researcher educated the patient on the importance of remaining 
active in phase IV to maintain these benefits. At this point, the researcher described 
the recommended amounts of physical activity required to improve and maintain health 
and fitness, and suggested ways to achieve these recommendations. Then 
participants thought of additional benefits that they would gain by remaining active in 
the long-term. Examples included preventing another heart attack, improved quality of 
life, living longer, and controlling weight. Patients were asked to identify possible 
barriers that may prevent them from remaining active in phase IV. For example, many 
patients' return to work after completing phase III exercise training, thus lack of time 
may be a potential barrier to activity in phase IV. The aim of the decision balance 
sheet was to help the participant realise that the benefits of increasing and maintaining 
activity outweighed the barriers. This is an effective technique for improving exercise 
adherence. 149 This followed with a discussion on ways to overcome potential barriers 
to activity in phase IV. Possible solutions to time constraints included using the stairs. 
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walking part or the entire journey to work or taking a brisk walk at luncht' Ime. 
Social support is a major determinant of adherence to exercise in cardiac 
rehabilitation. Thus, an important part of the consultation was to encourage patients to 
seek support for their activity plan. For example, family or friends could engage in 
some activity with the patient or praise them for continuing with an active lifestyle. 
Alternatively, joining a group exercise programme provided a supportive environment 
for some individuals. Clients received information on local exercise opportunities that 
were suitable for phase IV cardiac patients. For example, patients could attend GP 
exercise referral schemes called "Living Plus" located in the surrounding leisure 
centres. These schemes involved group exercise classes and gym-based programmes 
lasting 10 weeks. Following completion of these programmes, maintenance exercise 
classes called "Fit for Life" were available. In addition, patients and their partners could 
attend a community exercise programme, which took place in the evening once a 
week. BACR phase IV maintenance exercise programmes were not available in the 
surrounding area !--Intil near the end of the study. 
Relapse prevention training 150 was an important component of the exercise 
consultation process as patients had recently completed phase "I. Participants were 
asked to identify high-risk situations that may cause a lapse from activity, for example 
bad weather or illness. These lapses can accumulate and may lead to a return to a 
sedentary lifestyle. Thus, the researcher helped the patient to acquire strategies to 
cope with these situations, for example having an alternative indoor activity in bad 
weather, thereby reducing the likelihood of a lapse in activity and an overall decline in 
physical activity. Finally, the client was encouraged to set short-term (1 month), 
intermediate (3 month) and long-term (6-month) specific activity goals. The researcher 
assisted the client with the goal setting to ensure that the goals were acceptable and 
achievable met the client's needs and accounted for factors discussed during the 
, 
consultation such as solutions to barriers, likes and dislikes, and relapse prevention 
strategies. Participants were given a copy of the activity goals to take away with them. 
Exercise Consultation at Six Months 
Information recorded during the baseline exercise consultation was reviewed in the six-
month consultation. For example, participants were asked if they had achieved the 
activity goals set at baseline. If clients did not achieve their goals, then the reasons for 
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this were explored and new goals were set. Additionally, clients received feedback on 
their level of physical activity and cardiorespiratory fitness collected during the baseline 
and six-month assessments. Specifically, the researcher informed participants if they 
had improved, maintained or declined over the past 6 months in terms of their physical 
activity levels and fitness. If the patient's activity and fitness had declined from baseline 
to six months, then the reasons for this deterioration were explored. For example, 
clients were asked if they had encountered any barriers to activity or risky situations 
that had caused a lapse or relapse from activity over the past six months. Participants 
who had maintained or increased their activity from baseline to six months were 
praised by the researcher and instructed to "keep up the good work". However, 
barriers to activity, problem solving barriers, goal setting and relapse prevention 
strategies were briefly discussed with all patients to ensure they had acquired the 
necessary skills to help them remain active over the next six months. 
Support Phone Calls 
The exercise consultation also included two support phone calls, which were 
delivered three months after the baseline and six-month exercise consultations. The 
notes recorded during the exercise consultations were used to guide the phone 
calls. The phone calls lasted approximately 1 0 minutes and involved discussing any 
problems the patients were experiencing in achieving their activity goals, attending 
community exercise programmes, and remaining active. 
Control Group 
Subjects in the control group also received two phone calls, delivered three months 
after the baseline and six-month assessments, to maintain equal contact time between 
the experimental and control groups and to limit dropout from the study. The phone 
calls lasted approximately five to 10 minutes and the topics discussed were unrelated 
to exercise and included asking patients if they had attended their GP, any problems in 
relation to cardiac symptoms, medication or blood pressure. This is not standard 
management of patients in phase IV cardiac rehabilitation. 
Standard Exercise Information 
All study participants in the control condition and the experimental condition received a 
leaflet entitled Physical Activity and your Heart266 published by the British Heart 
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Foundation after the baseline and six month measurements P t' t . 
. . a len s normally receive 
this booklet in phase I and on completion of phase III. The leaflet included information 
on the benefits of regular physical activity, CHD risk factors, physical activity 
recommendations and examples of how to become more active. 
Primary Outcome Measures 
Physical Activity 
Stages of Exercise Behaviour Change 
The stages of exercise behaviour change 156 are: Precontemplation (inactive and no 
intention to change), Contemplation (inactive, but intending to change in the next 6 
months), Preparation (engaging in some activity, but not regularly), Action (regularly 
physically active, but only began in the past 6 months), and Maintenance (regularly 
active for more than six months).156 Patients in action or maintenance are meeting 
guidelines6;8 for regular physical activity. 
The method used to assess the stages of exercise behaviour change has been 
validated against subjective and objective measures of physical activity. 96;144;157-159 
Studies have reported an increase in self-reported physical activity and 
cardiorespiratory fitness with advancing stage of change in healthy adults and cardiac 
rehabilitation participants.96;144;157-159 The original stages of exercise behaviour change 
questionnaire developed by Marcus 160 in 1992 defined regular physical activity as 
"exercising at least three time per week for 20 minutes." The reliability and validity of 
this questionnaire has been demonstrated. 157;267 However, Loughlan and Mutrie260 
modified this questionnaire to include the 1995 physical activity recommendation (i.e. 
30 minutes of accumulated moderate activity on five days per week). The validity of 
the modified questionnaire has been demonstrated in the general population.268 
Lowther and Mutrie268 found that subjects in the action and maintenance stages (i.e. 
meeting the definition of regular physical activity) reported significantly more physical 
activity compared to those in preparation and contemplation. In addition, those in the 
preparation stage participated in significantly more physical activity compared to 
subjects in the contemplation stage. Similarly, a recent study used both physical 
activity recommendations to assess the stage of exercise behaviour change of a group 
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of patients before and after participation in 12 weeks cardiac rehabilitation. 96 The 
modified stage of exercise behaviour change questionnaire,260 which included the two 
physical activity recommendations was selected for use in this study. 
The questionnaire
260 
included a clear description of each stage of exercise behaviour 
change and regular physical activity was based on the current physical activity 
recommendations
6
;s (i.e. a minimum of 20 minutes of continuous, moderate to 
vigorous exercise on three days per week or accumulating a minimum of 30 minutes of 
moderate physical activity on five days per week. Based on this definition, subjects 
selected the stage of change that described their physical activity behaviour over the 
past six months. At the baseline assessment only, the stage of change questionnaire 
measured individuals physical activity behaviour over the past two months, as they 
had suffered a cardiac event in the preceding six months, but had attended cardiac 
rehabilitation classes in the past two months. 
Stanford Seven-Day Physical Activity Recall 
The reliability and validity of the Stanford Seven-Day Physical Activity Recall220 
(7DPAR) was discussed in Chapter One. The 7DPAR was administered in a 
structured interview format by the same researcher throughout the study period. A 
standardised interview process was followed222 to limit the interviewer's bias, minimise 
guessing and over- or underestimating a participant's physical activity. Gross found 
that individuals trained in the standardised interview process reliably administered and 
scored the seven-day physical activity recall. 225 The researcher performed a number of 
practice sessions conducting and scoring the questionnaire with cardiac rehabilitation 
participants before commencing the study. 
Subjects were asked to recall the duration spent sleeping and participating in 
moderate, hard and very hard intensity physical activity for each of the previous seven 
days. Participants were reminded that they had been wearing the CSA accelerometer, 
and were asked to recall the duration and intensity of their activities as accurately as 
possible and to report the activities they actually engaged in over the previous week 
instead of activities they would normally do. Information from the activity recording 
sheet (Appendix E) administered during visit one was used to assist patients with their 
recall. To further assist with recall, subjects were asked to recall activities in the 
morning, afternoon and evening for each of the seven days, beginning with the 
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previous day. After each day of recall and at the end of the interview, the participant 
was asked if there was any activity that they may have overlooked or forgotten. During 
the interview, prompts were used to help partiCipants recall their activity. For example, 
general questions like "Did you do any housework or gardening that was similar in 
intensity as a brisk walk?" or "How do you get to and from work?" were asked. 
Classifying the intensity level of activities is the most difficult and ambiguous part of the 
interview process. Thus, subjects were instructed that moderate intensity activities are 
similar to a brisk walk, very hard intensity activities are equivalent to running and hard 
activities are in between brisk walking and running (e.g. a brisk walk uphill). 
Physiological symptoms, such as perceptions of sweating, heart rate, and breathing 
were not used to define intensity because they vary greatly by age, weather, fitness 
level, cardiac medication and condition. In addition, subjects were shown a list of 
activities in each intensity category. Patients were instructed that light intensity 
activities were not included in the questionnaire, such as desk work, standing, light 
housework (e.g. ironing, washing dishes etc), strolling, and walking for less than 5 
minutes (e.g. shopping). Subjects were asked about the duration of each activity 
excluding breaks (e.g. being at the swimming pool for 1 hour but only swimming for 30 
minutes was recorded as 30 minutes, not 1 hour). The information recorded by the 
seven-day recall was summarised as follows: the number of minutes each day spent in 
sleep, and moderate, hard and very hard intensity activity was totalled for the week. 
Minutes spent in light intensity activity per week was determined by subtracting the 
time in sleep, and moderate to very hard activity from 10080 minutes. Total physical 
activity per week was calculated by summing the duration of moderate, hard and very 
hard activities per week. 
Total weekly energy expenditure can be estimated by multiplying the time spent in 
sleep (1 MET), light (1.5 METs), moderate (4 METs), hard (6 METs) and very hard (10 
METs) activities per week by their corresponding MET value. However, total energy 
expenditure was not determined in this study for the following reasons. The fixed MET 
values for estimating energy expenditure were derived from young adults. Duncan 
found that actual MET values for moderate, hard and very hard intensity activity were 
3.8, 5.3 and 6.2, respectively in a group of sedentary middle aged adults, which are 
lower than the fixed MET values used by the recall. 223 Furthermore, Duncan reported 
that the average aerobic capacity of the study group was 7.3 METs, thus these 
individuals would be unable to perform very hard activity (10 METs according to the 
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recall) as it would require 137% of their aerobic capacity. Therefore, fixed MET values 
used by the 7DPAR to estimate energy expenditure may not be appropriate for 
individuals with low exercise capacities. In addition, several studies reported that the 
seven-day recall significantly overestimated energy expenditure compared to DLW.230-
232 Th . t us, mlnu es per week in various physical activity intensities were used instead. 
Computer Science and Applications Accelerometer 
The Computer Science and Applications accelerometer (CSA) model 7164 (Shalimar, 
Florida) is small (5.1 x 3.8 x 1.5 cm), lightweight (42.6 g), measures dynamic 
movement in one direction and can be worn on the waist, ankle or wrist. 190 This 
instrument is illustrated in Figure 6. The CSA measures vertical movement using a 
piezoelectric bender, which generates a signal in response accelerations during bodily 
movement. The signal generated is proportional to the magnitude of the acceleration. 
Thus, greater accelerations produce higher signals. The acceleration signal is 
digitised, and these values are summed over a one-minute time interval (epoch). At 
the end of each ~poch, the summed value is expressed as an activity count and is 
stored in the memory. Each activity count represents the sum of accelerations during 
one minute. Thus, the greater the intensity of activity (i.e. in terms of the magnitude 
and frequency of accelerations) the higher the activity count. The CSA measures 
accelerations ranging in magnitude from 0.05 to 2 GiS in the vertical (z) direction. The 
instrument detects movements that occur within a frequency response from 0.25 to 2.5 
hertz so that normal human movement is detected and nonphysiological motion is 
filtered out. The reliability and validity of the CSA for measuring physical activity was 
discussed in Chapter One. However, a pilot stud/69 was conducted to examine the 
relationship between CSA accelerometer counts and V02 during daily living activities in 
15 cardiac patients recruited from a phase III hospital-based programme. Patients 
walked at three self-selected speeds (slow, normal and brisk) and performed other 
daily living activities (i.e. carrying loaded shopping bags and pushing a loaded 
shopping trolley at the normal walking pace). During each activity, steady state V02 
(ml/kg/min) was measured using a portable metabolic system (Cosmed K4b2) and 
activity counts/minute were recorded using CSA accelerometers worn on the waist, 
ankle and wrist. This study found that V02 (ml/kg/min) and activity counts/minute 
Significantly increased as walking speed increased. In addition, V02 (ml/kg/min) for 
carrying shopping bags and pushing shopping trolley were similar and significantly 
higher than normal walking. In contrast, activity counts/minute recorded during carrying 
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shopping bags and pushing shopping trolley were not significantly higher compared to 
normal walking. Similar results were obtained for CSA accelerometers worn on the 
wrist and ankle. Findings from this study suggest that changes in V02 during daily 
living activities are not always reflected by changes in accelerometer counts. Thus, 
CSA accelerometers do not accurately record all types of activity. 
The CSA was operated according to the manufacturer's instructions. 19o The instrument 
was initialised to begin recording at visit one and the monitor was instructed to collect 
data in one-minute time intervals (Le. epochs), thus output from the CSA was in 
activity counts per minute. The CSA was attached to the right ankle with a Velcro strap 
above the anklebone with the orientation of the notch toward the knee, as specified by 
the manufacturer. Although most studies using CSA accelerometers have attached the 
monitor to the waist, the ankle was chosen as the attachment site in this study. This 
was because during pilot studies,263;269 subjects reported that monitors attached to a 
belt and worn on the waist frequently became loose and turned upside down. 
Participants were .instructed to wear the monitor during all waking hours except during 
bathing or other water activities. Subjects recorded the time that the monitor was 
attached and removed each day, to ensure that the monitor was being worn during all 
waking hours. The recording sheet is shown in Appendix D. In addition, participants 
were asked to ensure that the orientation and placement of the monitor on the ankle 
was held constant from day to day in order to obtain accurate repeatable data. 
Participants wore the accelerometer for a minimum of seven days, so that the 
accelerometer data would correspond with the information obtained from the Stanford 
Seven Day Physical Activity Recall. The monitor was returned at visit 2 and data 
recorded by the accelerometer were downloaded to a desktop computer using a CSA 
reader interface unit connected to the PC serial port. Data were exported to excel and 
activity counts per minute for the seven-monitored days were summed to produce total 
activity counts per week. Activity counts were not used to estimate energy expenditure 
or the time spent in various intensity categories due to limitations of the equations 
used to predict these variables from accelerometer readings. Due to the small number 
of monitors available for use in the study, it was not possible to use the same CSA 
monitor on the same individual at each of the three measurement periods. 
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Figure 6 The Computer Science and Applications (CSA) accelerometer for 
measuring physical activity 
Cardiorespiratory Fitness 
Cardiorespiratory fitness, specifically exercise capacity and submaximal endurance 
capacity, was measured using a cardiopulmonary exercise test. This test was carried 
out on a motorised treadmill (Quinton 65) with gas exchange and ventilatory variables 
being analysed breath by breath using the Cosmed K4b2 (Cosmed, Italy). All tests 
were performed in the same laboratory. 
Cosmed K4b2 
The Cosmed K4b2 (Cosmed, Italy) is a breath by breath portable metabolic system, 
illustrated in Figure 7. The Cosmed K4b2 is valid for measuring gas exchange 
variables across a wide range of exercise intensities.270;271 In addition, a recent study 
found no significant difference between the Cosmed K4b2 and a stationary metabolic 
cart for measuring gas exchange during treadmill exercise in a group of cardiac 
patients attending phase "I exercise programmes.272 Although the reliability of the 
Cosmed K4b2 has not been assessed, the earlier model (Cosmed K4) was shown to 
be reliable. 273 The portable unit of the Cosmed K4b2 contains the oxygen and carbon 
dioxide analysers, sampling pump, UHF transmitter, barometric sensors and 
electronics and is powered by a rechargeable battery.274 The total system weighs less 
than 1 kg . The oxygen analyser has a measurement range of 7-24% O2, and accuracy 
to 0.02% O2. The carbon dioxide analyser has a measurement range of 0 - 8% CO2 
and accuracy to 0.01 % CO2. The O2 and CO2 analysers have a rapid response time 
and are thermostated and compensated for variations in barometric pressure, 
temperature, and environmental humidity. The flowmeter contains a bi-directional 
digital turbine that measures respiratory flow with a flow range capacity up to 20 
litres/sec and a wide ventilation range between 0 to 300 IImin with accuracy to ±2%. 
The flowmeter is fixed to a soft facemask (Hans-RUdolph, Kansas City, MO), that 
covers the subject's mouth and nose. The masks are available in different sizes and 
have two inspiratory valves to reduce inspiratory resistance. A Permapure tube 
connected to the flowmeter and the portable unit is used to sample oxygen and carbon 
dioxide in expired air. 
The manufacturer recommended that the portable unit (connected to the charger unit) 
was warmed up for at least 45 minutes before use.274 Before each exercise test, the 
following calibrations were performed, according to the manufacturer's guidelines,274 to 
ensure accurate and reliable readings. The system automatically performs a room air 
calibration by sampling room air to update the CO2 analyser baseline and the O2 
analyser gain to match the readings with predicted atmospheric values (20.93% for O2 
and 0.03% for CO2). The reference gas calibration involves sampling a gas with a 
known composition (Le. 16% O2 and 5% CO2, balance N2) from a calibration cylinder 
and updating the baseline and the gain of the analysers to match the measured 
readings with the predicted values. The output pressure from the calibration cylinder 
was set between 300 to 500 Kpa to ensure that room air was not mixed with the 
reference gas, which would affect the calibration. The delay calibration measures the 
time necessary for the gas sample to pass through the sampling line before being 
analysed. The turbine calibration consists of measuring the volume of a 3 litre 
calibration syringe and updating the gain of the flowmeter in order to match the 
predicted value. The calibration results were viewed to ensure that the measured 
values were within the acceptable range of the predicted values. 
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Figure 7 The Cosmed K4b2 portable metabolic system 
Exercise Testing Protocol 
An individualised exercise testing protocol275 was devised to accommodate each 
patient's capabilities and to achieve an optimal exercise test duration of 8 to 12 
minutes (excluding the 3 minute warm-up phase) for reasons previously discussed in 
Chapter One. The protocol consisted of: 1) 2 minutes at rest; 2) 3 minute warm-up 
phase, which involved gradually increasing treadmill speed to achieve a brisk walking 
pace (range 1-3.3mph), at 0% gradient; and 3) incremental phase, which involved 
increasing treadmill gradient by 1 %, 1.5% or 2% each minute until the test was 
terminated. However, if after five minutes of incremental exercise, the respiratory 
exchange ratio (RER) values were less than 0.90 and there were no ischaemic ECG 
changes, the treadmill speed was increased by 0.3 to 0.5mph per minute to achieve a 
fast walk or jog, (the gradient did not change). Once a fast walk or jog was achieved, 
the speed did not changed and the gradient was increased by 1.5% to 2% per minute 
until the test was terminated. 
Exercise Testing Procedure 
An established procedure for conducting cardiopulmonary exercise tests was 
followed. 83 Patients were advised to wear comfortable clothes and shoes, to adhere to 
his or her usual medical regimen, to eat a light meal no less than 2 hours before the 
test, and to avoid cigarettes and caffeine for at least 2 hours A full explanation of the 
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exercise test procedure was given to standardise the response to the test and to 
reduce the patient's anxiety. 
A cardiac technician fitted each patient with a 12 lead ECG and an automated blood 
pressure cuff. A resting 12 lead ECG and a blood pressure reading was obtained with 
the subject in a seated position. A heart rate belt was fixed to the patient's thorax and 
the heart rate probe was attached to the harness. The K4b2 portable unit and the 
battery were fixed to the back plates of the harness worn by the patient. The facemask 
was attached to the participant with a nylon mesh hairnet and velcro straps. The 
researcher ensured that the facemask fitted well and was fixed securely to prevent air 
leakage. The ambient humidity was determined using a hygrometer and entered into 
the portable unit along with physical characteristics of the participant (age, weight, 
height, and gender). After performing a room air calibration, the portable unit began 
recording gas exchange data. The data recorded by the portable unit was transmitted 
breath by breath to a laptop allowing the data to be displayed in table and graphic 
formats. 
Patients performed a practice walk on the treadmill to familiarise themselves with the 
treadmill and the equipment. Then subjects were seated and remained in this position 
until values for ventilation and RER returned to resting levels (i.e. ventilation below 10 
IImin and RER less than 0.85) to ensure that the patient was not hyperventilating, 
which may affect the estimation of the lactate threshold. During the exercise test 
patients received standardised encouragement from the cardiac technician, who was 
blinded to group allocation, to maximise exercise performance. Throughout the test, a 
12 lead ECG was monitored continuously and blood pressure readings were taken 
every 3 minutes. The patient could terminate the test by symptoms of chest pain, 
fatigue, and breathlessness. The supervising cardiac technician could also stop the 
test in the event of significant ECG changes (~2mm ST depression), significant 
arrhythmia or a fall in blood pressure. The following data were obtained breath by 
breath: oxygen uptake (V02 mllmin), V02 per kg (V02 ml/kg/min), carbon dioxide 
output (C02 ml/min), respiratory frequency (Rf breath/min), tidal volume (VT litres), 
heart rate (HR beats/min), ventilation (VE I/min), respiratory exchange ratio [RER 
(VC02N02)] ventilatory equivalent for O2 (VEN02) , ventilatory equivalent for CO2 
(VENC02), oxygen pulse (V02/HR ml/beat), end tidal partial pressures of O2 (PET02) 
and CO2 (PETC02). On test completion, data were downloaded from the portable unit 
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to the laptop and then exported to an excel spreadsheet for data management. 
Data Analysis 
Data were managed in excel in the following way. Graphs were drawn for V0
2
, VC0
2 
and VE versus time. Outlying points caused by the patient talking, coughing or 
abnormal breathing patterns (e.g. patient taking a deep breath) were deleted from the 
data sheet as they could affect the detection of the lactate threshold. The edited data 
was then used to determine exercise capacity and submaximal endurance capacity. 
Exercise Capacity 
Exercise capacity was determined by calculating the following variables at peak 
exercise: 
1. Peak exercise duration (excluding the three minute warm-up phase) 
2. Peak V02 ml/min (average V02 for the last 30 secs of the exercise test) 
3. Peak V02 mllkg/min (average V02 for the last 30 secs of the exercise test). 
4. Peak oxygen pulse (V02/HR ml/beat) was calculated from peak V02 divided by 
peak heart rate (highest heart rate measured by the K4b2 and ECG). This variable 
measures the amount of oxygen carried in each stroke volume, and gives an 
index of cardiac function. 
5. Peak respiratory exchange ratio (RER) is the ratio of VC02N02 at peak exercise 
and was used as an indicator of exercise effort. An RER greater than 1.15 at peak 
exercise indicates a maximal effort. 83 
Submaximal Endurance Capacity 
Submaximal endurance capacity was determined by estimating the lactate threshold 
using the V-slope and ventilatory equivalent methods, which were previously described 
in Chapter One. The V-slope and ventilatory equivalent methods were carried out 
using an established procedure?76 Breath by breath values for V02, VC02 , VEN02, 
VEVC02, PET02, and PETC02 were averaged (Le. 4, 6 and 8 breath averages), which 
makes it easier to estimate the threshold. For the V-slope method, a graph of VC02 
versus V02 graphs was drawn and the lactate threshold was estimated by visual 
inspection of the V02 at which a breakpoint in the VC02N02 relationship is first 
evident. For the ventilatory equivalent method, graphs of V02 versus VEN02, 
VENC02, PET02, and PETC02 were drawn. The lactate threshold was determined by 
the V02 at which an increase in VEN02 and PET02 occurs with no change or a 
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decrease in VENC02 and PETC02. These methods are demonstrated in Chapter One. 
Secondary Outcome Measures 
Psychological Functioning 
Quality of Life 
Quality of life was assessed using version 2 of the UK Short Form-36. 261 It is a self-
administered generic instrument containing 36 items that measure the following 8 
dimensions of general health: physical functioning (PF), social functioning (SF), role 
limitations due to physical problems (RLP), role limitations due to emotional problems 
(RLE), pain (P), energy/vitality (EV), mental health (MH) and general health perception 
(GHP). Scores for each dimension are obtained by reverse scoring, where necessary 
and summing responses. Raw scores can then be transformed on to a scale from 0 
(worst possible health) to 100 (best possible health). 
The validity, reliability and responsiveness of the SF-36 to assess quality of life in 
cardiac patients ~as been demonstrated (Chapter One). In 1999, version 2 of this 
questionnaire was developed to overcome some of the problems with the original 
instrument. 259 The wording and layout of the SF-36 was modified and the responses to 
the two role functioning domains were changed from dichotomous scales (yes/no) to 
five point response categories to reduce ceiling and floor effects for these dimensions. 
In addition, minor modifications to the wording of six items were made to make the 
questionnaire acceptable in the British context. The UK SF-36 version 2 demonstrated 
greater internal consistency and fewer floor and ceiling effects compared to the 
original questionnaire, which may improve the responsiveness of the instrument.259 
Normative values for this version are available for a UK general population. 259 
Anxiety and Depression 
Anxiety and depression was assessed by the Hospital Anxiety and Depression 
Scale.240 The validity, reliability and responsiveness of the HADS for measuring anxiety 
and depression in medical patients, including individuals with CHD has been discussed 
(Chapter One). The Hospital Anxiety and Depression Scale (HADS) is a brief, self-
report questionnaire that measures the states of anxiety and depression over the past 
week. The questionnaire is divided into anxiety and depression subscales both 
containing 7 items, each item is rated on a 4 point scale from 0 to 3, giving total scores 
ranging from 0 to 21 for each subscale. The HADS scores can be used to classify 
109 
individuals into normal (0-7), mild (8-10), moderate (11-14) and severe (15 or above) 
cate~ories for anxiety and depression.245 In addition, it has been suggested that a 
HADS score of 2 8 for both subscales identifies possible cases of psychological 
distress in the general population and medical patients. 239 
Processes of Exercise Behaviour Change 
The processes of change for exercise behaviour160 are strategies that people use 
when changing their exercise behaviour. There are five experiential (consciousness 
raising, social liberation, dramatic relief, environmental re-evaluation, self re-
evaluation) and five behavioural processes (helping relationships, stimulus control, 
counter conditioning, self-liberation, reinforcement management), see Table 6 for 
definitions. The ten processes were assessed using a 40 item questionnaire that 
asked participants to indicate on a 5 point likert scale ranging from 1 (never) to 5 
(repeatedly) how frequently in the past month they had used or thought about each 
process. 160 The internal consistency for each process and the validity of the processes 
of change questionnaire has been demonstrated.160;277 Several studies have used the 
questionnaire to measure process use in cardiac rehabilitation populations. 96;144;161 
Recently, Bock reported significant increases in the use of behavioural processes 
following participation in a 3 month cardiac rehabilitation exercise programme. 96 
Lipids 
A 12 hour fasting blood sample was obtained and analysed to determine total 
cholesterol, high-density cholesterol (HDL-C), low-density cholesterol (LDL-C) and 
triglycerides. The blood samples were analysed by the biochemistry laboratory at the 
Royal Alexandra Hospital. The concentration of total cholesterol, tryglycerides and 
HDL cholesterol in serum was directly quantified by enzymatic methods using an 
automated clinical chemistry analyser (Hitachi 917, Roche Diagnostics Ltd). LDL 
cholesterol was calculated using the Friedewald equation. 278 The accuracy and 
reliability of the biochemistry laboratory for measuring total cholesterol, triglycerides, 
HDL cholesterol and LDL cholesterol is tested throughout each day by analysing 
control samples and monthly by analysing reference samples supplied by a UK-CDC 
Network Laboratory at the Glasgow Royal Infirmary. The difference between values 
measured by the laboratory and target values were within acceptable limits (i.e. ± 
5%). 
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Smoking Status at Baseline 
Smoking status at baseline was assessed by asking patients if they were a current 
smoker, an ex smoker or a non-smoker. 
Social Class at Baseline 
Social class at baseline was determined using the new National Statistics Socio-
Economic Classification264 (NS-SEC), which replaces the two previous classifications' 
, 
Social Class based on Occupation (SC) and Socio-economic Groups (SEG). The SEC 
has been thoroughly tested and validated using the Labour Force Survey and a variety 
of national datasets (e.g. health, mortality and employment).264 The SEC has a full 
version, which involves 14 functional classes based on occupation and employment 
status. In addition, the full version can be collapsed into 9, 8, 5 or 3 socio-economic 
classes for analytical purposes. The full version of the SEC is very similar to the SEG, 
whereas the collapsed versions of the SEC resemble the SC. Thus, all three methods 
are closely related. 
The new classification (SEC) groups individuals according to both occupation and 
employment status.264 Therefore, information was collected on the patient's occupation 
and employment status (i.e. self-employed with 25 plus employees, self-employed with 
less than 25 employees, self-employed with no employees, and employee). In 
addition, information was collected on employees with managerial or supervisory 
status (i.e. manager with 25 plus employees, manager with less than 25 employees, 
supervisor/foremen and employee). Unemployed and retired individuals were classed 
using their last main job. In the five and three class versions, individuals who have 
never worked were allocated to working class. Women who had never worked and 
were married were classified using their husbands' occupation and employment status. 
The three-class version, which categorises individuals into Managerial/Professional, 
Intermediate and Working Class, was used to determine social class in this study. 
Mortality and Morbidity 
Total and cardiovascular mortality was recorded by reviewing patient's medical 
records. The number of cardiac hospital re-admissions (e.g. MI, UAP, receiving 
PTCA or CABG) was recorded by reviewing medical records and asking patients at 
the six and 12-month follow-up visits. 
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Figure 8 Summary of Study Design 
70 cardiac patients recruited from the phase III exercise programme 
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Baseline Assessment (within one month of completing phase III) 
Physical Activity 
Stage of Exercise Behaviour Change, 7DPAR, CSA Accelerometer 
Cardiorespiratory Fitness 
Exercise capacity, submaximal endurance capacity 
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Mortality and Morbidity 
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112 
] 
1 
Control Group (n = 35) 
Standard exercise Information 
1 
3 month Telephone Call 
T 
6 month Assessment 
Standard Exercise Information 
I 
9 month Telephone Call 
1 
12 month Assessment 1 
Statistical Analysis 
Analyses were performed using computer software packages Minitab version 13.30 
and SPSS version 11.0. Normality of all data were assessed by examining histograms, 
boxplots and normal probability plots of the data. In addition, comparisons of 
descriptive statistics were used to assess the normality of the data; such as mean and 
median, minimum and maximum values, and upper and lower interquartile ranges. 
Normally distributed data are expressed as mean ± standard deviation (SO); median 
and interquartile range (IQR) are used for data that are not normally distributed. The 
General Linear Model (GLM) repeated measures statistical test was considered to 
determine the effect of the exercise consultation (experimental) compared with 
standard exercise information (control) on the dependent variables (e.g. physical 
activity) from baseline to six and 12 months. The GLM test is based on the assumption 
that the data come from normal distributions within the groups and that the variances 
of these distributions are the same. Normal probability plots of the residuals, plots of 
residuals versus fitted values and the 8artletts test of equal variance were used to 
check these assumptions. However, results of these tests suggested that the 
assumption of normality and equal variance were not met for the following dependent 
variables (i.e. physical activity, lipids, quality of life, processes of change, anxiety and 
depression). In addition, performing normality and equal variance tests on log and 
square root transformed data suggested that the transformed data did not meet these 
assumptions. Therefore, using GLM repeated measures to analyse the data was 
rejected. 
The following statistical tests were performed instead. Normally distributed data were 
analysed using paired student's t tests for within group analyses and two sample t 
tests for between group analyses. Data that was not normally distributed were 
analysed using Wilcoxon signed rank tests for within group differences and Mann 
Whitney tests for differences between groups. Ninety eight percent confidence 
intervals were used to quantify the between and within group differences. Ninety eight 
percent confidence limits were used to control for Type 1 errors due to the number of 
comparisons being conducted. Categorical data are reported as number of patients 
and proportions and analysed using chi square tests and Fisher's exact tests. Dr Lilian 
Murray, Statistician, University of Glasgow provided statistical advice. 
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CHAPTER FOUR 
RESULTS 
Flow of Participants Through the Study 
Figure 9 demonstrates the flow of participants through each stage of the study. In 
total, 85 patients were invited to participate in the study, and 15 patients refused to 
take part. Therefore, 70 patients were assessed at baseline and then randomised to 
the experimental or control group. At baseline, all patients received the allocated 
intervention or standard care. Ninety three percent (65nO) of the sample were 
assessed at six months (n=32 experimentals and n=33 controls). Two control patients 
were lost to follow-up at six months; one patient died and one patient received non-
cardiac surgery. Three experimental patients were lost to the six month follow-up; one 
patient received CABG, one patient could not be contacted and one patient was 
suffering from depression. Ninety four percent (66nO) of the sample were assessed at 
12 months (n=33 'experimentals and n=33 controls). In the control group, two patients 
had died at 12 months. In the experimental group, one patient could not be contacted 
and one patient was suffering from depression at 12 months. In addition, the two 
patients who received surgery at six months, thus were lost to the six-month follow-up, 
returned for the 12 month assessment. 
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Figure 9 Flow of participants through the randomised controlled trial 
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Assessment at six-months (n=32) 
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Baseline Demographic and Clinical Characteristics 
Table 7 displays the baseline demographic and clinical characteristics of the 
experimental and control groups. The experimental and control groups were 
comparable for age (95%CI -3.1, 7), and gender (X2=1.4, p=0.23). However, mean 
weight (kg) of the experimental group was significantly greater compared to the 
control group (95%CI -13.8, -0.1). In addition, there was trend for a greater mean 
body mass index in the experimental group compared to the control group (95%CI -
3.1, 0.2). As shown in Table 7, the majority of patients in both groups were male and 
had suffered a myocardial infarction. A small number of experimental and control 
patients were current smokers, had suffered a previous MI or were diagnosed with 
type II diabetes mellitus. Most of the patients in each group were married or 
cohabiting. The majority of patients in the experimental and control groups were either 
employed or retired. Within each group, a comparable number of patients were 
employed or retired. In the experimental group, 46% (16/35) were in the 
managerial/professional social class and 37% (13/35) were working class. Similarly, 
43% (15/35) of the control group were in the managerial/professional social class and 
29% (10/35) were working class. 
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Table 7 Baseline Demographic and Clinical Characteristics of Study Groups 
Characteristic Experimental Control 
(n = 35) (n = 35) 
Mean age + SO, y 59.0 ± 9.7 60.9 ± 11.3 
Males, n (%) 30 (86) 26 (74) 
Mean weight ± SO, kg 86.0 ± 13.9 79.1 ± 14.7 
Mean 8MI ± SO, kg/m2 28.5 ± 3.5 27.0 ± 3.5 
Cardiac diagnosis, n (%) 
MI 22 (62.9) 24 (68.6) 
CABG 8 (22.9) 6(17.1) 
PTCA 4 (11.4) 3 (8.6) 
UAP 1 (2.9) 2 (5.7) 
Smoking status, n (%) 
Current Smoker 2 (5.7) 4 (11.4) 
Previous Smoker 22 (62.9) 21 (60.0) 
Non Smoker 11 (31.4) 10 (28.6) 
Previous MI, n (%) 7 (20.0) 6 (17.1) 
Diabetes Mellitus, n (%) 4(11.5) 5 (14.3) 
Marital status, n (%) 
Married/cohabiting 29 (82.9) 28 (80.0) 
Widowed/divorced/single 6(17.1) 7 (20.0) 
Employment status, n (0/0) 
Employed 16 (45.7) 16 (45.7) 
Retired 16 (45.7) 
15 (42.9) 
Unemployed 3 (8.6) 
1 (2.9) 
Unable to work due to illness 0 
3 (8.5) 
Socio-economic class, n (%) 
Managerial/Professional 16 (45.7) 
15 (42.9) 
Intermediate 6(17.1) 
10 (28.6) 
13 (37.1) 10(28.6) Working 
BMI = body mass index; MI = myocardial infarction; CABG = coronary artery bypass graft; 
PTCA = percutaneous transluminal coronary angioplasty; UAP = unstable angina pectoriS. 
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A similar number of exp· tid enmen a an control subjects were taking the cardiac 
medications described in Table 8. As shown in Table 8 74°1 (26/35) f . . 
,10 0 patients In 
each g~oup were taking beta-blocker medication. Only one patient from the sample 
population was not prescribed anti-platelet medication, this patient was taking anti-
coagulent therapy instead. In addition, 89% (31/35) of patients in the control group and 
100
% 
of those in the experimental group were taking lipid-lowering medication. Forty 
percent (14/35) of the control group and 26% (9/35) of the experimental group were 
prescribed oral nitrates or nitrate patches for angina. 
Table 8 Proportion of Patients Taking Cardiac Medication at Baseline 
Cardiac Medication 
Beta blocker 
Lipid lowering 
Anti-platelet 
ACE inhibitor 
Nitratea 
Calcium channel blocker 
Anti-coagulent 
Diuretic 
Experimental 
(n = 35) 
26 (74.3) 
35 (100) 
34 (97.1) 
19 (54.3) 
9 (25.7) 
12 (34.3) 
1 (2.9) 
6(17.1) 
Control 
(n = 35) 
26 (74.3) 
31 (88.6) 
35 (100) 
19 (54.3) 
14 (40.0) 
10 (28.6) 
0 
6(17.1) 
a Nitrate includes oral nitrate and nitrate patch, nitrate spray is not included. 
Note. Values represent number of patients and percentages in parentheses. 
PhYSical Activity at Baseline 
This section describes the baseline physical activity level of the total study sample 
(n=70). 
Physical activity was measured objectively using the CSA accelerometer,190 and 
subjectively using the Stanford Seven-Day Physical Activity Recall220 and the Stage of 
Exercise Behaviour Change.22o The Seven-Day Recall measures the duration of sleep, 
and light, moderate, hard, very hard and total physical activity in minutes per week. 
Total physical activity is the sum of moderate, hard and very hard intensity physical 
activity. The stages of exercise behaviour change are: Precontemplation (inactive and 
no intention to change), Contemplation (inactive, but intending to change in the next 6 
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months), Preparation (engaging in some activity, but not regularly), Action (regularly 
physically active, but only began in the past 6 months), and Maintenance (regularly 
active for more than six months). Patients selected the stage of exercise behaviour 
change that described their physical activity behaviour over the previous two months at 
baseline. Patients in the action or maintenance stages considered themselves to be 
regularly physically active. 
Stage of Exercise Behaviour Change 
There were no study patients in the precontemplation or contemplation stages of 
change at baseline. Results revealed that 17.1 % (12nO) of the study sample were in 
preparation, 45.7% (32/70) were in action and 37.1 % (26/70) were in maintenance at 
baseline. Thus, 83% of the sample population were regularly physically active at 
baseline. This is because physical activity was measured within one month of the 
study sample completing an 11-week phase III exercise programme. 
Computer Scienc.e and Applications (CSA) Accelerometer 
CSA accelerometer counts/week at baseline were not normally distributed, thus 
median and interquartile range values are reported. In the total group, median 
accelerometer counts/week at baseline were 4025432 (3034626,5095810). 
Stanford Seven-Day Physical Activity Recall 
Baseline physical activity in minutes per week measured by the Stanford Seven-Day 
Recall were not normally distributed, thus median and interquartile range values are 
stated. Only two patients reported participating in very hard intensity physical activity, 
thus hard and very hard intensity categories were combined to produce a vigorous 
intensity activity category. Table 9 reports median values for total, moderate, vigorous 
and light intensity physical activity in minutes/week at baseline for the study group. 
Subjects participated in 248 minutes/week of moderate intensity activity and 26 
minutes/week of vigorous intensity activity. Total physical activity, which was the sum 
of moderate and vigorous intensity activity, was 288 minutes/week at baseline. 
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Table 9 Baseline Physical Activity (mins/week) Measured by the Seven-Day 
Physical Activity Recall 
Physical Activity Category 
Totala 
Moderate 
Vigorous 
Median (IQ Range) 
288 (192, 460) 
248 (142,381) 
26 (0, 82) 
Light 6029 (5560, 6282) 
a Total activity is the sum of moderate and vigorous intensity activity. 
Note. Values represent median and interquartile (IQ) range. 
Effect of an Exercise Consultation on Physical Activity 
Stage of Exercise Behaviour Change 
There were no experimental or control patients in the precontemplation or 
contemplation stages at baseline, six and 12 months. Table 10 shows the proportion of 
patients in the preparation, action and maintenance stages of exercise behaviour 
change at each time period by group. Subjects in the action and maintenance stages 
are considered to be regularly physically active. Therefore, the action and 
maintenance stages were combined to produce an action/maintenance category. Chi 
square tests and Fisher's exact tests were used to compare the number of patients in 
the preparation stage versus the action/maintenance category between and within the 
experimental and control groups. 
Table 10 shows that 88% of the experimental group and 77% of the control group 
were in action/maintenance at baseline, chi squared analysis reveals that this 
difference was not significant (x2=1.6, df=1, p=O.2). Thus, the majority of patients in 
both groups were regularly active at baseline. At six months, 84% of the experimental 
group and 690/0 of the control group were in the action/maintenance stage, this 
difference was not significant (X2=2.2, df=1, p=0.1). At 12 months, a greater proportion 
of the experimental group (85%) were in the action/maintenance category compared to 
the control group (67%), chi square analysis shows that this difference was not 
statistically significant (X2=3.0, df=1, p=O.08). 
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Chi square analysis revealed that the number of control patients who were in the 
action/maintenance category did not significantly change at six (X2=0.6, df=1, p=OA) 
and 12 months (X2=0.9, df=1, p=O.3) compared with baseline. Similarly, Fisher's exact 
tests found that the number of experimental patients in the action/maintenance 
category was similar at six months (p=0.73) and 12 months (p=0.73) compared with 
baseline. Thus, the number of regularly active patients in the experimental and control 
group did not significantly change at six and 12 months compared to baseline. 
Table 10 Proportion of Patients in the Preparation, Action and Maintenance Stages 
of Change at Baseline, Six and 12 Months by Group 
Stage of Change Experimental Group Control Group 
Baseline 
Preparation 11 % (4/35) 23% (8/35) 
Action 51 % (18/35) 40% (14/35) 
Maintenance 37% (13/35) 37% (13/35) 
Six months 
Preparation 16% (5/32) 31 (10/32) 
Action 19% (6/32) 7% (2/32) 
Maintenance 65% (21/32) 62% (20/32) 
12 months 
Preparation 15% (5/33) 33% (11/33) 
Action 6% (2/33) 3% (1/33) 
Maintenance 79% (26/33) 64% (21/33) 
Note. Values in parentheses represent number of patients. 
Change in Stage of Exercise Behaviour from Baseline to Follow-up 
The change in stage of exercise behaviour from baseline to six and 12 months in each 
group was determined by the following method. Patients were categorised into four 
groups: progression (progressed from preparation to action or maintenanc~), 
regression (regressed from action or maintenance to preparation), stable a~tlve 
(remained in action or maintenance) and stable inactive (remained in preparation). 
Table 11 shows the number of patients in each category at six and 12 months by 
group. 
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Table 11 Change in Stage of Exercise Behaviour from Baseline to Follow-up by Group 
Category 0 6M 0-12M 6-12M 
Experimental Control Experimental Control Experimental Control 
n = 32 n = 32 n = 33 n = 33 n = 32 n = 32 
Progression 1 3 2 4 3 4 
Regression 3 5 3 7 2 6 
Stable Active 26 19 26 18 25 17 
Stable Inactive 2 5 2 4 2 5 
Note. Values represent number of patients. 
Table 11 shows that few patients in both groups were in the progression, regression 
and stable inactive categories. Therefore, the progression and stable active categories 
were combined, as these patients were regularly physically active, in order to conduct 
chi-square analysis. Similarly, the stable inactive and regression categories were 
combined, as these patients were not regularly active. Figure 10 shows the proportion 
of patients in eac~ group who were regularly physically active at follow-up compared to 
baseline. From baseline to six months, 69% of the control group and 84% of the 
experimental group had progressed to action/maintenance or remained in 
action/maintenance (Figure 10), thus were regularly active (x2=2.2, df=1, p=0.1). From 
baseline to 12 months, a greater number of patients in the experimental group 
compared to the control group had remained regularly active or become regularly 
active, see Figure 10 (X2=3.0, df=1, p=0.08). From six to 12 months, a significantly 
greater proportion of experimental patients had remained in action/maintenance or 
progressed to action/maintenance than controls, see Figure 10 (x2=4.3, df=1, p=0.04). 
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Figure 10 Change in stage of exercise behaviour from baseline to six and 12 
months by group. Bars represent the proportion of patients remaining In 
action/maintenance stage or progressing from preparation to action/maintenance. 
Computer Science and Applications (CSA) Accelerometer 
Two control patients refused to wear the accelerometer at 12 months. In the 
experimental gro~p, one accelerometer malfunctioned and one patient refused to wear 
the accelerometer at six months. At 12 months, one accelerometer malfunctioned in 
the experimental group. 
GSA accelerometer data were not normally distributed, thus non-parametric tests were 
used to analyse the data. Table 12 reports medians and interquartile ranges for weekly 
GSA accelerometer counts at baseline, six and 12 months in the experimental and 
control group. Figure 11 and Table 13 demonstrates the median change in weekly 
GSA accelerometer counts from baseline to follow-up in the two groups. 
A Mann Whitney test revealed that GSA accelerometer counts per week at baseline 
were similar between the experimental and control group (98%CI -856002, 889959). 
In the experimental group, accelerometer counts increased by 1.9% (76431/3999309) 
from baseline to six months, 0.8% (33619/4257833) from six to 12 months, and 2.2% 
(86575/3999309) from baseline to 12 months. However, Wilcoxon signed rank tests 
revealed that the change in weekly accelerometer counts was not significant from 
baseline to follow-up in the experimental group (Table 13). In the control group, 
accelerometer counts decreased by 5.2% (-215141/4105603) from baseline to six 
months, 3% (-109691/3621195) from six to 12 months, and 8% (-328116/4105603) 
from baseline to 12 months. Similar to the experimental group, there was no Significant 
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change in weekly accelerometer counts from baseline to follow-up in the control group, 
reported in Table 13. Furthermore, Mann Whitney tests found that the difference 
between the groups for the change in weekly accelerometer counts was not significant 
from baseline to six months (98%CI -1143720, 607430), baseline to 12 months 
(98%el -1131128, 366473) and six to 12 months (98%CI -861968,647527). 
Table 12 CSA Accelerometer Counts at Baseline, Six and 12 Months by Group 
Time Experimental group Control group 
(months) Median (IQ Range) Median (IQ Range) 
0 3999309(2652408,5105019) 4105603(3089611,4779881) 
6 4257833(3074216,5556053) 3621195(3008800,5063930) 
12 4221539(2640305,5600396) 3674479(2746242,5035637) 
Note. The values represent median and interquartile (IQ) range. 
Experimental group: n=35 at baseline, n=33 at six months, n=31 at 12 months. Control 
group: n=35 at baseline, n=31 at six months, n=31 at 12 months. 
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Figure 11 Median values for CSA accelerometer counts/week at baseline, six and 
12 months in the experimental and control groups. 
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Table 13 Change in CSA Accelerometer Counts from Baseline to Follow-Up 
Time Period Experimental group Control group 
Baseline 6 months (-705643, 860599) (-680366, 349212) 
Baseline - 12 months (-381927, 504719) (-906564, 268168) 
Six months - 12 months (-737184, 671240) (-514984, 303570) 
Note. Values represent 98% confidence intervals for the change 
Stanford Seven Day Physical Activity Recall 
The Stanford Seven Day Physical Activity Recall measures minutes of sleep, and light, 
moderate, hard, very hard and total physical activity over the previous week. Total 
activity is the sum of moderate, hard and very hard intensity physical activity. 
Physical activity data was not collected at six months for one patient in the control 
group. Physical activity data was not normally distributed, therefore non-parametric 
tests were used to detect between and within group differences for each physical 
activity variable. Table 14 reports median values for total physical activity, vigorous, 
moderate and light intensity activity, and sleep in minutes/week at baseline, six and 12 
months by group. 
Table 14 Physical Activity (mins/week) by Group at Baseline and FollOW-Up 
PAa (mins/week) Baseline 6 months 12 months 
Totalb 
Experimental 300 (195, 470) 330 (188, 664) 360 (208, 590) 
Control 275 (175, 460) 235 (110, 369) 205 (68, 310) 
Vigorous 
Experimental 56 (5, 100) 73.5 (16, 250) 65 (0, 178) 
Control 10 (0, 40) 0(0,44) 
o (0, 0) 
Moderate 
Experimental 250 (115, 382) 235 (120, 489) 
215 (98, 371) 
Control 240 (145, 375) 222 (11 0, 311) 
190 (68, 282) 
Light 
Experimental 6120 (5615, 6460) 6028 (5629, 6402) 
5940 (5535, 6478) 
Control 5885 (5584, 6240) 6000 (5671,6390) 
6082 (5875,6410) 
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Sleep 
Experimental 3645 (3315, 3870) 3660 (3454, 3870) 3720 (3383, 4095) 
Control 3825 (3645, 4230) 3720 (3428, 4035) 3750 (3473, 3968) 
a PA Physical Activity b Total - moderate + vigorous intensity PA. 
Note. Values represent median and interquartile (IQ) range. 
Experimental group: n=35 baseline, n=32 at six months, n=33 at 12 months. Control 
group: n=35 baseline, n=32 at six months, n=33 at 12 months. 
Total Physical Activity 
Table 14 shows that total physical activity at baseline was 300 minutes/week in the 
experimental group and 275 minutes/week in the control group, there was no 
significant between group difference (98%CI -120, 100). The change in total activity 
(minutes/week) from baseline to six and 12 months in the experimental and control 
group is shown in Figure 12 and Table 15. Wilcoxon signed rank tests found that there 
was no significant change in total activity from baseline to six and 12 months in the 
experimental group, thus total activity was maintained over the study period in this 
group (Figure 12, Table 15). In the control group, total activity did not significantly 
change from baseline to six months. In contrast, total activity significantly decreased 
by 115 minutes/week from baseline to 12 months and 63 minutes/week from 6 to 12 
months in the control group. In addition, the between group difference for the change 
in total activity was borderline significant from baseline to 6 months (108 mins/week; 
98%CI -272, 25), was significant from baseline to 12 months (130 mins/week; 98%CI 
-295, -20) and was not significant from 6 to 12 months (75 mins/week; 98%CI-178, 40). 
Figures 11 and 12 show that the change in CSA accelerometer counts/week and total 
physical activity (minutes/week) from baseline to six months appear to track each other 
in both groups. In contrast, from six to 12 months Figures 11 and 12 illustrate a further 
increase in total physical activity (minutes/week) in the experimental group and a 
further decrease in the control group, whereas CSA accelerometer counts/week 
showed no further change from six to 12 months in either group. Thus, the change in 
total activity and weekly accelerometer counts do not track each other from six to 12 
months in either group. 
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Figure 12 Total physical activity (PA) in minutes/week at baseline, six and 12 
months in the experimental and control group 
Table 15 Median Change in Total Physical Activity (mins/week) from Baseline to 
Six and 12 Months by Group 
Total PAa (mins/week) Experimental Group Control Group 
Baseline - 6 months 47 (-43, 191) -55(-178,45) 
Baseline - 12 months 23 (-63, 154) -115 (-228, -28) 
6 months - 12 months 3 (-128,95) -63 (-126, -5) 
a PA = Physical Activity. Note. Values represent median change and 98% confidence 
interval for the change. Significant changes are represented in italics. 
Moderate Intensity Physical Activity 
Moderate intensity activity at baseline was similar (98%CI -85, 110) between the 
experimental group (250mins/week) and the control group (240 mins/week), as shown 
in Table 10. The change in moderate intensity activity (minutes/week) from baseline to 
follow-up in the experimental and control group is displayed in Figure 13 and Table 16. 
In the experimental group, there was no significant change in moderate activity from 
baseline to six and 12 months, therefore moderate intensity activity was maintained 
over the study period (Figure 13, Table 16). In the control group, moderate activity did 
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not significantly change from baseline to SIX months. In contrast, there was a 
significant decrease in moderate activity by 83 minutes/week from baseline to 12 
months (Figure 13, Table 16). In addition , there was a trend for a decrease in 
moderate activity by 48 minutes/week from six to 12 months in the control group 
(Figure 13, Table 16), However, the difference between the groups for the change in 
moderate activity was not significant from baseline to six months (60 mins/week; 
98% CI -190, 39), baseline to 12 months (75 mins/week; 98%CI -198, 30) and six to 
12 months (22 mins/week; 98%CI -99, 68) , 
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Figure 13 Moderate intensity physical activity (PA) in minutes/week at 
baseline, six and 12 months in the experimental and control group 
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Table 16 Median Change in Moderate Physical Activity (mins/week) from 
Baseline to Six and 12 Months by Group 
Moderate PAa (mins/week) Experimental Group Control Group 
Baseline 6 months 35 (-60, 113) -47 (-149, 49) 
Baseline - 12 months -10 (-90,83) -83 (-175, -14) 
6 months - 12 months -30 (-120, 39) -48 (-92, 2) 
a PA - Physical Activity. Note. Values are median change and 98% confidence interval 
for the change. Significant changes are represented in red text. 
Vigorous Intensity Physical Activity 
The change in vigorous intensity activity from baseline to follow-up by group is shown 
in Figure 14 and Table 17. There was a trend for baseline vigorous intensity activity to 
be higher in the experimental group compared to the control group (98%CI -61, 0). At 
baseline, vigorous activity was 56 minutes/week in the experimental group and 10 
minutes/week in the control group, see Table 14. Vigorous activity did not significantly 
change from baseline to follow-up in the experimental group (Figure 14, Table 17). In 
the control group, vigorous activity did not significantly change from baseline to six 
months, however there was a trend for a decrease in vigorous activity from baseline to 
12 months and six months to 12 months (Figure 14, Table 17). Between group 
differences for the change in vigorous activity was non-significant from baseline to six 
months (98%CI -90, 20) and six to 12 months (98%CI -90, 30). However, there was a 
bordeline significant difference between the groups for the change in vigorous activity 
from baseline to 12 months (45 mins/week; 98%CI -110, 0). 
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Figure 14 Vigorous physical activity (PA) in mins/week at baseline, six and 12 
months by group 
Table 17 Median Change in Vigorous Activity (mins/week) from Baseline to Six 
and 12 Months by Group 
Vigorous PAa (mins/week) 
Baseline - 6 months 
Baseline - 12 months 
6 months - 12 months 
Experimental Group 
31 (-21, 117) 
35(-15,112) 
o (-68, 65) 
Control Group 
0(-20, 22) 
-8 (-40, 0) 
-5 (-40, 0) 
a PA = Physical Activity. Note. Values represent median change and 98% confidence 
interval. 
Light Intensity Physical Activity 
Light intensity activity per week at baseline was not significantly different between the 
experimental and control group (98%CI -485, 65) . There was no significant change in 
light intensity physical activity from baseline to six and 12 months follow-up in the 
experimental group (Figure 15, Table 18). In the control group, light intensity activity 
did not significantly change from baseline to six months, and six to 12 months (Table 
18, Figure 15). In contrast, light activity significantly increased by 205 minuteslweek 
from baseline to 12 months in the control group. Furthermore, there was a significant 
difference between the groups for the change in light activity from baseline to 12 
months (290 minutes/week; 98%CI 50, 550). 
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Table 18 Median Change in Light Activity (mins/week) from Baseline to Six and 
12 Months by Group 
Light PAa (mins/week) Experimental Group Control Group 
Baseline 6 months -20 (-249, 185) 95 (-95, 347) 
Baseline - 12 months -70 (-308, 104) 205 (48, 388) 
6 months - 12 months -21 (-185, 113) 71 (-90, 248) 
a PA Physical Activity. Note. Values represent median change and 98% confidence 
interval for the change. Significant changes are represented italics. 
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Figure 15 Light intensity physical activity (PA) in minutes/week week at baseline, 
six and 12 months in the experimental and control groups 
Sleep 
Baseline minutes of sleep per week was higher in the control group compared to the 
experimental group, this difference was not statistically significant (98%CI -30, 450) 
Sleep did not significantly change from baseline to follow-up in the either group (Table 
19). 
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Table 19 Median Change in Sleep (mins/week) from Baseline to Six and 12 
Months by Group 
Sleep (minutes/week) Experimental Group Control Group 
Baseline 6 months -44 (-233, 158) -45 (-210,75) 
Baseline - 12 months 53 (-105, 248) -90 (-233, 53) 
6 months - 12 months 60 (-38, 278) o (-143, 113) 
Note. Values represent median change and 98% confidence interval. 
Effect of an Exercise Consultation on Cardiorespiratory Fitness 
Cardiorespiratory fitness, specifically exercise capacity and submaximal endurance 
capacity, was determined by cardiopulmonary exercise testing. Cardiorespiratory 
fitness data was normally distributed, therefore parametric tests were used to detect 
differences between and within groups. 
Exercise Capacity 
Cardiorespiratory variables measured at peak exercise were used to determine 
exercise capacity. In the control group, values for oxygen uptake, ventilation and 
respiratory exchange ratio (RER) were unavailable for one patient at baseline as the 
portable metabolic system malfunctioned. In the experimental group, values for 
oxygen uptake, ventilation and RER were unavailable for one patient at baseline and 
three patients at six months as the portable metabolic system malfunctioned. 
Table 20 reports mean values for exercise capacity variables at baseline, six and 12 
months in each group. The mean change in exercise capacity parameters from 
baseline to follow-up by group is demonstrated in Table 21. 
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Table 20 Exercise Capacity Variables by Group at Baseline, Six and 12 Months 
Baseline 6 months 12 months 
n Mean ± SO n Mean ± SO n Mean ± SO 
Peak V02 ml/min 
Experimental 34 2287 ± 579 29 2129 ± 561 33 2118 ± 584 
Control 34 1950 ± 643 33 1817 ± 641 33 1774 ± 690 
Peak V02 ml/kg/min 
Experimental 34 26.9 ± 6.6 28 26.1 ± 6.9 33 25.1 ± 6.2 
Control 34 24.4 ± 6.5 33 22.5 ± 6.2 32 22.0 ± 6.1 
Exercise Time (sees) 
Experimental 31 513 ± 155 27 508 ± 166 29 532 ± 179 
Control 33 470 ± 226 32 481 ± 281 32 484 ± 264 
Peak VE 
Experimental 34 69.9 ± 17.8 29 68.6 ± 18.7 33 69.9 ± 20.9 
Control 34 61.1±20.0 33 57.9 ± 18.9 33 56.6 ± 19.3 
RER 
Experimental 34 0.94 ± 0.09 29 1.02 ± 0.12 33 1.04±0.10 
Control 34 0.93 ± 0.08 33 0.97±0.11 33 0.98 ± 0.12 
Peak HR 
Experimental 34 126.6±22.8 28 128.8±26.6 33 126.2±24.8 
Control 34 121.8±20.2 33 116.5±22.4 32 114.2±20.1 
Peak V02/HR 
Experimental 34 17.9±3.5 28 16.9±3.7 
33 16.9±3.7 
Control 34 16.1±4.8 33 15.6±4.7 
32 15.4±5.3 
V0
2 
= oxygen uptake; VE = ventilation; RER = respiratory exchange ratio, HR - heart rate; 
V02/HR = oxygen pulse. 
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Table 21 Mean Change in Exercise Capacity Variables from Baseline to Six and 
12 Months by Group 
0 6 months 0-12 months 6 - 12 months 
Peak V02 ml/min 
Experimental 
-82 (-169, 5) 
-136 (-267, -5) 
- 57 (-180,65) 
Control 
-121 (-244,2) 
-147 (-270, -23) 
-23(-121,75) 
Peak V02 ml/kg/min 
Experimental 
-1.0 (-2.2, 0.2) 
-1.8 (-3.2, -0.3) 
-1.1 (-2.5,0.3) 
Control 
-1.6 (-3.0, -0.1) 
-2.3 (-3.8, -0.8) 
-0.6 (-2.0, 0.7) 
Exercise Time (secs) 
Experimental 
-1.2 (-52, 50) 16 (-42, 75) 22 (-25, 70) 
Control 24 (-44,91) 25 (-44, 94) 
-5 (-54, 44) 
Peak VE (11m in) 
Experimental 0.9 (-3.1, 4.9) 1.4 (-2.8,5.7) 
-0.1 (-4.0, 3.8) 
Control 
-1.9 (-6.7, 3.0) 
-1.7 (-6.6, 3.2) 
-0.05 (-3.2, 3.1) 
RER 
Experimental 0.07 (0.03, 0.11) 0.09 (0.06, 0.13) 0.02 (-0.01, 0.06) 
Control 0.05 (0.01, 0.10) 0.07 (0.03,0.11) 0.01 (-0.03, 0.06) 
Peak HR 
Experimental 0.5 (-4.5, 5.4) -0.3 (-5.0, 4.5) -1 .6 (-6.3, 3. 1 ) 
Control -4.4 (-9.6, 0.82) -5.6 (-10.6, -0.7) -1.8 (-4.8,1.3) 
Peak V02/HR 
Experimental -0.6 (-1.5, 0.3) -1.0 (-1.9, 0) -0.3 (-1.4, 0.9) 
Control -0.5 (-1.5, 0.5) -0.5 (-1.3, 0.3) o (-0.9, 1.0) 
Note. Values represent median change and 98% confidence interval for the change. 
V02 = oxygen uptake; VE = ventilation; RER = respiratory exchange ratio, HR = heart 
rate; V02/HR = oxygen pulse. Significant changes are represented in italics. 
Baseline mean peak V02 (mllmin) was higher in the experimental group compared to 
the control group, this between group difference was not statistically significant (98%CI 
--691, 17), see Table 20. Peak V02 in mllmin decreased by 3.6% (82/2287) in the 
experimental group and 6.2% (121/1950) in the control group from baseline to six 
months, this difference was near significant (Table 21). Furthermore, there was a 
significant decrease in peak V02 mllmin by 5.9% (136/2287) in the experimental group 
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and 7.5% (147/1950) in the control group from baseline to 12 months (Table 21). In 
contrast, peak V02 mllmin did not significantly change from six to 12 months In the 
experimental group [2.7% (57/2129)] and the control group [1.3% (23/1817)], as 
displayed in Table 21. Furthermore, the difference between the groups for the change 
in peak V02 ml/min was not significant from baseline to six months (98%CI -185.3, 
108) and 12 months (98%CI -186.6, 164.5), and six to 12 months (98%CI -118.8, 
187.0). Thus, the decrease in peak V02 from baseline to follow-up was similar in the 
experimental and control group. 
Table 20 shows that baseline peak V02 corrected for body weight was 26.9 (SO 6.6) 
ml/kg/min in the experimental group and 24.4 (SO 6.5) ml/kg/min in the control group, 
this difference was not significant (98%CI -6.24, 1.30). Peak V02 declined from 
baseline to six months by 1 ml/kg/min (3.7%) in the experimental group and 1.6 
ml/kg/min (6.5%) in the control group, this decline was borderline significant in the 
experimental group and was significant in the control group (Table 21). From baseline 
to 12 months, ex~rcise capacity significantly decreased by 1.8 ml/kg/min (6.7%) in the 
experimental group and 2.3 ml/kg/min (9.4%) in the control group (Table 21). From six 
to 12 months, peak V02 decreased by 1.1 ml/kg/min (4.2%) in the experimental group 
and 0.6 ml/kg/min (2.7%) in the control group. This decrease in peak V02 (ml/kg/min) 
from six to 12 months was borderline significant in the experimental group. Two 
sample t tests revealed that the decline in peak V02 ml/kg/min was similar in the 
experimental and control groups from baseline to six (98%CI -2.4, 1.2) and 12 months 
(98% CI -2.5, 1.5) and six to 12 months (98%CI -1.4, 2.4). Figure 16 illustrates the 
decline in peak V02 ml/kg/min from baseline to follow-up in the experimental and 
control groups. 
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Figure 16 Mean peak V02 (ml/kg/min) at baseline, six and 12 months follow-up 
by group. 
Exercise duration (seconds) at baseline was similar between the groups (98%CI -
158.2, 72.7), shown in Table 20_ Exercise duration did not significantly change from 
baseline to follow-up in the experimental group or the control group, as shown in Table 
21 and Figure 17. Furthermore, there was no significant difference between the 
groups for the change in exercise duration from baseline to six months (98%CI -58, 
107), baseline to 12 months (98%CI -79, 96), and six to 12 months (98%CI -93, 39) . 
Exercise duration at each time period by group is shown in Figure 17. 
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Figure 17 Mean exercise duration (sees) at baseline, six and 12 months follow-
up by group. 
Peak ventilation at baseline was higher in the experimental group compared to the 
control group (Table 20), the between group difference was not statistically significant 
(9B%CI -19.B, 2.1). Table 21 shows that peak ventilation did not significantly change 
from baseline to six and 12 months follow-up in either group. Similarly, the between 
group difference for the change in peak ventilation was not significant from baseline to 
six months (9B% CI -B.B, 3.4), baseline to 12 months (9B%CI -9.4, 3.2) and six to 12 
months (9B%CI -4.B, 4.9). 
As reported in Table 20, baseline respiratory exchange ratio (RER) at peak exercise 
was 0.93 in the control group and 0.94 in the experimental group, the between group 
difference was not significant (9B%CI -0.06, 0.04). There were similar significant 
increases in peak RER from baseline to six and 12 months in both groups (Table 21) . 
In contrast, RER did not significantly change from six to 12 months in either group. 
Peak heart rate at baseline was 126.6 bpm (SO 22.B) in the experimental group and 
121.B bpm (SO 20.2) in the control group (9B%CI -17.7, B.1), see Table 20. In the 
control group, there was a decline in peak heart rate from baseline to six months by 
4.4 bpm (9B%CI -9.6, 0.B2) and a significant decrease from baseline to 12 months by 
5.6 bpm (9B%CI -10.6, -0.7) , as shown in Table 21. In contrast, peak heart rate did not 
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significantly change from baseline to six and 12 months follow-up in the experimental 
group (Table 21). Two sample t tests revealed a greater decline in peak heart rate 
from baseline to 12 months in the control group compared to the experimental group 
(98%CI -12.0, 1.3) . 
Table 20 shows that there was a trend for baseline peak V02/HR (ml/beat) to be 
higher in the experimental group compared to the control group (98%CI -4.3, 0.7) . 
Peak oxygen pulse did not significantly change from baseline to six and 12 months in 
the control group (Table 21). Similarly, there was no significant change in peak oxygen 
pulse from baseline to six months and from six to 12 months in the experimental group 
(Table 21). In contrast, there was a trend for decline in peak oxygen pulse in the 
experimental group from baseline to 12 months. However, two sample t tests revealed 
no significant difference between the groups for the change in peak oxygen pulse from 
baseline to six (98%CI -1.2,1.4),12 months (98%CI -0.7,1.6) and six to 12 months 
(98%CI -1.1, 1.8). Peak oxygen pulse at baseline, six and 12 months by group is 
illustrated in Figur~ 18. 
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Figure 18 Peak oxygen pulse (V02/HR) in ml/beat at baseline, six and 12 months 
in the experimental and control groups 
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Proportion of Patients Taking Beta-blocker Medication 
Beta-blocker medication can affect exercise capacity in terms of peak V02 and peak 
heart rate. Therefore, the change in beta-blocker medication from basel ine to fo llow-up 
was examined to determine if alterations in medication could have influenced the 
outcome of the exercise capacity variables. 
Figure 19 displays the proportion of patients taking beta-blocker medication at 
baseline, six and 12 months in each group. At baseline, 74.3% (26/35) of patients in 
the control group and the experimental group were taking beta-blocker medication. 
Figure 19 shows that the proportion of patients taking beta-blocker medication did not 
markedly change at six and 12 months in either group. Four control patients and two 
experimental patients had their dose of medication changed at six months compared 
to baseline. In addition, three controls and five experimental patients had their 
medication dose altered at 12 months compared to baseline. 
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Figure 19 Proportion of patients taking beta-blocker medication at baseline, six 
and 12 months in both groups. 
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Submaximal Endurance Capacity 
Submaximal endurance capacity was determined by estimating the oxygen uptake in 
mllmin at the lactate threshold (V02 L T). The lactate threshold could not be detected at 
each time period for five control patients and three experimental patients. In addition, 
data was unavailable for two experimental patients at 6 months as the portable 
metabolic system malfunctioned. 
Table 22 reports mean values for oxygen uptake (ml/min) at the lactate threshold at 
baseline, six and 12 months in each group. The mean change in V02 L T from baseline 
to follow-up by group is demonstrated in Table 23. 
Oxygen uptake (ml/min) at the lactate threshold (V02 L T) at baseline was similar 
between the experimental and control group (98%CI -257.0, 108.8). In the control 
group, there was a trend for a decrease in V02 L T by 52 ml/min from baseline to six 
months (Table 23). However, there was no further significant change in V02 L T from 
baseline to 12 months, and six to 12 months in the control group (Table 23). In the 
experimental group, there was a trend for an increase in V02 L T by 47ml/min from 
baseline to six months and a significant increase by 81 ml/min from baseline to 12 
months (Table 23). Although, there was no significant change in V02 L T from six to 12 
months in the experimental group. The difference between the groups for the change 
in V02 L T was significant from baseline to 6 months (98%CI -185.4, -12.6) and 
baseline to 12 months (98%CI -216.7, -34.6). Figure 20 demonstrates the V02 L T at 
baseline, six and 12 months by group. 
Table 22 Oxygen Uptake at the Lactate Threshold (V02 L T) at Baseline, Six and 
12 Months by Group 
Time Period 
Baseline 
Six months 
12 months 
Experimental Group 
1251±273 
1274±267 
1332±278 
Note. Values represent mean ± SD. 
Control Group 
1177±311 
1140±285 
1132±316 
Experimental group: n=30 baseline, n=27 at six months, n=30 at 12 months. Control 
group: n=29 baseline, n=28 at six months, n=29 at 12 months. 
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Figure 20 Oxygen uptake (mllmin) at lactate threshold in the experimental and 
control groups at baseline, six and 12 months 
Table 23 Mean Change in Oxygen Uptake (mllmin) at the Lactate Threshold from 
Baseline to Six and 12 Months by Group 
Time Period Experimental Group Control Group 
Baseline - Six months 47 (-14, 109) -52 (-116, 12) 
Baseline - 12 months 81 (22, 140) -45 (-118,28) 
Six months - 12 months 43 (-28, 113) 7 (-43, 57) 
Note. Values represent median change and 98% confidence interval for the change. 
Significant changes are represented in italics. 
Effect of an Exercise Consultation on the Processes of Exercise Behaviour 
Change 
The processes of change are strategies that individuals use when changing their 
exercise behaviour.16o The five experiential processes of exercise behaviour change 
are consciousness raising (CR), social liberation (SL), dramatic relief (DR), 
environmental re-evaluation (ER) and self re-evaluation (SR). The five behavioural 
processes are: helping relationships (HR), stimulus control (SC), counter conditioning 
(CC), self-liberation (SO), reinforcement management (RM). A description of each 
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process of exercise behaviour change is provided in Table 6, Chapter One. The 
processes of exercise behaviour change were measured using a questionnaire, the 
score for each process ranges from 4 to 20. 
Scores for the processes of change were not normally distributed, therefore non-
parametric tests were used to analyse between and within group differences for each 
process of exercise behaviour change. In the control group, one patient at six months 
and one patient at 12 months did not complete the process of change questionnaire. 
In the experimental group, one patient at baseline, two patients at six months and one 
patient at 12 months did not complete the questionnaire. 
Experiential Processes 
The median values for the use of the experiential processes at baseline and follow-up 
in the experimental and control groups. The use of the five experiential processes at 
baseline was similar between the experimental and control groups (Table 24). The 
median change in the use of each experiential process from baseline to six and 12 
months follow-up is described in Table 25. There was a borderline decrease in 
consciousness raising from baseline to 12 months in both groups. Social liberation did 
not significantly change from baseline to follow-up in either group. Dramatic relief did 
not significantly change from baseline to six and 12 months in the experimental group, 
whereas there was a significant decrease in the use of this process from baseline to 
12 months in the control group. Environmental re-evaluation did not significantly 
change from baseline to follow-up in the control group, whereas this process 
significantly decreased from baseline to 12 months in the experimental group. There 
was a trend for self re-evaluation to decrease from baseline to 12 months in both 
groups. In addition, there was a trend for a decrease in self re-evaluation from 
baseline to six months in the experimental group. However, the difference between the 
experimental and control group for the change experiential process use from baseline 
to six and 12 months follow-up was not significant. 
1-+2 
Table 24 Experiential Processes by Group at Baseline, Six and 12 Months 
Experiential Processes Baseline 6 months 12 months 
CR 
Experimental 11 (9, 13.2) 12 (8, 13) 10 (8, 12) 
Control 11 (7, 14) 9.5 (7.2, 14.5) 10 (7.2, 12.8) 
SL 
Experimental 15 (12, 17) 14.5 (11.8,16) 14(11,17.8) 
Control 13 (11, 16) 13.5 (11,16) 13(10,15) 
DR 
Experimental 7.5(5,11) 7 (5, 9.2) 6.5 (5, 8) 
Control 8 (6, 12) 7 (5, 10) 6 (5,8) 
ER 
Experimental 12 (8, 13) 10(8, 12) 9 (7, 10) 
Control 10 (7, 13) 8.5 (6.2, 12) 8.5 (7, 11.8) 
SR 
Experimental 15 (11.5, 16) 13 (10.8, 15.2) 12 (10.2, 15.8) 
Control 13 (9,16) 12 (9, 15) 11 (9, 14) 
Note. Values represent median and interquartile range. 
CR = consciousness raising, SL = social liberation, DR = dramatic relief, SR = self re-
evaluation, ER = environmental re-evaluation. 
Experimental group: n=34 baseline, n=30 at six months, n=32 at 12 months. Control group: 
n=35 baseline, n=32 at six months, n=32 at 12 months. 
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Table 25 Median Change in Experiential Processes by Group from Baseline to 
Six and 12 Months 
Experiential Processes 0 6 months 0-12 months 6 -12 months 
CR 
Experimental 
-0.5 (-1.5, 0.5) 
-1.5 (-3, 0) 
-1.0 (-2, 0.5) 
Control 
-0.5 (-1.5, 0.5) 
-1.0 (-2, 0) 
-0.5 (-1.5, 0.5) 
SL 
Experimental 
-0.5 (-2.5, 0.5) 
-1 (-2.5, 1) 
-0.5 (-1.5, 1) 
Control 0(-1.5,1.5) 
-0.5 (-2, 1) 0(-1,1) 
DR 
Experimental 0(-1,1) -0.5(-2,1) 
-1 (-2,0.5) 
Control 
-0.5 (-1.5, 0.5) -1.5 (-2.5, -0.5) 
-0.5 (-1.5, 0.5) 
ER 
Experimental -1 (-2.5, 0) -2 (-3, -0.5) -0.5 (-2, 0.5) 
Control 0(-1.5,1) -0.5 (-2, 1) -0.5 (-2,1) 
SR 
Experimental -1.5 (-3, 0) -1.5 (-3, 0) 0(-1,1) 
Control 0(-1.5,1) -1 (-3, 0) -0.5 (-2, 0.5) 
Note. Values represent median change and 98% confidence interval for the change. 
CR = consciousness raising, SL = social liberation, DR = dramatic relief, SR = self re-
evaluation, ER = environmental re-evaluation. 
Significant changes are shown in italics. 
Behavioural Processes 
Table 26 demonstrates the median values for the use of the behavioural processes of 
change at baseline and follow-up in the experimental and control groups. The use of 
four of the five behavioural processes of change at baseline were similar between the 
experimental and control group (Table 26). In contrast, there was a trend for the 
experimental group to use counterconditioning more often than the control group 
(98° loCI -4, 0). The change in the use of each behavioural process from baseline to six 
and 12 months follow-up is described in Table 27. There was a trend for a decrease in 
helping relationships from baseline to six in the control group. In addition, there was a 
trend for helping relationships to decrease from baseline to 12 months in both groups. 
Stimulus control and counter conditioning did not significantly change from baseline to 
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six and 12 months follow-up in the control group. However, there was a trend for a 
decrease in the use of both these processes from baseline to 12 months in the 
experimental group. There was no significant change in self-liberation and 
reinforcement management from baseline to six and 12 months in either group. Mann 
Whitney tests found that difference between the groups for the change in the use of 
the five behavioural processes was not significant from baseline to six and 12 months. 
Table 26 Behavioural Processes by Group at Baseline, Six and 12 Months 
Behavioural Processes 
HR 
Experimental 
Control 
SC 
Experimental 
Control 
CC 
Experimental 
Control 
SO 
Experimental 
Control 
RM 
Experimental 
Control 
Baseline 
8 (6, 11) 
9 (6, 12) 
6 (5, 9) 
7 (4, 9) 
13.5 (10, 15.20 
11 (9, 13) 
10 (8, 12.2) 
10 (7, 13) 
10 (8, 12) 
9 (8, 11) 
6 months 
6.5 (4,10) 
7.5 (5, 11.8) 
6.5 (5,9) 
6.5 (5.2, 8.8) 
12.5 (9.8, 15) 
12 (10, 14) 
8.5 (7, 13) 
9 (7, 11) 
10 (7.8,12) 
10 (8, 12) 
Note. Values represent median and interquartile range. 
12 months 
7 (5, 9.8) 
6.5 (4, 11.8) 
6.5 (4.2,8) 
7 (5, 8) 
11.5(9,14) 
11 (9,13) 
8(7.2,11) 
9(7,11.8) 
9 (7, 11.8) 
10 (7, 12) 
HR = helping relationships, SC = stimulus control, CC = counter conditioning, SO = self-
liberation, RM = reinforcement management. 
Experimental group: n=34 baseline, n=30 at six months, n=32 at 12 months. Control group: 
n=35 baseline, n=32 at six months, n=32 at 12 months. 
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Table 27 Median Change in Behavioural Processes by Group from Baseline to Six 
and 12 Months 
Behavioural Processes 0 6 months 0-12 months 6 -12 months 
HR 
Experimental 
-1 (-2, 0.5) 
-1.5 (-2.5, 0) 0(-1.5,1) 
Control 
-1 (-2.5, 0) 
-1.5 (-3, 0) 
-0.5 (-2, 1.5) 
SC 
Experimental 
-0.5 (-2, 0.5) 
-0.5 (-1.5, 0) 
-0.5 (-1, 0.5) 
Control 0(-1,1) 
-0.5 (-1.5, 0.5) o (-1, 0.5) 
CC 
Experimental 
-0.5 (-2.5, 0.5) 
-1.5 (-2.5, 0) 
-1 (-2, 0.5) 
Control 0.5 (-1, 1.5) -1 (-2, 0.5) 
-0.5 (-2, 0.5) 
SO 
Experimental -0.5 (-2, 1) -1 (-2, 0.5) 0(-1.5,1) 
Control -0.5 (-2, 0.5) -1 (-2, 0.5) 0(-1.5, 1.5) 
RM 
Experimental -0.5 (-2, 0.5) -0.5 (-2, 0.5) 0(-1,1) 
Control 0(-1,1) -0.5 (-1.5, 0.5) -0.5 (-1.5, 1) 
Note. Values represent median change and 98% confidence interval for the change. HR 
= helping relationships, SC = stimulus control, CC = counter- conditioning, SO = self-
liberation, RM = reinforcement management. 
Effect of an Exercise Consultation on Anthropometric Variables 
Weight and BodyMass Index 
Anthropometric data was normally distributed. Therefore, parametric tests were used 
to determine between and within group differences for weight and body mass index 
(8MI). Weight was not recorded for one control patient at 12 months, and two 
experimental patients (one subject at six months and one subject at 12 months). 
Mean values for weight and 8MI at baseline, six and 12 months by group are 
displayed in Figure 21 and Figure 22, respectively. The mean change in weight and 
8MI from baseline to six and 12 months are reported in Table 28. 
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There was trend for mean weight at baseline to be higher in the experimental group 
compared to the control group (98%CI -15.1, 1.2), see Figure 21 . Figure 21 and 
Table 28 shows that mean weight did not significantly change from baseline to six and 
12 months in either group. 
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Figure 21 Mean weight (kg) at baseline, six and 12 months by group. 
Experimental group: n=35 baseline, n=31 at 6 months, n=32 at 12 months. Control 
group: n=35 baseline, n=33 at 6 months, n=32 at 12 months. 
Table 28 Mean Change in Weight and BMI from Baseline to Follow-Up by Group 
Variable 0-6 months 0-12 months 6 -12 months 
Weight (kg) 
Experimental 0.06 (-1.35, 1.48) 0.06 (-1.78, 1.90) 0.10 (-1.26, 1.45) 
Control 0.27 (-1.48, 2.02) 0.75 (-1.32, 2.82) 0.55 (-0.57, 1.67) 
BMI 
Experimental 0.01 (-0.48, 0.50) 0.01 (-0.60, 0.62) 0.03 (-0.39, 0.46) 
Control 0.14 (-0.46, 0.50) 0.28 (-0.44, 1.0) 0.16 (-0.22,0.55) 
Note. Values represent mean change and 98% confidence interval for the change 
Mean BMI at baseline was 27.01 kg/m 2 in the control group and 28.48 kg/m 2 in the 
experimental group, the between group difference was borderline significant (98%CI -
147 
-N E 
-C'l 
.:.:: 
-
2: 
OJ 
3.47, 0.52) . Mean 8MI did not significantly change from baseline to six and 12 months 
in either group, as shown in Figure 22 and Table 28. 
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Figure 22 Mean 8MI (kg/m 2) at baseline, six and 12 months by group. 
Proportion of Obese Patients 
The proportion of obese patients, defined as those with a BMI>30kg/m2, in each group 
at baseline, six and 12 months was calculated and is displayed in Figure 23. Chi 
square analysis found that the number of obese patients were similar between the 
experimental group and the control group at baseline (X2=1 .30; df =1, p=0.26), six 
months (X2=0.97; df =1, p=0.32) and 12 months (X2=0.72; df =1, p=0.40). At baseline, 
28.5% (10/35) of the experimental group and 17.1 % (6/35) of the control group were 
obese, as shown in Figure 23. The number of obese patients in the control group did 
not significantly change from baseline to six (X2=0.52; df =1 , p=0.47) and 12 months 
(x2=0.24; df =1, p=0.63). Similarly, in the experimental group there was no significant 
change in the number of obese patients from baseline to six months (X2=0.36; df =1 , 
p=0.55) and 12 months (X2=0.06; df=1 , p=0.81). 
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Figure 23 Proportion of obese patients (BMI>30kg/m2) in the experimental and 
control groups at baseline, six and 12 months. 
Proportion ot Overweight Patients 
The proportion of overweight patients, defined as those with a BMI>25kg/m2 , in each 
group at baseline, six and 12 months was calculated and the results are shown in 
Figure 24. A similar number of patients in the experimental group and the control 
group were overweight at baseline (X2=O.36; dt =1, p=O.55), six months (X2=O.27; dt 
=1, p=O.60) and 12 months (x2=1.64; dt =1, p=O.20), see Figure 24. At baseline, 
82.9% (29/35) of the experimental group and 77.1 % (27/35) of the control group were 
overweight. In the control group, the number of overweight patients did not significantly 
change from baseline to six months (X2=O.03; dt =1, p=O.87) and 12 months (x2=O.04; 
dt =1, p=O.83). Similarly, there was no significant change in the number of overweight 
patients in the experimental group from baseline to six months (X2=O.01; dt=1 , p=O.91) 
and 12 months (X2=O.28; df=1, p=O.60). 
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Figure 24 Proportion of overweight patients (BMI>25kg/m2) in the 
experimental and control groups at baseline, six and 12 months. 
Effect of an Exercise Consultation on Blood Lipids 
Non-parametric tests were used to analyse the between and within group differences, 
as the lipid data were not normally distributed. Cholesterol and triglyceride values were 
not recorded for one control patient and one experimental patient at six months. LDL 
and HDL cholesterol values were not recorded at baseline for two control patients and 
two experimental patients. Median values for cholesterol , triglycerides, LDL 
cholesterol, HDL cholesterol and cholesterol/HDL cholesterol ratio at baseline, six and 
12 months in the experimental group and the control group are displayed in Table 29. 
The median change in lipid values from baseline to six and 12 months by group are 
shown in Table 30. 
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Table 29 Blood Lipid Levels by Group at Baseline, 6 and 12 Months 
Baseline 6 months 12 months 
Cholesterol 
Experimental 4.34 (3.81,4.79) 4.31 (3.69, 4.93) 4.51 (3.80, 5.97) 
Control 4.19 (3.86, 4.89) 4.50 (3.83, 4.82) 4.29 (3.98, 5.05) 
Trig Iycerides 
Experimental 1.66 (1.23, 2.28) 1.65 (1.12, 2.06) 1.66 (1.26, 2.26) 
Control 1.50 (0.95, 1.98) 1.28 (0.97, 2.28) 1.44 (1.00, 2.21) 
LDL-C 
Experimental 2.51 (2.04, 2.76) 2.29 (1.96, 2.76) 2.31 (1.90,2.77) 
Control 2.30 (1.96, 2.89) 2.44 (1.89, 2.90) 2.39 (1.90, 2.83) 
HDL-C 
Experimental 1.10 (1.00,1.30) 1.20 (1.09, 1.40) 1.25 (1.08, 1.48) 
Control 1.20 (1.00, 1.40) 1.24 (1.08, 1.52) 1.24 (1.10, 1.56) 
ChoI/HDL-C 
Experimental . 3.68 (3.08, 4.58) 3.49 (2.80, 3.98) 3.32 (2.94, 4.13) 
Control 3.42 (3.22, 4.49) 3.46 (3.11, 4.10) 3.47 (3.02, 4.09) 
Note. Values represent median and interquartile (IQ) range. 
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Table 30 Median Change in Blood Lipid Levels from Baseline to Six and 12 
Months by Group 
0 6 months 0-12 months 6 - 12 months 
Cholesterol 
Experimental 0.07 (-0.20, 0.30) 0.14 (-0.11, 0.3S) 0.08 (-0.09,0.24) 
Control 0.03 (-0.30, 0.28) 0.08 (-0.3S, 0.34) -0.04 (-0.23, 0.16) 
Trig Iycerides 
Experimental 0.04 (-0.20, 0.28) 0.09 (-0.08, 0.30) 0.06 (-0.19, 0.36) 
Control -0.08 (-0.33, 0.22) 0.07 (-0.14, 0.28) 0.08 (-0.09,0.22) 
LDL-C 
Experimental -0.04 (-0.2S, 0.14) -0.10 (-O.3S, 0.11) 0.02 (-0.20, 0.21) 
Control 0.01 (-0.23, 0.20) -0.02 (-0.34, 0.21) -0.02 (-0.22, 0.17) 
HDL-C 
Experimental 0.08 (-0.01, 0.19) 0.11 (0.04, 0.18) 0.02 (-O.OS, 0.09) 
Control O.OS (-0.10, 0.12) 0.06 (-0.02, 0.14) -0.01 (-0.06, 0.06) 
ChoI/HDL-C 
Experimental -0.21 (-0.72, 0.06) -0.21 ( -OA4, -0.02) 0.04 (-0.21, 0.32) 
Control -0.16 (-0.46, 0.12) -0.11 (-OAO, 0.11) 0.03 (-0.18, 0.23) 
Note. Values represent median change and 98% confidence interval for the change. 
Total Cholesterol 
Baseline cholesterol values were 4.34 mmol/l in the experimental group and 4.19 
mmol/l in the control group (Table 29), which are below the level recommended by 
national guidelines (i.e. < S mmol/l). A Mann Whitney test revealed that baseline 
cholesterol levels were similar between the groups (98%CI -OA4, 0.S1). Table 30 
demonstrates that cholesterol levels did not significantly change from baseline to six 
and 12 months in the experimental group or the control group. Similarly, there was no 
significant difference between the groups for the change in cholesterol from baseline 
to six months (98%CI -OAO, 0.32), baseline to 12 months (98% CI -0.41,0.28) and six 
to 12 months (98%CI-0.37, 0.14). 
Triglycerides 
Table 29 shows that baseline triglyceride concentrations were 1.66 mmol/l in the 
experimental group and 1.S0 mmol/l in the control group, which are within the normal 
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range (i.e. <5.2 mmol/l). Mann Whitney test revealed that baseline triglyceride levels 
were similar between the groups (98%CI -0.58, 0.18). Triglyceride levels did not 
significantly change from baseline to follow-up in either group (Table 30). Similarly, 
there was no significant difference between the groups for the change in triglycerides 
from baseline to six months (98%CI -0.45, 0.23), baseline to 12 months (98%CI _ 
0.29, 0.24) and six to 12 months (98%CI -0.31, 0.30). 
LOL Cholesterol 
Table 29 shows that median values for LDL cholesterol were similar in the 
experimental and control groups at baseline (98%CI -0.39, 0.47), and were lower than 
recommended targets (Le. < 3 mmol/l) at baseline, six and 12 months in both groups. 
LDL cholesterol concentrations did not significantly change from baseline to six and 12 
months in either group (Table 30). Similarly, there was no significant difference 
between the groups for the change in LDL-C from baseline to six months (98%CI -
0.22,0.29), 12 months (98%CI -0.24, 0.40) and six to 12 months (98%CI -0.29,0.24). 
HOL Cholesterol 
As shown in Table 29 and Figure 25, baseline HDL cholesterol concentrations were 
similar (98% CI -0.1, 0.2) in the experimental group (1.10 mmol/l) and the control 
group (1.20 mmol/l) and were within the normal range (i.e. >0.91 mmol/l). In the 
experimental group, there was a trend for an increase in HDL cholesterol from 
baseline by 0.08 at six months mmol/l and a significant increase by 0.11 mmol/l at 12 
months (Table 30). In contrast, HDL cholesterol did not significantly change from six to 
12 months. In the control group, there was a trend for an increase in HDL cholesterol 
from baseline by 0.05 mmol/l at six months and 0.06 mmol/l at 12 months, with no 
significant change from six to 12 months (Table 30). The difference between the 
groups for the change in HDL cholesterol was not significant from baseline to six 
months (98%CI -0.14, 0.09), 12 months (98%CI -0.15, 0.06) and six to 12 months 
(98% CI -0.12, 0.07). The change in HDL-C over the study period in each group is 
shown in Figure 25. 
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Figure 25 Median values for HDL cholesterol at baseline, six and 12 by group 
Total Cholesterol/HOL Cholesterol Ratio 
Table 29 and Figure 26 shows that the median values for the cholesterol/HDL 
cholesterol ratio at baseline and follow-up were below the recommended target of 5. A 
Mann Whitney test revealed that baseline values were similar between the groups 
(98%CI -0.59, 0.42). Table 30 indicates that the cholesterol/HDL cholesterol ratio did 
not significantly change from baseline in the control group. In contrast, the ratio of 
cholesterol to HDL significantly improved from baseline to six and 12 months in the 
experimental group, with no significant change from six to 12 months (Table 30). 
There was no significant between group difference for the change in cholesterol/HDL 
cholesterol ratio from baseline to six months (98%CI -0.33, 0.48), 12 months (98%CI 
-0.16, 0.41) and six to 12 months (98%CI -0.36, 0.32). Figure 26 displays the change 
in cholesterol/HDL-C ratio over the study period in each group. 
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Figure 26 Median values for ratio of cholesterol to HDL-C at baseline, six and 12 
by group 
Proportion of Patients Taking Lipid Lowering Medication 
Figure 27 displays the proportion of patients taking lipid-lowering medication at 
baseline, six and 12 months in each group. At baseline, 88.6% of the control group 
and 100% of the experimental group were taking lipid-lowering medication. The 
number of patients taking lipid-lowering medication did not change at six and 12 
months in either group, see Figure 27. Three control patients and five experimental 
patients had their dose of medication changed at six months compared to baseline. 
Furthermore, three controls and seven experimental patients had their medication 
dose altered at 12 months compared with baseline. 
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Figure 27 Proportion of patients taking lipid lowering medication at baseline, six 
and 12 months in the experimental and control group. 
Effect of an Exercise Consultation on Psychological Function 
Anxiety and Depression 
Anxiety and depression was measured using the Hospital Anxiety and Depression 
Scale. The total score for the anxiety and depression subscales ranges from 0 to 21 . 
The scores for the anxiety and depression subscales can be used to classify 
individuals into normal (0-7), mild (8-10), moderate (11-14) and severe (~15) 
categories. In addition, it has been suggested that individuals with HADS scores ~ 8 on 
the anxiety or depression subscales are psychologically distressed. 
HADS scores were not normally distributed, thus non-parametric tests were used to 
analyse the between and within group differences. Median scores for anxiety and 
depression at baseline, six and 12 months follow-up in the experimental and control 
group are displayed in Figure 28. The median scores for anxiety and depression were 
within the normal range (i.e. 0 - 7) at baseline, six and 12 months in both groups. 
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Mann Whitney tests revealed that baseline scores for anxiety and depression were 
similar between the groups, (98%CI -3, 1) and (98%CI -1 , 1), respectively. Wilcoxon 
signed rank tests found that anxiety and depression scores did not significantly change 
from baseline to six and 12 months follow-up in the experimental group and the control 
group (Table 31). From six to 12 months, anxiety scores remained unchanged in both 
groups, however there was a trend for a median increase in depression by 0.5 in both 
groups (Table 31). The difference between the groups for the change in anxiety was 
not significant from baseline to six months (98%CI -2, 1), baseline to 12 months 
(98%CI -1, 2) and six to 12 months (98%CI -1, 1). Similarly, the difference between 
the groups for the change in depression was not significant from baseline to six 
months (98%CI -1, 1). However, the increase in depression was greater in the control 
group compared to the experimental group from baseline to 12 months (98%CI 0, 1) 
and six to 12 months (98%CI 0, 1). 
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Figure 28 Median scores for anxiety and depression at baseline, six and 12 
months in the experimental and control groups. 
Experimental group: n=35 baseline, n=32 at six months, n=33 at 12 months. Control 
group: n=35 baseline, n=33 at six months, n=32 at 12 months. 
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Table 31 Median Change in Anxiety and Depression from Baseline to Six and 12 
Months by Group 
0 6 months 0-12 months 6 -12 months 
Anxiety 
Experimental 0(-1.5,1) -0.5 (-1, 0.5) o (-1, 0.5) 
Control -0.5 (-1.5, 1) 0(-1.5,1) o (-0.5, 1) 
Depression 
Experimental -0.5 (-1,0.5) o (-0.5, 0.5) 0.5 (0, 1) 
Control o (-1, 0.5) 0.5 (-0.5, 1.5) 0.5, (0, 1.5) 
Note. Values represent median change and 98% confidence interval for the change 
Psychologically Distressed Patients 
Psychologically distressed patients were identified as those having a baseline HAD 
score ~ 8 on the anxiety or depression subscales. At baseline, 33% (23/70) of the 
sample population were psychologically distressed. In addition, 25% (9/35) of the 
control group and 40% (14/35) of the experimental group were psychologically 
distressed at baseline (x2 = 1.6, df = 1, P = 0.23). Figure 29 displays the median 
scores for anxiety and depression at baseline, six and 12 months in both groups. A 
Mann Whitney test found similar baseline anxiety scores between the experimental 
and control groups (98%CI -1, 5). Baseline anxiety scores were 10 in the control 
group and 9 in the experimental group. Thus, distressed individuals in both groups 
were mildly anxious. Anxiety scores did not significantly change from baseline to six 
and 12 months in the control group and the experimental group (Figure 29, Table 32). 
Additionally, there was no significant difference between the groups for the change in 
anxiety from baseline to six months (98%CI -5, 5), baseline to 12 months (98%CI -6, 
5) and six to 12 months (98% CI --4, 3). 
Figure 29 shows that median scores for depression were within the normal range (i.e. 
less than 8) at baseline, six and 12 months in both groups. There was no significant 
difference between the groups (98%CI -2, 5) for depression scores at baseline. 
Depression scores did not significantly change from baseline to six and 12 months in 
the experimental group and the control group (Table 32). From six to 12 months, there 
was no significant change in depression in the control group, however there was a 
borderline increase in depression from six to 12 months in the experimental group 
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(Table 32). There was no difference between the groups for the change in depression 
from baseline to six months (98%CI -2, 4), baseline to 12 months (98%CI -2, 5) and 
six to 12 months (98%CI -2, 6) . 
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Figure 29 Median scores for anxiety and depression at baseline, six and 12 by 
group in patients who were psychologically distressed at baseline. 
Table 32 Median Change in Anxiety and Depression by Group in Patients Who 
Were Psychologically Depressed at Baseline 
0-6 months 0-12 months 6 -12 months 
Anxiety 
Experimental -1.5 (-4,1.5) -1 (-3, 1.5) 0.5 (-1, 2) 
Control -1 (-6, 6) -1.5 (-6, 4) o (-4, 4) 
Depression 
Experimental 0(-1.5,1.5) o (-1, 3) 0.5 (0, 1.5) 
Control 0.2 (-2, 4) 2.5 (-2, 6) 3 (-2, 6) 
Note. Values represent median change and 98% confidence interval for the change 
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Non-Distressed Patients 
Patients with a baseline score less that 8 on the anxiety or depression subscales were 
classified as non-psychologically distressed. Figure 30 shows that anxiety and 
depression scores were within the normal range at baseline, six and 12 months in both 
groups. Similar baseline scores were observed between the experimental and control 
groups for anxiety (98%CI -2, 2) and depression (98%CI -2, 2). Wilcoxon signed rank 
tests revealed that anxiety scores remained unchanged from baseline to fo llow-up in 
both groups (Table 33) . In addition, there was no significant difference between the 
groups for the change in anxiety from baseline to six months (98%CI -2, 1), baseline 
to 12 months (98%CI -1, 2) and six to 12 months (98%CI -1 , 2) . Depression did not 
significantly change from baseline to six and 12 months in the experimental group, as 
displayed in Table 33. In the control group, there was no significant change in 
depression from baseline to six and 12 months, however there was a borderline 
significant increase in depression by 0.5 from six to 12 months. The between group 
difference for the change in depression was not significant from baseline to six months 
(98%CI -1 , 1), baseline to 12 months (98%CI -1 , 1) and six to 12 months (98%CI -1 , 
1 ). 
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Figure 30 Median scores for anxiety and depression at baseline, six and 12 by 
group in non-distressed patients at baseline 
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Table 33 Median Change in Anxiety and Depression in Non-Distressed Patients 
o 6 months 0 -12 months 6 - 12 months 
Anxiety 
Experimental 0.5 (-0.5, 1) 0(-1,1) 
-0.5 (-1.5, 0.5) 
Control -0.5 (-1.5, 1) 0.5 (-1, 1.5) 0(-1,1) 
Depression 
Experimental -0.5 (-1.5, 0.5) o (-1, 0.5) 0.5 (-0.5, 1) 
Control o (-1, 0.5) o (-0.5, 0.5) 0.5 (0, 1) 
Note. Values are median change and 98% confidence interval for the change 
Quality of Life 
Quality of life was assessed at baseline, six and 12 months by the UK SF-36 version 2. 
This questionnaire assess the following 8 dimensions: physical functioning (PF), social 
functioning (SF), role limitations due to physical problems (RLP), role limitations due to 
emotional problems (RLE), pain (P), energy/vitality (EV), mental health (MH), and 
health perception· (HP). For each dimension, the scale ranges from 0 (worst possible 
health) to 100 (best possible health). The SF-36 data were not normally distributed, 
thus non-parametric tests were used to detect between and within group differences. 
Figure 31 displays the median scores for the SF-36 subscales at baseline in the 
experimental and control group. The figure shows that baseline values for social 
functioning (SF) and role limitations emotional (RLE) were 100% in both groups, which 
indicates best possible health. Baseline values for physical functioning (PF), role 
limitations physical (RLP) mental health (MH) and pain (P) were high, ranging from 
800/0 to 90% in both groups. Scores for energy/vitality and health perception were 
between 60% and 70% in both groups. There was a trend for the median scores for 
physical functioning (980/0CI -10.0, -0.01) and pain (98%CI -11.1, 0) to be higher in 
the experimental group compared to the control group. Whereas, there was a trend for 
role limitations due to emotional problems to be higher in the control group compared 
to the experimental group (98%CI 0, 8.33). In contrast, there was no difference 
between the groups for social functioning (98%CI -0.01, 0.0), role limitations physical 
(980/0CI -12.5, 6.2), mental health (98%CI -10.0, 5.0), energy/vitality (98%CI -6.25, 
12.5) and health perception (98%CI-12.0, 10.0). 
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Figure 31 Median scores for SF-36 subscales at baseline by group. 
A score of 100 · indicates best possible health. Physical functioning (PF), social 
functioning (SF), role limitations physical (RLP), role limitations emotional (RLE), pain 
(P), energy/vitality (EV), mental health (MH) and health perception (HP). 
The median change in the SF-36 subscales from baseline to follow-up in the 
experimental and control group is shown in Table 34. Scores for four SF-36 subscales 
were maintained from baseline to six and 12 months in the experimental group; these 
were physical function, mental health, energy/vitality and health perception. Similarly, 
there was no significant change in social function, role limitations due to physical , 
mental health and health perception from baseline to six and 12 months in the control 
group. From baseline to six months, there was a trend for an improvement in social 
function and a deterioration in pain in the experimental group. In the control group, 
there was a trend for a decline in role limitations due to emotional problems and 
energy/vitality in the control group. From baseline to 12 months, there was a trend for 
an improvement in three SF-36 subscales in the experimental group; these were social 
function, role limitations due to physical problems and role limitations due to emotional 
problems. In contrast, there was a trend for a decline in physical function and role 
limitations emotional in the control group. From six to 12 months, there was a trend for 
an improvement in role limitations emotional and energy/vitality in the experimental 
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group, and a trend for an improvement in pain in both groups. 
Table 34 Median Change in Quality of life from Baseline to Follow-Up by Group 
SF-36 Subscales 0 6 months 0-12 months 6 -12 months 
PF 
Experimental o (-S.O, 2.S) ° (-S.O, 2.S) ° (-2.S, 2.5) 
Control 
-2.S (-7.5, 2.5) 
-5.0 (-10.0,0) 
-2.5 (-7.5,2.5) 
SF 
Experimental 6.3 (0, 12.S) ° (0, 12.5) ° (0, 0) 
Control ° (-6.3, 6.3) ° (-6.3, 6.3) ° (0, 0) 
RLP 
Experimental ° (-6.3, 9.4) 6.3 (0, 12.5) 6.3 (-3.1,15.6) 
Control ° (-9.4, 9.4) ° (-9.4, 9.4) ° (-9.4, 6.3) 
RLE 
Experimental ° (-4.2, 8.3) ° (0, 8.34) 0(0,4.16) 
Control 
-4.2 (-16.7,0) 
-4.2 (-8.3, 0) ° (-8.3, 4.2) 
MH 
Experimental o (-2.5, 5.0) 1.5 (-2.5, 5.0) ° (-2.5, 5.0) 
Control o (-5.0, 7.5) ° (-2.5, 5.0) ° (-2.5, 5.0) 
EV 
Experimental o (-6.3, 6.3) 3.1 (-3.1,9.4) 3.13 (0, 6.2) 
Control -3.1 (-9.4, 0) -3.1 (-9.4, 3.1) ° (-6.3, 6.3) 
P 
Experimental 0(-11.1,0) ° (-S.6, 5.6) ° (0, 5.6) 
Control o (-11.1, S.6) ° (-5.6, 5.6) ° (0, 5.6) 
HP 
Experimental -1.0 (-7.5, 5.0) ° (-5.0, 7.5) 1.5 (-5.0, 7.5) 
Control -2.5 (-8.0, 5.0) -2.5 (-11.0, 6.0) -2.0 (-10.0,6.5) 
Notes. Values are median change and 98% confidence interval for the change. 
A score of 100 indicates best possible health. PF = Physical function, SF = Social 
function, RLP = Role limitations physical, RLE = Role limitations emotional, P = Pain, EV 
= Energylvitality, MH = Mental health, HP = Health perception. 
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In addition, the difference between the groups for the change in SF-36 dimensions 
from baseline to six and 12 months was examined. These findings are shown in 
Figures 32, 33 and 34. There was a trend for a greater improvement in social function, 
role limitations due to emotional problems and energy/vitality from baseline to six and 
12 months in the experimental group compared to the control group, as shown in 
Figures 32 and 33. From six to 12 months, there was a borderline significant difference 
between the groups for the change pain favouring the experimental group (Figure 34). 
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Figure 32 98% confidence intervals for the difference between the groups for the 
change in quality of life from baseline to six months. 
Red bars represent borderline significant differences between the groups for changes in 
SF-36 subscales. Red bars skewed to the right indicate an advantage to the 
experimental group. 
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Figure 33 980/0 confidence interval for the difference between the groups for the 
change in quality of life from baseline to 12 months. 
Red bars represent borderline significant differences between the groups for changes 
in SF-36 subscales. Red bars skewed to the right indicate an advantage to the 
experimental grou·p. 
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Figure 34 98% confidence intervals for the difference between the groups for the 
change in quality of life from six to 12 months. Red bars represent borderline 
significant differences between the groups for changes in SF-36 subscales. Red bars 
skewed to the right indicate an advantage to the experimental group, 
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Clinical Outcomes from Baseline to Six and 12 Months 
In the experimental group, one patient received coronary artery bypass surgery, three 
patients were admitted to hospital with unstable angina and subsequently received 
angioplasty, and one patient was diagnosed with Type 2 diabetes over the 12 month 
study period. In the control group, two patients died which were classed as sudden 
cardiac deaths, one control received non-cardiac surgery and one patient was 
diagnosed with Type 2 diabetes during the study period. Overall, cardiac mortality was 
5.70/0 (2/35) in the control group and 0% in the experimental group. However, the 
revascularisation rate (i.e. CABG and PTCA) was 11.4% (4/35) in the experimental 
group and 0% in the control group. 
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CHAPTER FIVE 
DISCUSSION 
In total, 85 patients were invited to participate in the study, 15 of these patients 
declined to take part. 
Baseline characteristics of the study group were reported. The majority of patients 
were men (800/0) and had suffered a myocardial infarction (65.8%). Information from 
the BACR national database on client groups taking part in phase III cardiac 
rehabilitation programmes are 68% MI and 25% female. 5 Thus, the study sample 
appears to be representative of people who attend phase III cardiac rehabilitation 
programmes. 
Baseline Physical Activity of Study Sample 
This study investigated the effect of an exercise consultation on maintenance of 
physical activity following completion of a phase III exercise programme. Baseline 
physical activity levels were assessed within one month of completing phase III. Thus, 
it was expected that subjects would be physically active at baseline. We found that 
46% of the study sample were in the action stage of change, and 37% were in 
maintenance at baseline. Thus, 83% of patients were regularly physically active 
following completion of phase III. Similarly, Bock96 found that after completion of a 12-
week phase II supervised exercise programme, 96% of the study group were in the 
action and maintenance stages, thus were considered regularly active. 
At baseline, patients participated in a median 248 minutes/week of moderate intensity 
physical activity, 26 minutes/week of vigorous activity and 288 minutes/week of total 
physical activity (Le. moderate and vigorous activity combined) measured by the 
7DPAR. Thus, patients were exceeding the 1995 ACSM/CDC physical activity 
guidelines of 150 minutes/week of moderate intensity activity.s Bock96 reported that 
patients participated in 10.98 hours/week of moderate to vigorous physical activity 
measured by the 7DPAR after completion of a 12-week phase II exercise programme. 
Thus, there was a large difference between physical activity participation in the present 
study and the results reported by Bock. However, the 7DPAR was self-administered in 
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Bock's study96 and was interview-administered in the present study. Administering the 
questionnaire in an interview format may generate more accurate and reliable 
information than self-administering the 7DPAR, as interviewing subjects can minimise 
guessing and over-reporting physical activity participation. 221 In addition, subjects may 
mis-classify the intensity level of various activities. For example, in the present study 
some individuals classed ironing in the moderate intensity category because it made 
them hot and tired, when ironing is clearly a light intenSity activity. However, the 
researcher could clarify if the patient thought that ironing was a similar effort to a brisk 
walk (i.e. definition of moderate intensity), whereas determining this in a self-
administered format is not possible. In a pilot study, we found that patients participated 
in a median of 555 minutes/week (9.15 hours/week) of moderate to vigorous physical 
activity shortly after completion of phase 111.178 The Scottish Physical Activity 
Questionnaire279 (SPAQ), a self-administered questionnaire, was used to measure 
physical activity in the pilot study. Results of this pilot study revealed that subjects 
reported participating in 5 to 6 hours of gardening or decorating at a moderate to 
vigorous intensity,_ however it is unlikely that these activities were exclusively moderate 
to vigorous intensity. Thus, it is possible that individuals over-estimate physical activity 
participation in self-administered questionnaires more than interview-administered 
instruments. An alternative explanation for lower self-reported physical activity levels 
after phase III found in this study compared to other trials is that physical activity was 
monitored objectively using accelerometers over the same sampling period as the 
7DPAR. Thus, individuals may be more likely to report their activities accurately and 
state the activities they actually performed instead of activities that they may normally 
do. In addition, subjects completed an activity recording sheet, which was used to 
assist patients with their recall and prevent subjects from over-estimating the intensity 
or duration of activities. 
The CSA accelerometers recorded a median of 4025432 activity counts/week at 
baseline in the total group. As previously discussed, CSA recordings can be used to 
estimate energy expenditure or the time spent in various intensities of physical activity, 
which would allow investigators to interpret how active their subjects were. However, 
studies have shown that accelerometers substantially underestimate the energy cost 
of household, gardening and leisure activities and energy expenditure under free-living 
conditions. 191 ;196-198 Thus, researchers have recommended using the raw output from 
accelerometers (i.e. activity counts) to quantify physical activity rather than converting 
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the data to estimate energy expenditure. A limitation of using the raw data from 
accelerometers is that it is not possible to describe how active the study sample was at 
baseline. In addition, no other studies have measured physical activity using 
accelerometers after completing exercise-based cardiac rehabilitation. Thus, it is not 
possible to compare the accelerometer results from this study with findings from other 
cardiac rehabilitation studies. A study conducted by Kirk et al measured physical 
activity using the 7DPAR and CSA accelerometers in a group of sedentary patients 
with type II diabetes. 177 Patients participated in 45 minutes/week of moderate intensity 
activity measured by the questionnaire, thus these patients were not meeting physical 
activity guidelines. In addition, CSA accelerometer readings were 2908974 
counts/week in this inactive group of patients, which is much lower than the 4025432 
counts/week recorded in the current study. 
Effect of an Exercise Consultation on Physical Activity 
Physical activity was measured using subjective and objective methods. There are 
advantages and. limitations to using each method, thus researchers have 
recommended using multiple methods to measure physical activity as no single 
technique is able to quantify all aspects of physical activity.217 The 7DPAR measures 
the duration of moderate and vigorous intensity physical activity, thus can determine 
whether individuals are meeting current physical activity recommendations. 
Accelerometers provide an objective measure of physical activity, however they do not 
give meaningful information on patterns of physical activity. Although accelerometers 
are able to detect if any changes occurred in physical activity over the study period. 
At baseline, total physical activity was 300 minutes/week in the experimental group 
and 275 minutes/week in the control group. Thus, both of these groups were regularly 
physically active at baseline. No significant change was observed in moderate, 
vigorous and total physical activity measured by the 7DPAR from baseline to six and 
12 months in the experimental group. Similarly, total activity counts/week recorded by 
the CSA accelerometer did not significantly change from baseline to follow-up in the 
experimental group. These findings suggest that physical activity was maintained over 
the study period in the experimental group. At 12 months, the experimental group 
participated in 360 minutes/week of moderate to vigorous intensity physical activity, 
thus were clearly exceeding the physical activity guidelines of 150 minutes/week of 
moderate intensity activity.8 In the control group, there was a non-significant decline in 
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total and moderate intensity physical activity measured by the 7DPAR from baseline to 
six months by 55 minutes/week and 47 minutes/week, respectively. In addition, total 
physical activity significantly decreased by 115 minutes/week from baseline to 12 
months and 63 minutes/week from six to 12 months in the control group. Similarly, 
there was a significant decrease in moderate intensity activity by 83 minutes/week 
from baseline to 12 months and a trend for a decrease by 48 minutes/week from six to 
12 months in the controls. These results show a significant decline in self-reported 
physical activity over the study period in the control group. Despite a decrease in self-
reported physical activity, at 12 months control patients were participating in 205 
minutes/week of moderate to vigorous activity, thus were regularly physically active. 
Total activity counts/week measured by accelerometry decreased by 5.2% from 
baseline to six months, 8% from baseline to 12 months and 3% from six to 12 months , 
although this decline was not significant. Thus, the results suggest that physical 
activity measured by self-report and CSA accelerometers declined from baseline to six 
months in the control group. In contrast, a further decrease in self-reported physical 
activity was observed from six to 12 months, however there was no further decline in 
CSA accelerometer counts/week. Thus, findings from the CSA accelerometers did not 
parallel the decrease in self-reported physical activity from six to 12 months in the 
control group. 
Results from the stage of change questionnaire support the results of the 7DPAR. At 
baseline, the majority of patients in the experimental and control groups were in the 
action and maintenance stages of change, thus were regularly physically active (88% 
experimental group vs 77% control group), with no significant difference between the 
groups. At six months, a similar number of patients in each group were in action or 
maintenance (84% experimental group vs 69% control group). However at 12 months, 
a greater proportion of the experimental group were regularly physically active 
compared to the control group, this difference was near significant (85% experimental 
group vs 67% control group). Furthermore, the results show that a greater proportion 
of experimental patients compared to controls remained in action and maintenance or 
progressed to action or maintenance from baseline to 12 months and six to 12 
months. Overall, the results show that physical activity measured by self-report was 
maintained in the experimental group compared to the control group over the study 
period. These findings suggest that the exercise consultation was more effective than 
standard exercise information in maintaining self-reported physical activity for 12 
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months following completion of a phase III exercise programme. Results from the CSA 
accelerometers agree with the findings from the self-report method in the experimental 
group, suggesting that physical activity was maintained in this group for 12 months 
after phase III. In contrast, although a decline in physical activity measured by CSA 
accelerometers was observed over the study period in the control group, this decline 
was not significant and did not parallel the marked decrease in self-reported physical 
activity. 
A significant decrease in self-reported physical activity from baseline to 12 months was 
observed in the control group. Similarly, a number of studies have reported a decline in 
physical activity following completion of exercise-based cardiac 
h b'I't t' 20'56'67"79'91'94-96'98 re a II a Ion. ' , , " , Bock measured physical activity using the 7DPAR in 62 
cardiac patients before and after a 12-week supervised exercise programme and at 
three months follow-up.96 On programme completion, the time spent in moderate to 
vigorous intensity activity had increased significantly. In contrast, three months after 
rehabilitation, ne,arly 50% of participants had reduced their physical activity 
participation compared to the end of the programme. Furthermore, 16% of patients 
had regressed from the action/maintenance stage to an earlier stage of change. The 
present study found that 33% of control patients regressed from action or maintenance 
to preparation or remained in the preparation stage from baseline to 12 months. 
The change in total activity counts/week measured by the CSA accelerometer from 
baseline to 12 months did not parallel the decrease in self-reported physical activity in 
the control group. Instead, the CSA accelerometer results suggested that physical 
activity was maintained over the study period in both groups. However, CSA 
accelerometers have limitations, which could explain these conflicting findings. 
Accelerometers cannot record all types of activity such as water activities, activities 
that increase energy expenditure without a proportional increase in bodily acceleration 
(e.g. walking uphill) and activities that require upper body movement (e.g. washing 
windows) unless the accelerometer was attached to the wrist. Modest to poor 
correlations have been observed between activity counts and measured V02 during 
daily lifestyle activities (e.g. housework, gardening and leisure activities).191;196 Most of 
these activities required modest leg movement and a large amount of upper body 
work which would not be detected accurately using accelerometers attached the , 
ankle. In contrast, the 7DPAR would be able to record these types of daily lifestyle 
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activities. This reasoning is supported by poor to modest correlations ranging from 0.2 
to 0.46 between CSA activity counts/week and self-reported physical activity observed 
in this study. Thus, the decrease in self-reported physical activity in the control group 
could reflect a decline in lifestyle physical activity, which would not be recorded by the 
accelerometers. In addition, it is possible that repeated use of the CSA accelerometers 
throughout the study may have made them less sensitive to measuring physical 
activity at 12 months compared to baseline and six-month measurement periods. 
Results show that the change in CSA accelerometer counts/week and self-reported 
physical activity from baseline to six months appear to track each other in both groups. 
However, despite further changes in self-reported physical activity from six to 12 
months in both groups, there was no further change in CSA accelerometer readings. 
There are no studies investigating the effect of repeatedly using CSA accelerometers 
on the reliability of these instruments for measuring physical activity. 
An alternative explanation for the discrepancy between the 7DPAR and CSA results is 
that the experimental group may have over-estimated the duration and/or intensity of 
their activities at six and 12 months. The aim of the exercise consultations was to 
encourage patients to remain regularly active following completion of the phase III 
exercise programme. Thus, the experimental group may have overestimated their 
physical activity to demonstrate to the researcher that they had remained active over 
the study period. Conversely, as the researcher was not blinded to group allocation, 
she could have unfairly influenced the information collected by the 7DPAR. However, a 
standardised interview process222 was followed when administering the questionnaire 
to limit the interviewer's bias. 
This study demonstrated that exercise consultation was more effective than 
standard exercise information in maintaining self-reported physical activity for 12 
months after completion of a phase III exercise programme. Despite the decline in 
physical activity and other lifestyle changes following completion of phase III 
documented in several studies, there is limited research on effective interventions to 
encourage maintenance of physical activity in phase IV. Brubaker181 randomized 31 
patients, who had completed a 12-week phase III supervised exercise programme to 
either a phase IV home-based maintenance programme or standard care. In 
addition, a comparison group (n = 17) who attended a phase IV supervised 
maintenance programme after completion of phase III were randomly selected. The 
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phase IV home-based programme lasted 9 months and included an initial physical 
activity counselling session on self-monitoring exercise intensity and daily activity 
levels, problem solving exercise barriers, and regular telephone contact to discuss 
exercise compliance, feedback on exercise levels and to provide support and 
encouragement. This intervention seems to be similar to the exercise consultation 
used in the present study. Standard care involved advice on continuing with exercise 
and other lifestyle modifications. The comparison group attended a phase IV 
supervised maintenance programme for 9 months, involving supervised exercise 
training three times a week and regular counselling on exercise compliance and 
modification of other risk factors. Exercise capacity, blood lipids, and body 
composition were assessed before and after phase III and at 9 months follow-up. 
However, physical activity levels were not assessed. Results revealed comparable, 
significant improvements in these outcomes in all 3 groups on completion phase III. 
In addition, these improvements in blood lipids, exercise capacity and body 
composition were maintained in all groups at 9 months follow-up. These findings 
suggest that a home-based exercise programme is just as effective for patients who 
cannot attend a phase IV supervised maintenance exercise programme. Although 
the standard care patients received no further intervention in phase IV, they also 
maintained these changes, suggesting that follow-up testing alone may be sufficient 
to maintain lifestyle changes after phase III. A number of patients stated that 
knowing they were being reassessed at 12 months motivated them maintain lifestyle 
changes. Thus, it is possible that assessing physical activity and cardiorespiratory 
fitness at regular intervals in the present study could have encouraged patients to 
remain active over the study period. Without this level of monitoring, a greater 
decline in physical activity may have occurred in the control group over the study 
period. In fact, several control patients stated that they were grateful for being invited 
to take part in the study as it "encouraged them to keep active after they finished 
phase III". 
Effect of an Exercise Consultation on Cardiorespiratory Fitness 
Measuring exercise capacity and submaximal endurance capacity was used as 
indicators of cardiorespiratory fitness. 
Exercise Capacity 
Cardiorespiratory variables measured at peak exercise were used to determine 
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exercise capacity. Exercise capacity parameters included peak oxygen uptake (V0
2
) , 
total exercise duration, peak ventilation (VE), peak heart rate (HR), peak respiratory 
exchange ratio (RER) and peak oxygen pulse (V02/HR). 
Baseline peak V02 corrected for total body weight (mllkg/min) was similar between 
the groups. At baseline (i.e. on completion of phase III), peak V02 was 26.9 
mllkg/min (SO 6.6) in the experimental group and 24.4 mllkg/min (SO 6.5) in the 
control group. It is difficult to compare baseline results in the present study with 
other studies reporting exercise capacity values on completion of exercise-based 
cardiac rehabilitation. This is because many studies have estimated peak V02 from 
treadmill test duration,20;46;127;85;35;41;58;88;47;66 which can overestimate exercise 
capacity by up to 40%.57 In addition, several studies determined exercise capacity by 
measuring watts achieved during cycle testing. 36;37;50;51;53;55;56;67 Furthermore, findings 
from the present study cannot be compared with trials that directly measured peak 
V02 using cycle testing, as exercise capacity is 10 to 15% lower in cycle versus 
treadmill testing. _ In contrast, a few studies have assessed exercise capacity by 
directly measuring peak V02 during treadmill testing.48;49;57;59;69;82;99;121;280;281 However, 
various treadmill protocols were used in these trials, which influences the 
measurement of peak oxygen uptake.237 Although, several of these studies reported 
similar values for peak V02 after three to five months of exercise training as the 
48'49'99'121'281 baseline results found in the present study. ' , , , 
There was a trend for a decrease in peak V02 (mllkg/min) in experimental group by 
3.7%) and a statistically significant decrease by 6.7% in the control group from 
baseline to six months. From baseline to 12 months, peak V02 significantly 
decreased by 6.7% (1.Bmllkg/min) in the experimental group and 9.4% (2,3 
ml/kg/min) in the control group. These findings suggest that exercise capacity was 
not maintained over the 12-month study period in either group. There was no 
significant change in body weight from baseline to follow-up in either group and peak 
V02 (mllmin), not corrected for total body weight, also decreased significantly from 
baseline to 12 months in the experimental and control group. In contrast to the 
decline in peak V02, total exercise duration did not significantly change from 
baseline to six and 12 months in either group. 
174 
Possible explanations for the decrease in peak V02 observed from baseline to 12 
months in both groups are discussed. Firstly, improvements in peak aerobic capacity 
with exercise training may be partly due to a reduction in body fat, which 
overestimates the true improvement in exercise capacity with training. 280 Thus, it has 
been suggested that changes in peak V02 corrected for lean body mass should be 
used to assess the individual effect of exercise conditioning alone. 28o Body 
composition was not assessed in the present study, but it is possible that changes in 
body composition could have partially caused the decline in exercise capacity after 
completion of phase III exercise training. Secondly, the decline in peak V02 could 
not be caused by a decrease in motivation during follow-up exercise tests compared 
with baseline, as there was no significant change in total exercise duration over the 
study period. In addition, peak respiratory exchange ratio (RER), an indicator of 
exercise effort, did not decrease in either group over the study period. Finally, it is 
likely that the decrease in peak V02 reflects a decline in the capacity of the 
cardiovascular system to supply oxygen to exercising skeletal muscles and the 
potential for oxygen extraction by the exercising muscle. As previously discussed, 
improvements in exercise capacity after training in CHD patients is primarily due to 
peripheral adaptations rather than central (cardiac) adaptations. 70-73 Peripheral 
changes reflect an improvement in the supply of oxygen to active skeletal muscles, 
and enhanced oxygen extraction and utilisation by the exercising muscles. Thus, it is 
likely that a decrease in peak V02 is a result of a deterioration in these peripheral 
adaptations. Peak oxygen pulse (V02/HR ml/beat) was calculated in the present 
study, which measures the amount of oxygen carried in each stroke volume and 
gives an index of cardiac function. There was no significant change in peak oxygen 
pulse in either group over the study period. This finding further supports the concept 
that a decline in peak V02 was not due deterioration in cardiac function, but rather 
due to negative changes in the skeletal muscles. 
This study found a decline in peak V02 by 6.7% (1.Bml/kg/min) in the experimental 
group and 9.4% (2.3 ml/kg/min) in the control group from baseline to 12 months, 
suggesting that aerobic fitness decreased in both groups after completion of phase III. 
Other studies have found that improvements in exercise capacity with cardiac 
. . 37;50;55;67 
rehabilitation exercise training decline after programme completIon. As these 
studies did not directly measure peak V02 during treadmill testing, it is difficult to 
compare the decline in exercise capacity observed in the present study with findings 
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from other trials. Thus, it is not clear whether the magnitude of the decrease in peak 
V02 is clinically important. However, several studies have reported a significant 
relation between exercise capacity and mortality in CHO patients. 91 ;282-285 Researchers 
have found that a low fitness level « 4 METs) measured before entry to exercise-
based cardiac rehabilitation is a significant predictor of total and cardiac 
d th 91 ;282;283;285 R 283 
ea . ecently, Kavanagh examined the relation between mortality and 
peak V02 measured on entry to a cardiac rehabilitation exercise programme in 12169 
men after MI, CABG and CHO. The study found that estimated 15 year survival rates 
for patients with peak V02 values of <15, 15 to 22 and >22 mllkg/min were 65%, 81 % 
and 88%>, respectively. Thus, estimated 15 year prognosis was substantially lower for 
patients in the least fit group «15 mllmg/min; 35% mortality) compared to the middle 
group (15 to 22 mllkg/min, 19% mortality) and patients with the highest peak V02 (>22 
mllkg/min; 12% mortality). Results from these studies suggest that a fitness level of 15 
mllkg/min, which is equivalent to 4 METs, is an important cutoff for mortality risk. Thus, 
it may be that a decline in exercise capacity is not clinically important as long as 
patients maintain. their exercise capacity above 15 mllkg/min (4 METs) in the long-
term. Despite a decrease in peak V02 over 12-months in the present study, the 
average peak V02 values at 12 months were 25.1 (SO 6.2) ml/kg/min in the 
experimental group and 22.0 (SO 6.1) ml/kg/min in the control group. 
These studies also examined the relation between the change in peak V02 and 
mortality.282-284 Kavanagh found that a 1 mllkg/min advantage in peak V02 was 
associated with a 9% improvement in prognosis. Vanhees282 investigated the relation 
between mortality and the change in peak V02 with exercise-based cardiac 
rehabilitation in a group of MI and CABG patients. Peak V02 increased by 33% after 
the three-month exercise programme. Thirty seven (9%) patients died during the 6-
year follow-up period, 21 (5%) died from cardiovascular causes. Total and 
cardiovascular mortality was significantly related to both the change in peak V02 
with training and the peak V02 after training, which was independent of age and 
other significant covariates. In addition, the study found that a 1 % increase in 
exercise capacity with training was associated with a 2% reduction in cardiovascular 
mortality, which was independent from the exercise capacity before training. Oorn 
also showed that an increase in exercise capacity reduces total and cardiovascular 
mortality.284 This study found that each 1 MET increase in exercise capacity from 
baseline to the end of a three year trial of exercise-based cardiac rehabilitation was 
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associated with a significant reduction in all-cause and cardiac mortality throughout 
the 19-year follow-up period. These results included all patients who increased 
exercise capacity by at least 1 MET, regardless of initial exercise capacity level and 
group assignment (i.e. control group or rehabilitated group). Thus, findings from 
these studies suggest that small increases in exercise capacity have a marked effect 
on survival. Thus, it is possible that the decline in peak V02 by 6.7% (1.8 ml/kg/min 
or 0.5 METs) the experimental group and 9.4% (2.3 mllkg/min or 0.7 METs) in the 
control group over the 12 month follow-up period in the present study may be 
clinically relevant. 
Results revealed that although there was a decline in peak aerobic capacity, total 
exercise duration was maintained over the study period in both groups. The 
following reason is a possible explanation for the discrepancy in results between 
peak V02 and total exercise duration. Peak V02 measures aerobic capacity, which 
represents the capacity of the cardiovascular system to supply oxygen to exercising 
skeletal muscles and the potential for oxygen extraction by the exercising muscle. In 
contrast, total exercise duration measures total work performed without 
differentiating between aerobic and anaerobic metabolism. Thus, a decrease in peak 
V02 from baseline to 12 months indicates a decline in aerobic capacity. It is possible 
that total exercise duration was maintained over the study period because patients 
performed a greater amount of work anaerobically at 12 months compared with 
baseline. This concept is supported by a significant increase in RER at follow-up 
compared with baseline in both groups, which may indicate greater lactate 
production at peak exercise. 
Results from the present study suggest that physical activity was maintained from 
baseline to 12 months in the experimental group, whereas exercise capacity 
significantly declined over the 12 month follow-up. The following reason may be an 
explanation for the discrepancy in results between physical activity and fitness. Studies 
in healthy adults suggest that to maintain initial improvements in aerobic fitness, 
exercise must be continued on a regular basis, as a significant reduction in 
cardiorespiratory fitness occurs after 2 weeks of stopping training. Although the 
minimal level of exercise necessary to maintain fitness is not known, evidence 
suggests that missing an exercise session periodically or reducing the frequency and 
duration of training will not adversely affect cardiorespiratory fitness as long as training 
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intensity is maintained.? A study found that if training intensity remained unchanged, 
cardiorespiratory fitness was maintained for up to 15 weeks when the duration and 
frequency of training was reduced. On the other hand, when the duration and 
frequency of training was held constant and the intensity was reduced there was a 
significant reduction in cardiorespiratory fitness. Thus in the present study, it is 
possible that the intensity of patients' physical activity was lower than the intensity of 
exercise training in phase III, which resulted in a decline in peak V02, whilst the level of 
physical activity was maintained. At the time of the study, there were few supervised 
exercise programmes available in the community for patients to attend. Thus, most of 
the patients stayed active by participating in moderate intensity activities, such as 
walking. Alternatively, experimental patients may not have met physical activity 
guidelines every week throughout the 12-month follow-up period, which may have 
caused the decline in aerobic fitness. Frequent lapses from activity would not have 
been detected in the study, as physical activity was only measured three times over 12 
months. 
Submaximal Endurance Capacity 
Submaximal endurance capacity was determined by estimating the oxygen uptake 
(mllmin) at the lactate threshold. Oxygen uptake at the lactate threshold was 1251 
mllmin in the experimental group and 1177 mllmin in the control group at baseline. 
These results are comparable to other studies reporting V02 values at the lactate 
threshold following participation in exercise-based cardiac rehabilitation.
81
;82 
Hambrecht found that V02 at L Twas 1170 mllmin after 12 months of supervised and 
unsupervised exercise. 84 Although, few studies have evaluated the effect of the 
exercise-based cardiac rehabilitation on submaximal endurance capacity by 
measuring the onset of the lactate threshold. 
Results revealed a significant increase in the V02 at the lactate threshold from 
baseline to six and 12 months in the experimental group relative to the control group. 
From baseline to six months, there was a trend for an increase in V02 at the L T by 47 
ml/min (3.80/0) in the experimental group and a decline by 52 mllmin (4.4%) in the 
control group. Furthermore, the lactate threshold significantly increased by 81 ml/min 
(6.50/0) in the experimental group and decreased by 45 mllmin (3.8%) in the control 
group from baseline to 12 months. Hambrecht reported a small but significant increase 
in V0
2 
at the L T by 7% (80 mllmin) after 12 months of supervised and unsupervised 
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exercise training. The magnitude of the increase in the L T is very similar to the results 
observed in the experimental group in the present trial. Hambrecht also found that V0
2 
at L T decreased by 90 ml/min (8%) in the control group from baseline to 12 m th on s, 
which is greater than the decline observed in the control group in the present study. 
Other studies have found significant improvements in the lactate threshold after three 
t · th f . .. 51 "75·81·82 o SIX mon s 0 exercise training, , , , however they did not examine whether this 
beneficial effect was maintained after programme completion. 
These results indicate that the onset of the L T was delayed in the experimental group 
compared to the control group from baseline to follow-up. Hambrecht demonstrated 
that the change in the L T significantly correlated with both changes in physical activity 
related energy expenditure measured by questionnaire and peak V02.84 In the present 
study, changes in L T may be a result of continued participation in moderate to 
vigorous physical activity in the experimental group and a decline in physical activity in 
the control group. However, peak aerobic capacity declined over the study period in 
both groups. Studies that reported increases in the L T after exercise-based cardiac 
rehabilitation also found significant improvements in peak aerobic capacity.51;81;82;84 
This is in contrast to the present study, which found that peak V02 declined in both 
groups over the study period. 
The delayed onset of the LT is beneficial to the daily lives of cardiac patients. The 
lactate threshold is the exercise V02 at which the concentration of lactate in arterial 
blood increases above the resting value due to the supplementation of aerobic energy 
production with anaerobic metabolism.83 Below the lactate threshold, exercise at a 
given work rate can be sustained for a prolonged period of time without fatigue and 
with relatively little stress to the subject. In contrast, work rates above the lactate 
threshold lead to metabolic acidosis, an increased ventilatory response and muscle 
fatigue, thus exercise above this threshold cannot be sustained as long. Therefore, the 
delayed onset of the lactate threshold enhances an individual's ability to perform 
physical activity at a given work rate. Proposed mechanisms for a delayed onset of the 
lactate threshold include improved oxygen supply to active skeletal muscles, increased 
oxidative capacity of mitochondria and delayed activation of type II muscles fibres that 
function anaerobically.83 However, positive changes in these peripheral mechanisms 
as an explanation for the increased L T in the experimental group relative to the control 
group seems unusual since peak aerobic capacity declined in both groups over the 
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study period, suggesting that negative changes occurred in peripheral mechanisms. 
In the present study, the lactate threshold was indirectly estimated using the V-slope 
and ventilatory equivalent techniques. These methods are valid and reliable 
techniques for estimating the lactate threshold.23s;s3 However, directly measuring the 
concentration of blood lactate during the exercise test would have confirmed that the 
changes in the L T in the experimental and control groups were due to changes lactate 
concentration. 
Effect of an Exercise Consultation on the Processes of Exercise Behaviour 
Change 
The processes of change are strategies that individuals use when changing their 
exercise behaviour. The frequency of using the five experiential processes 
(consciousness raising, social liberation, dramatic relief, environmental re-evaluation 
and self re-evaluation) did not significantly change from baseline to six months and six 
to 12 months in either group. From baseline to 12 months, there was a significant 
decrease in the use of dramatic relief in the control group and environmental re-
evaluation in the experimental group. The use of the five behavioural processes 
(helping relationships, stimUlus control, counter conditioning, self-liberation, 
reinforcement management) did not significantly change from baseline to follow-up in 
either group. Thus, nine out of ten processes of change remained stable over the 
study period in both groups. The following reasons may explain the lack of change in 
process use observed in this study. A meta-analysis 159 by Marshall and Biddle found 
that the use of experiential and behavioural processes increased with advancing stage 
of change, with the largest increase occurring from precontemplation to contemplation 
and preparation to action. Similarly, Marcus found that the transition from an inactive 
stage (i.e. precontemplation or contemplation) to an active stage (i.e. preparation, 
action or maintenance) was associated with a significant increase in the use of 
experiential and behavioural processes. In the present study, there were no patients in 
precontemplation or contemplation (i.e. inactive stages) at baseline or follow-up. 
Secondly, few patients in either group progressed from preparation to the action or 
maintenance stages. 
The meta-analysis also found minimal change in the use of experiential and 
behavioural processes as individuals progressed from action to maintenance. 
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Likewise, Marcus found that process use did not significantly change for subjects who 
remained in an active stage (i.e. preparation, action or maintenance). In the present 
study, the majority of patients in both groups remained in the action and maintenance 
stages (i.e. regularly active) throughout the study period. Marcus also reported that 
subjects who relapse over the study period (regression from preparation, action or 
maintenance to either contemplation or precontemplation) reported a significant 
decline in the use of all behavioural processes and 1 experiential process (dramatic 
relief). Similarly, Bock found that individuals who had regressed three months after 
completion of a phase II programme had significantly lower scores for the frequency of 
using behavioural processes compared to participants who remained active at three 
months. In the present study, few patients in either group regressed from action or 
maintenance to the preparation stage of change. In addition, patients that did regress, 
moved to a somewhat active stage (i.e. preparation), whereas in Marcus's study, 
patients relapsed from an active to inactive stage. 
It would have beE3n interesting to conduct subgroup analysis to determine whether 
changes in process use occurred in patients that regressed and progressed through 
the stages of change during the study period. However, this could not be carried out 
due to the small number of patients in these categories. Overall, the exercise 
consultation compared to standard care had little effect on the frequency of using the 
experiential and behavioural processes of change. This lack of change in process use 
may be because the majority of patients in both groups remained in the action and 
maintenance stages of change throughout the study period. Although, a near 
significant difference was observed in the proportion of the experimental group in the 
action and maintenance stages of change at 12 months compared to the control group 
(85% experimental group vs 67%) control group). In addition, a significantly greater 
proportion of patients in the experimental group compared to the control group 
remained regularly active or became regularly active from baseline to 12 months and 
six to 12 months. However, the magnitude of these differences were probably not 
sufficient to produce significant changes in process use. 
Results from the present study and previous trials suggest that maintenance of 
physical activity does not require further changes in the use these processes. Findings 
from previous trials suggest that continued use of behavioural processes may be 
important to prevent relapse. Therefore, interventions to maintain physical activity after 
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completion of exercise-based cardiac rehabilitation should encourage people to 
increase the frequency of using the behavioural processes of change. For example, 
encouraging individuals to use reminders, rewards or seek support to help them 
remain active in the long-term. These strategies are incorporated into the exercise 
consultation. 
Effect of an Exercise Consultation on Weight and 8MI 
There were no significant between or within group changes recorded in weight or BMI 
over the study period in either group. At baseline, 28.5% of the experimental group 
and 17.1 % of the control group were obese (BMI>30kg/m2). In addition, the proportion 
of overweight patients (BMI>25kg/m2) in the experimental and control group was 
82.90/0 and 77.1%, respectively. The number of overweight and obese patients did not 
significantly change in either group from baseline to follow-up. Thus the exercise 
consultation had no effect on body weight and body mass index compared to standard 
exercise information. The following reasons are possible explanations for the lack of 
significant changes in these variables observed in the present study. A systematic 
review found that the majority of studies reporting improvements in body weight and 
BMI with exercise-based cardiac rehabilitation included dietary advice in addition to 
exercise training. 1 This review stated that exercise only rehabilitation had an 
inconsistent effect on weight management. Thus, combining dietary modification and 
exercise training is recommended to optimise weight management. In the present 
study, the intervention did not include advice or counselling on diet in addition to 
physical activity, which may explain the lack of effect on weight and 8MI. However, all 
patients participating in the present trial would have received information on healthy 
eating in phases I to 111. 3 In addition, overweight patients would have received dietary 
advice for weight management in accordance with national guidelines.3 Thus, the 
majority of participants in both groups may have been on a weight reducing diet. 
However, this study did not attempt to encourage patients to adhere to dietary 
changes after completion of phase III. In addition, it was not possible to assess 
whether patients continued to make dietary changes after completing phase III as 
eating habits were not measured. It is also possible that changes in body composition, 
specifically fat mass and fat free mass could have occurred, which would not be 
detected by measurement of body weight and BMI. 
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Effect of an Exercise Consultation on Lipids 
No significant changes in total cholesterol, triglycerides and LDL cholesterol were 
observed from baseline to follow-up in either group. The literature suggests that 
exercise programmes have little impact on blood lipids, unless patients have abnormal 
lipid levels before exercise training.28 In this study, baseline levels for total cholesterol 
triglycerides and LDL cholesterol in both groups were in the normal range 
recommended by SIGN,2 which may explain the lack of change in these variables over 
the study period. 
Evidence suggests that a combination of diet, exercise training and lipid-lowering 
medication produces favourable lipid profiles and reaches lipid targets.9 Guidelines 
state that lipid lowering medication should be prescribed to individuals with a total 
cholesterol ~ 5mmol/l or LDL cholesterol ~ 3 mmo1/1. 2;115 Although, results from the 
Heart Protection Study indicate that all CHD patients should be prescribed lipid 
lowering medication irrespective of their initial cholesterollevel. 119 Patients participating 
in the present study would have had their lipid levels assessed in phase I and received 
lipid-lowering medication if required. In addition, blood lipids would have been re-
assessed during phase III and lipid lowering medication would have been altered if 
values were above national targets. In the present study, 88.6% of the control group 
and 100% of the experimental group were taking lipid-lowering medication on 
completion of phase III, which did not significantly change at six and 12 months follow-
up. In addition, lipid levels were within normal ranges throughout the study period. 
Thus, the lack of change in lipid levels observed in this study may be because patients' 
blood lipids were very well controlled before entry to the trial. 
This study did find an increase in HDL from baseline to follow-up in both groups. 
However, the only significant improvement in HDL occurred from baseline to 12 
months in the experimental group. In addition, there was a significant improvement in 
the ratio of total cholesterol to HDL from baseline to six and 12 months in the 
experimental group, whereas no significant change was recorded in the control group. 
A meta-analysis28 reported that exercise-based cardiac rehabilitation did not improve 
HDL cholesterol compared with usual care, although this finding was based on only 
three studies. Similarly, a systematic review observed that studies using exercise only 
rehabilitation or comprehensive rehabilitation documented inconsistent effects on HDL 
choletserol. 1 Conversely, other studies61 ,121 have reported significant improvements in 
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HDL cholesterol with three to six months of moderate intensity exercise training. 
Brochu 121 found a significant increase in HDL cholesterol by 8% after a three month 
exercise programme, with no change in the other lipid levels. In the present study, 
HDL cholesterol increased significantly by 10% (0.11 mmol/l) in the experimental 
group and non-significantly by 5% (0.06 mmol/l) in the control group from baseline to 
12 months. However, the difference between the groups for the change in HDL was 
not significant. The median values for HDL cholesterol were within the normal range 
(>0.91 mmol/l) in both groups at baseline and follow-up. Thus, the clinical importance 
of a 10% increase in HDL cholesterol observed in the experimental group is not clear. 
It is likely that patients with low levels of HDL cholesterol at baseline would benefit 
more from a 10% increase in HDL cholesterol at follow-up. However, subgroup 
analysis was not possible in this study due to the small number of patients. 
There is evidence to suggest that changes in HDL cholesterol may be influenced more 
by changes in physical activity than fitness. Brochu 121 found no association between 
the change in peak V02 and changes in coronary risk factors, including HDL 
cholesterol. Furthermore, Hambrecht84 reported that improvements in lipids were more 
closely correlated with increases in total energy expenditure than changes in peak 
V02. 
Effect of an Exercise Consultation on Psychological Function 
Anxiety and Depression 
Anxiety and depression was measured using the Hospital Anxiety and Depression 
Scale. The scores for the anxiety and depression subscales can be used to classify 
individuals into normal (0-7), mild (8-10), moderate (11-14) and severe (215) 
categories. 
At baseline, median scores for anxiety were 6 in the experimental group and 5 in the 
control group. Similarly, median depression scores at baseline were 2 in each group. 
Thus, low levels of anxiety and depression were reported following completion of the 
phase III exercise programme. Several studies have shown that participation in 
exercise-based cardiac rehabilitation significantly improves anxiety and depression 
and produces low levels of psychological distress on programme 
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completion 37;38;66;109;110 V . t" 
. anous ques lonnalres were used to measure anxiety and 
depression in these studies making it difficult to compare findings with the current trial. 
Lewin 110 found that mean HADS scores were 4.9 for anxiety and 3.1 for depression 
after six weeks of home-based cardiac rehabilitation. Similarly, Hevey286 found that 
following completion of a 10-week programme, mean scores for anxiety and 
depression were 4.7 and 3, respectively. Thus, baseline scores for anxiety and 
depression observed in the present study were similar to results reported in previous 
trials that used the HADS scale to measure anxiety and depression after cardiac 
rehabilitation. Gradual improvements in anxiety and depression in control patients who 
received no formal rehabilitation have been demonstrated,37;59;67 which may be due to 
the natural course of recovery after a cardiac event. Thus, the low baseline levels of 
anxiety and depression observed in this study may be because study participants were 
at least four months post cardiac event and had recently completed a cardiac 
rehabilitation programme. 
Results revealed. that anxiety and depression did not significantly change from 
baseline to six and 12 months in either group. However, a slight increase in depression 
occurred in the control group compared to the experimental group from baseline to 12 
months and six to 12 months, but this difference did not reach significance. Despite 
this slight increase in depression, scores remained low in the control group at follow-
up. Median scores for anxiety at 12 months follow-up were 5 in the experimental group 
and 4 in the control group. Similarly, depression scores were 2 in both groups at 12 
months. Thus, the results show that low levels of anxiety and depression were 
maintained throughout the 12-month study period in both groups. Other studies have 
shown that improvements in anxiety and depression with exercise-based cardiac 
. 37·67·110 
rehabilitation were maintained 6 to 12 months after programme completion. ' , 
Lewin reported a mean score of 5 for anxiety and 3.4 for depression 12 months after 
participation in a six week home-based rehabilitation programme. 
Studies have demonstrated that the greatest psychological benefits of exercise-based 
cardiac rehabilitation occur in patients with high levels of anxiety or depression at study 
entry.108;110;112;113 Thus, the lack of change in anxiety and depression observed in the 
present study may be because median scores for these variables were low at 
baseline. Thus, subgroup analysis was performed to determine if changes in anxiety 
and depression occurred in patients who had high baseline levels of psychological 
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distress, defined by a HADS score of 8 or more on anxiety or depression subscales. 
Results revealed that 33% of the study sample were psychologically distressed at 
baseline. In addition, 25% (9/35) of the control group and 40% (14/35) of the 
experimental group had anxiety or depression scores of 8 or more. In the distressed 
group, baseline scores for anxiety were 9 in the experimental group and 10 in the 
control group, which corresponded to mild anxiety according to the HADS 
classification. Anxiety scores did not significantly change from baseline to follow-up in 
either group, suggesting that mild levels of anxiety persisted in both groups over the 
study period. These findings suggest that the exercise consultation had no significant 
effect on anxiety compared to standard exercise information in patients who were 
psychologically distressed at study entry. However, the number of distressed patients 
may have been too small to detect between or within group differences in anxiety. The 
median score for depression was 6 in the control group and 2.5 in the experimental 
group, which is in the normal range. Results show that depression did not significantly 
change from baseline to six and 12 months in either group. However, there was a 
slight increase in depression in the experimental group from six to 12 months, 
although this did not reach significance. Despite this slight increase in depression in 
the experimental group, depression scores remained low at six and 12 months follow-
up. 
Patients with a baseline HADS score less than 8 for anxiety or depression were 
classed as non-psychologically distressed. As expected, median scores for anxiety 
and depression at baseline were low in both groups and did not significantly change 
from baseline to follow-up in either group. There was a borderline significant increase 
in depression from six to 12 months in the control group, although depression scores 
remained low at six and 12 months follow-up. Thus, low levels of anxiety and 
depression were maintained for 12 months in patients who were not psychologically 
distressed at study entry. 
A randomised controlled trial110 evaluated the effect of a 6-week home-based 
programme on anxiety and depression measured using the HADS scale at 6 weeks, 6 
months and 1 year. The study found that 52% of the study group had scores of 8 or 
more on anxiety or depression subscales measured three days post MI. In the non-
distressed group, mean anxiety and depression scores were low at baseline and did 
not significantly change at 12-months in the rehabilitation or control groups. These 
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results were similar to findings from the present study. In the distressed group, mean 
anxiety and depression scores significantly decreased in the rehabilitation group, with 
no change in the control group from baseline to 6 weeks, 6 months and 1 year. These 
findings conflict with the results of the present trial, which reported no significant 
change in anxiety or depression in patients who were distressed at baseline. Lewin 
found that mean anxiety scores declined from 10 at baseline to six at 12 months in the 
rehabilitation group and remained at 10 from baseline to 12 months follow-up in the 
control group. In the distressed group in the present study, median scores for anxiety 
declined from nine at baseline to seven at 12 months in the experimental group and 
increased from 10 to 11 in the control group. Thus similar to the results by Lewin, 
anxiety levels declined in the experimental group compared to the control group from 
baseline to 12 months, however this difference was not significant. In addition, anxiety 
decreased from the mild to normal category in the experimental group and remained in 
the mild category in the control group. However, the small number of patients that 
were psychologically distressed at baseline may have prevented any between or within 
group differences from becoming significant. 
Quality of Life 
Quality of life was assessed using the UK SF-36 version 2, which measures 8 
dimensions of quality of life (physical functioning, social functioning, role limitations due 
to physical problems, role limitations due to emotional problems, pain, energy/vitality, 
mental health and general health perception. At baseline, median scores for social 
function and role limitations due to emotional problems were 100 in both groups, 
indicating best possible health. Scores for physical function, role limitations due to 
physical problems, mental health and pain ranged from 80 to 90 in each group. In 
addition, median values for energy/vitality and general health perception were between 
60 to 70 in each group. These results indicate that quality of life was high at baseline in 
both groups. Jenkinson259 published normative data for a UK general population for 
the questionnaire that was used in the present study. This study found that mean 
scores for four out of eight subscales ranged from 80 to 90 in the general population. 
Furthermore, values for three subscales ranged from 70 to 80, and the score for the 
energy/vitality subscale was 58 in this group. Thus, median scores on several SF-36 
subscales observed in the present study were similar to normative data for the general 
population. Furthermore, values were higher in the present study compared to the 
general population for social function, role limitations due to emotional problems, 
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energy/vitality and pain. 
Several studies have used the SF-36 to measure quality of life before and after 
participation in exercise-based cardiac rehabilitation. 61 ;8o;89;108;286 However, these 
studies did not use version 2 of this questionnaire. Recently, Hevel86 found that on 
completion of a 10 week rehabilitation programme, median scores ranged from 80 to 
900/0 for most SF-36 subscales except role limitations due to physical problems (45%) 
and energy/vitality (68%). Thus, comparable quality of life scores were reported 
between Hevey's study and the present trial, except that general health perception was 
lower and role limitations physical was higher in the present study. Similarly, Morrin89 
and Ades80 reported high quality of life scores ranging from 70 to 90% following 
participation in three months of supervised or home-based cardiac rehabilitation. In 
addition, Morrin89 demonstrated that most quality of life scores were comparable for 
cardiac rehabilitation participants and normative data from the US. 
The present study found no significant changes in the eight quality of life dimensions 
from baseline to follow-up in either group. These results suggest that high levels of 
quality of life were maintained in both groups throughout the study period. However, in 
the experimental group there was a trend for an improvement in four subscales 
including social function, role limitations due to physical problems, role limitations due 
to emotional problems and energy/vitality, and a deterioration in pain, although these 
changes did not reach significance. In the control group, there was a trend for a 
decline in role limitations due to emotional problems, energy/vitality, and physical 
function from baseline to follow-up, again these changes were not significant. 
Conversely, there was a borderline improvement in the pain subscale from six to 12 
months in both groups. Additionally, there was a trend for a greater improvement in 
three dimensions in the experimental compared to the control group from baseline to 
follow-up; social function, role limitations due to emotional problems and 
energy/vitality. 
Several trials have found that improvements in quality of life with exercise-based 
cardiac rehabilitation are maintained six to 12 months after programme 
completion. 37;59;79 In addition, two of these studies59;79 found that exercise capacity 
and physical activity was also maintained 12 months after programme completion. 
Whereas, Oldridge37 reported a decline in exercise capacity at 12 months follow-up, 
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despite quality of life scores remaining unchanged. Stahle67 found significant 
improvements in several quality of life dimensions measured using a disease-
specific questionnaire after a three-month rehabilitation programme. In contrast to 
other trials, Stahle found that some of these benefits had deteriorated at 12 months. 
In addition, physical activity levels and fitness had also declined from programme 
completion to 12 months follow-up. Similarly, Stern66 found that improvements in 
several quality of life measures after a three-month rehabilitation programme had 
declined at 12 months. However, the improvement in exercise capacity was 
maintained at 12 months. Overall, conflicting results have been reported for changes 
in quality of life after completion of exercise-based cardiac rehabilitation. In addition, 
the change in quality of life did not parallel the change in fitness or physical activity 
in many of these studies. Similarly, the change in quality of life did not correspond 
with the change in exercise capacity or physical activity in the present trial. Newton 
reported that improvements in psychological functioning with exercise-based cardiac 
rehabilitation were independent of changes in exercise capacity.38 Thus, it is 
possible that quality of life may not be influenced by fitness or physical activity, 
which may explain the differing results found for quality of life, fitness and physical 
activity observed in the present trial. Alternatively, a variety of disease-specific and 
generic instruments were used to measure quality of life in the previous trials, which 
may explain the contradictory results. 
The present study did find a trend for an improvement in several quality of life 
dimensions in the experimental group and deterioration in a few SF36 subscales in 
the control group, although these changes did not reach significance. These lack of 
significant changes in quality of life may be because a generic instrument was used 
to measure quality of life. This instrument may not have been sensitive to changes 
that an individual with CHD experiences as his or her condition improves or 
deteriorates. However, studies have shown that disease-specific questionnaires are 
not responsive to change, whereas the SF-36 and the HADS were sensitive to 
change in cardiac rehabilitation settings. 247;249 In addition, many disease-specific 
instruments focus on a specific cardiac condition, thus would not have been 
appropriate for the heterogeneous population used in this study. However, it is 
possible that a disease-specific questionnaire may have been more able to detect 
changes in quality of life. 
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Effect of an Exercise Consultation on Mortality and Morbidity 
Meta-analyses31 have consistently found that exercise-based cardiac rehabilitation 
improves survival and has no significant effect on rates of non-fatal MI, or 
revascularisation (i.e. CABG or PTCA) compared with usual care, although few trials 
reported CABG or PTCA as an outcome. In the present trial, mortality was 5.7% 
(2/35) in the control group and 0% in the experimental group over the 12 month 
study period. The revascularisation rate (i.e. CABG and PTCA) was 11.4% (4/35) in 
the experimental group and 0% in the control group. However, the present trial28;30 
was not powered to detect any differences in mortality and morbidity between the 
experimental and control groups. 
Summary and Conclusions 
Participation in exercise-based cardiac rehabilitation produces many physiological and 
psychological benefits. In addition, sustaining these benefits requires maintenance of 
physical activity and other lifestyle changes in the long-term. However, evidence 
suggests that improvements in exercise capacity, physical activity and quality of life 
are not maintained following completion of rehabilitation programmes. However, the 
research is limited on effective interventions to encourage maintenance of physical 
activity in the long-term during phase IV. Physical activity counselling and exercise 
consultation, based on theoretical models of behaviour change, use strategies to 
increase and maintain physical activity. Research has shown that these interventions 
are effective for promoting and maintaining physical activity in the general population 
and clinical populations. 168;171;175-177;181 In addition, a pilot study found that the exercise 
consultation improved short-term (4 weeks) adherence to physical activity after 
completion of a phase III exercise programme. 178 
The research in this thesis evaluated the effect of an exercise consultation on 
maintenance of physical activity measured subjectively by self-report and objectively 
by accelerometry for 12 months after completion of phase III. This study demonstrated 
that exercise consultation was more effective than standard exercise information in 
maintaining self-reported physical activity for 12 months after completion of a phase III 
exercise programme. However, the objective measure of physical activity did not 
support these findings. This study found that the change in CSA accelerometer 
readings over the 12-month study period did not parallel the decrease in self-reported 
physical activity observed in the control group. Instead, the CSA accelerometer results 
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suggested that physical activity was maintained over the study period in both groups. 
Reasons for the lack of agreement between these outcomes have been discussed 
previously. 
This study also determined the effect of the exercise consultation on measures of 
cardiorespiratory fitness. Small significant decreases in peak V02 from baseline to 12 
months were observed in both groups. Thus, the exercise consultation was not 
effective in maintaining aerobic fitness for 12 months after completion of phase III. 
Reasons for the decline in peak V02 and the discrepancy between the results for 
physical activity and fitness in the experimental group are discussed. In contrast, the 
study found an improvement in the lactate threshold, which is an index of submaximal 
endurance capacity, in the experimental group compared to the control group from 
baseline to follow-up. 
The effect of this intervention on processes of exercise behaviour change, blood lipids 
and psychological function was also assessed. Results revealed that the exercise 
consultation compared to standard exercise information had no significant effect on 
processes of exercise behaviour change, lipid profile and psychological function. 
However, these variables were normal at baseline, as patients had recently completed 
a phase III cardiac rehabilitation programme. 
Finally, we expected to find greater differences in the study outcomes between the 
groups. However physical activity and other variables did not decline in the control 
group as much as was anticipated. It is possible that assessing physical activity, 
cardiorespiratory fitness and other variables at regular intervals in experimental and 
control patients could have encouraged them to remain active over the study period. 
Without this level of monitoring, a greater decline in physical activity may have 
occurred in the control group over the study period. In fact, several patients in the 
control group stated that they were grateful for being invited to take part in the study 
as it "encouraged them to keep active after they finished phase III". 
Study Limitations 
The limitations of the instruments used to measure the study outcomes have already 
been discussed. The main limitation of this research is related to time constraints of 
doctorate study. The exercise consultation was evaluated over a 12-month period. 
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However, the effect of the exercise consultation on maintenance of physical activity 
and other outcomes should be studied over a longer follow-up period. In addition, 
several variables were also maintained over the 12-month study period in the control 
group, which explains the lack of effect of the exercise consultation on some 
outcomes. However, a more substantial deterioration in these variables may have 
been observed in the control group over a longer time period. 
Seventy patients were entered into the trial and only a small number of participants 
dropped out over the follow-up period. The primary aim of the study was to determine 
the effect of the exercise consultation on maintenance of physical activity. Several 
physical activity counselling trials in the general population based their sample size 
calculation on physical activity measured by the Stanford Seven-Day Reca11.171-173 
These trials reported that more than 100 individuals were required to detect 
differences between groups. However, it would not have been possible to recruit this 
number of patients in the present study. Thus, the power calculation was based on 
physical activity measured by accelerometry. No studies have evaluated the effect of 
exercise-based cardiac rehabilitation on physical activity measured using 
accelerometers. However, a pilot study compared the effect of an exercise 
consultation with standard care on physical activity measured using accelerometry in a 
group of people with type II diabetes.263 Thus, the difference between the experimental 
and control group for the mean change accelerometer readings was used to calculate 
the sample size. This calculation found than 50 patients in total were required to detect 
a 22% difference in accelerometer counts between the experimental and control 
groups. However, the actual difference between the groups for the change in activity 
counts from baseline to 12 months was 10% (392946/4025432). Therefore, this trial 
was not powered to detect small differences between groups. We expected to find 
greater differences between the groups in physical activity outcomes, however 
physical activity did not decline in the control group as much as was anticipated, thus 
the trial was underpowered to detect a difference. In addition, the study did find several 
trends for differences in quality of life and processes of behaviour change favouring 
the experimental group. However, the sample size may have been too small to 
determine if these differences were significant and clinically meaningful. However, if 
small changes in these outcomes are clinically important then future studies should be 
powered to detect these changes. 
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The small number of women in each group means that it was not possible to compare 
maintenance of physical activity in men and women after completion of phase III. No 
studies have investigated maintenance of physical activity in men and women following 
cardiac rehabilitation to gain information on gender differences in this health 
behaviour. 
The same researcher delivered the exercise consultation and measured the outcomes 
of this study, thus the researcher was not blinded to group allocation when conducting 
the outcome measures. Therefore, the measurements could have been influenced in 
favour of the experimental group. However, standardised procedures for data 
collection were followed in an attempt to control for this limitation. For example, during 
the exercise tests the Cardiac Clinical Scientific Officer, who was blinded to group 
allocation, was responsible for encouraging the participants. In addition, 
questionnaires measuring psychological function and the processes of behaviour 
change were self-administered. Although the researcher administered the Seven-Day 
Physical Activity Recall, a standardised interview process222 was followed to limit the 
interviewer's bias. 
Implementing the Exercise Consultation 
The results of this study demonstrate that the exercise consultation may be an 
effective intervention for maintaining physical activity after completion of phase III 
hospital-based exercise programmes. Presently, patients completing phase III can 
attend phase IV maintenance exercise programmes in the community. However, 
these exercise opportunities are not available in all areas. Furthermore, it is likely 
that a minority of patients will attend these phase IV programmes, due to barriers 
associated with supervised exercise training including transportation problems, high 
costs, limited access, work and domestic conflicts. Thus, the exercise consultation 
may provide an alternative to supervised exercise in phase IV. Furthermore, the 
intervention could be used to facilitate patients' progression from phase III hospital-
based exercise programmes to community-based programmes or independent 
exercise. Thus, the exercise consultation could be routinely provided to cardiac 
patients on completion of phase III to encourage maintenance of physical activity in 
phase IV. 
Is it feasible to incorporate the exercise consultation into current cardiac rehabilitation 
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services? Firstly, the consultations are relatively inexpensive in terms of t' Ime, 
resources and personnel. Exercise consultations last approximately 20 to 30 minutes, 
and the support phone calls are five to 10 minutes in duration. In addition, it is possible 
that patients could record their physical activity habits, and the pros and cons for 
physical activity before attending the intervention to reduce time during the 
consultation. Resources required to conduct the exercise consultation include the 
materials (e.g. goals sheet, and guidelines for physical activity) and a quiet room. The 
exercise consultation could be delivered by a number of professionals. In the United 
Kingdom, physiotherapists playa central role in the exercise component of cardiac 
rehabilitation. Physiotherapists have an ideal opportunity to deliver the exercise 
consultation to patients entering phase IV as they have good insight into the patient's 
progress from phases I to III cardiac rehabilitation with regards to physical activity and 
could incorporate the intervention into existing programmes. The approximate cost of a 
Senior 1 physiotherapist delivering a 30 minute exercise consultation is £6 to £7.17 per 
patient. In addition, BACR trained phase IV exercise staff could use the exercise 
consultation to provide support to patients who are having difficulty remaining active. 
The approximate cost of a BACR trained phase IV instructor delivering a 30 minute 
exercise consultation is £4.40 to £4.94 per patient. In order to train in the exercise 
consultation, individuals need to understand the behaviour change theories on which 
the consultation is based, and the counselling skills and strategies required to deliver 
the intervention. This could be achieved by appropriate in-service training. In addition, 
individuals would need to practice the consultation process. 
Currently, the exercise consultation has been included in two courses for individuals 
involved in cardiac rehabilitation services. The MSc Module in Rehabilitation in 
Cardiology at Glasgow Caledonian University is aimed at specialist nurses and 
physiotherapists delivering phase III cardiac rehabilitation programmes. Training for 
these individuals involves a three-hour lecture on theories of exercise behaviour 
change, and counselling skills and strategies required to deliver the intervention. There 
is also a four-hour practical session, where the individuals have the opportunity to 
practice the exercise consultation process. The exercise consultation has also been 
incorporated into the British Association of Cardiac Rehabilitation (BACR) Phase IV 
Training. This course trains exercise instructors to deliver phase IV maintenance 
exercise programmes in the community for cardiac rehabilitation patients. Due to time 
constraints, this course involves a two-hour lecture on theories of behaviour change for 
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exercise and the exercise consultation process. 
Future Research 
Reviewing the literature on exercise-based cardiac rehabilitation for this thesis has 
identified several important areas for further research. Numerous studies have 
assessed physical activity participation for up to 11 years after completion of formal 
rehabilitation programmes. However, few trials have used a validated questionnaire or 
an objective method to measure physical activity. In addition, many trials reported the 
proportion of patients that "exercised regularly", however the definition of regular 
exercise varied greatly and was not based on current physical activity 
recommendations. Only one study used the current physical activity guidelines to 
determine the proportion of patients who remained regularly active after exercise 
rehabilitation.96 Thus, more studies are required to accurately assess physical activity 
levels after completion of exercise rehabilitation and determine the proportion of 
patients that continue to meet current physical activity guidelines in phase IV. 
Cardiac rehabilitation guidelines2;5 recommend that all centres should audit their 
cardiac rehabilitation programmes to ensure that standards for cardiac rehabilitation 
set out by the Clinical Standards Board for Scotland and the National Service 
Framework for Coronary Heart Disease for England and Wales are being met. These 
guidelines have recommended a minimum common data set that should be collected 
by all centres, which could be accessed nationally for audit and evaluation of cardiac 
rehabilitation. Physical activity outcomes should be included in the data set, which 
could then be used to determine the proportion of patients that meet current physical 
activity guidelines in each phase of cardiac rehabilitation. 
Many studies have examined the factors influencing uptake and adherence to 
supervised cardiac rehabilitation exercise programmes. Whereas, the factors that 
contribute to maintenance of physical activity following programme completion have 
not been explored. Understanding these factors is an important step in the 
development of interventions to improve maintenance of physical activity and 
exercise. Further research in this area is warranted. In addition, few studies have 
examined the effect of interventions to encourage long-term maintenance of physical 
activity following completion of phase III cardiac rehabilitation exercise programmes. 
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Thus, research is needed to test different forms of intervention aimed at improving 
long-term compliance to physical activity. 
There are numerous phase IV maintenance exercise programmes available in the UK. 
However, the efficacy of these phase IV programmes to maintain the benefits gained 
during phase III exercise training, including exercise capacity and increased physical 
activity, has not been assessed. In addition, there is no data available on the 
proportion of patients who participate in these phase IV maintenance programmes 
after completing phase III. 
The modest success of the exercise consultation in the present study provides the 
basis for further research with this intervention. Firstly, can the exercise consultation 
maintain physical activity for more than 12 months? Are repeat exercise consultations 
required? Could the exercise consultation be delivered successfully in a group or by 
post, telephone or World Wide Web? The possibility of delivering this intervention to 
patients in a group setting at the end of phase III is a good area of further study. First 
of all, delivering this intervention to groups of patients as an alternative to one to one 
consultations would be more feasible for cardiac rehabilitation services in terms of time 
and staff resources. In addition, conducting an exercise consultation in a group setting 
would provide patients with the opportunity to discuss certain issues with each other, 
such as potential barriers to maintaining activity after phase III, problem solving these 
barriers and identifying high risk situations for relapse. In addition, group discussion on 
exercise opportunities in the community, such as phase IV classes, may encourage 
patients to attend these programmes together. In general, patients routinely receive a 
discharge interview at the end of phase III, which provides cardiac rehabilitation staff 
with an ideal opportunity to review the patients' goaJs for remaining active that were 
devised during the group consultations. Physical activity counselling trials in the 
general population and other clinical groups have successfully delivered this type of 
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The exercise consultation may also be useful at the beginning of phase III to improve 
adherence to the supervised exercise programme and encourage patients to 
participate in physical activity outwith the exercise classes. A pilot study found that 
web-based and one to one exercise consultations were equally effective in increasing 
physical activity measured by the 7DPAR in a group of patients participating in a 
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phase III supervised exercise programme. Are there any other strategies that could be 
included in the exercise consultation to increase its efficacy? Recently, physical activity 
intervention studies and weight management programmes have found pedometers to 
be effective in promoting physical activity.209 Thus, pedometers may be a promising 
strategy to encourage maintenance of physical activity in phase IV. Results from this 
trial showed that although physical activity was maintained in the experimental group, 
exercise capacity declined. Thus, should the aim of the exercise consultation in phase 
IV be maintenance of physical activity or cardiorespiratory fitness? 
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Dear Dr MacIntyre 
LREC 5/99 
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THE EFFECT OF AN EXERCISE CONSULTATION ON EXERCISE 
ADHERENCE IN PHASE IV CARDIAC REHABILITATION 
Many thanks for submitting an amendment to the above protocol. The committee reviwed 
this on the 5th July, 2000 and are happy to grant approval. 
A list of Conunittee members present at meeting held on 19th January 2000 is appended. 
Yours sincerely 
J.J. Morrice F.R.C.S. 
Chairman 
LOCAL RESEARCH ETHICS COMMITTEE 
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APPENDIX 8 
CARDIAC REHABILITATION RESEARCH 
FORM OF INFORMATION AND CONSENT 
Title of Research 
Physical activity levels in a group of cardiac rehabilitation patients 
Summary 
We i~:ite. you t? take part in a study looking at physical activity in a group of cardiac 
reh.a~lhtatlOn ~atlents. This study will allow you to learn more about the benefits of physical 
activIty and wIll provide regular medical check-ups over one year as part of your rehabilitation. 
If you agree to take part, you will be asked to visit the Royal Alexandra Hospital between 6 and 
8 times over the course of 1 year. These visits will last 30 to 60 minutes: the details of each 
visit are described in more detail below. 
Visit 1: Total duration Ihour. 
During visit one you will be asked to complete a personal health questionnaire and your weight 
and height will be measured. You will also be asked to perform an exercise test, which will last 
approximately 10 minutes. We will assess your exercise performance by asking you to exercise 
on a treadmiII and measuring the amount of oxygen you use. During the test, we will monitor 
your heart rate using an ECG and measure your blood pressure by an inflation cuff. We will 
measure your breathing during the exercise test by asking you to breathe through a mouthpiece. 
You will be asked to keep exercising until you can no longer continue. The test will be stopped 
if you develop chest pain or if there are changes on the ECG. You wi II also be given a small 
monitor about the size of a 50p piece, which you will be asked to wear on your ankle. This will 
record the amount of physical activity you do. The researcher will show you how to attach the 
monitor and instruct you to wear it during all waking hours (except during bathing or other 
water activities) for 7 days immediately after the first visit. 
You will be asked to return for visit 2 one week after your first visit. 
Visit 2: Total duration 30 minutes. 
During this visit, a blood sample will be taken from your arm. A fasting blood sample is 
required, therefore you will be asked to refrain from eating for 12 hours before your visit. 
Breakfast will be provided after you have given the sample. During this visit you will return 
the activity monitor and the researcher will ask you about your physical activity during the 
previous 7 monitored days. You will also be asked to complete a questionnaire about your 
present exercise habits. 
You may be asked to return for a third visit within 7 days after visit 2. 
Visit 3: Total duration 30 minutes. 
This visit involves a discussion with the research assistant on exercise. You will also receive a 
telephone call phone call 3 months after this visit. 
Six and 12 months after visit 3, you will be asked to return to the Royal Alexandra Hospital 
where the procedures carried out during visits 1, 2 and 3 will be repeated. Visit 3 will not be 
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repeated at 1 year. 
Final Points to Note 
If you do not wish to participate, it will not affect your current or future medical treatment in 
anyway. You are free to withdraw from the study at any point without providing any 
explanation and with no obligation. Should you decide to take part your GP will be informed. 
The only people who will have access to your results with be those involved in the testing 
and analysis of the data. It is possible that the results of this study will be published in a 
medical journal. Although your own results will be part of any publication your identity will 
not be disclosed at any point. If you are, or are likely to become pregnant, you should not 
participate in this study. If you are harmed by taking part in this research, there is no special 
compensation arrangements. If you are harmed due to someone' s negligence, then you may 
have grounds for legal action but you may have to pay for it. Regardless of this, if you wish 
to complain about any aspect of the way you have been approached or treated during the 
course of this study, the normal National Health complaints mechanism is available to you. 
If you have any questions about the study or need to contact us for any reason, please use any of 
the following means: 
Adrienne Hughes, Research assistant, L5 North, RAH, Paisley. 0141 580 4628 or 0141 330 
2830 
Dr Paul MacIntyre, Consultant Cardiologist: L5 North, RAH, Paisley. 0141 5804628 
Consent: 
I, ..................................................................................................... . 
give my consent to the research procedures de~cribed above, the nature, purpose and 
possible consequences of which have been descnbed. 
SIgned· ........ . =_ .. ' ......................................... . 
Date: ......................................... . 
WItness .................... ···························· ... . ~=~
Date: ......................................... . 
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APPENDIX C 
EXERCISE CONSULTATION 
• Current physical activity status (summarise from 7 -day recall and Stage of Change) 
Decisional Balance Table 
Benefits/Pros Barriers/Cons 
• Problem solving barriers/cons of physical activity 
• Review current physical activity guidelines 
• Past physical activity Status 
• Possible activities 
• High risk situations for lapse/relapse 
• Plan to to cope with these situations . 
• Sources of support for physical activity. 
Goals 
One Month Three Month Six Month 
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APPENDIX D 
ACTIVITY MONITOR INFORMATION 
• THE ACTIVITY MONITOR IS NOT WATERPROOF, HOWEVER, SMALL 
WATER SPLASHES WILL NOT CAUSE ANY DAMAGE. YOU WILL HAVE 
TO TAKE THE MONITOR OFF TO BATHE, SWIM OR SHOWER. PLEASE 
RECORD THE TIME YOUR REMOVE AND RE-ATTACH THE MONITOR ON 
THE BACK OF THIS SHEET. 
• THE ACTIVITY MONITOR SHOULD BE WORN ON YOUR ANKLE 
ABOVE YOUR ANKLE BONE. USE THE STRAP PROVIDED, AND MAKE 
SURE THE ARROW IS POINTING UPWARD. 
• WEAR THE MONITOR DURING ALL WAKING HOURS, EXCEPT WHEN 
BATHING. LEAVE THE MONITOR IN PLACE UNTIL YOU GO TO BED. 
WHEN YOU TAKE THE MONITOR OFF RECORD THE TIME ON THE BACK 
OF THIS SHEET. ON WAKING IN THE MORNING, REATTACH THE 
MONITOR TO YOUR ANKLE IMMEDIATELY. RECORD THE TIME OF 
REATTACHMENT ON THE BACK OF THIS SHEET. CONTINUE WEARING 
THE MONITOR IN THIS MANNER EVERY DAY UNTIL YOUR NEXT VISIT. 
• AS THESE TOP-OF-THE-RANGE MONITORS ARE EXPENSIVE, YOU 
ARE ASKED TO TAKE VERY GOOD CARE OF THEM. 
• PLEASE RECORD ANY DAY AND TIME THE ACTIVITY MONITOR IS 
NOT WORN ON THE BACK OF THIS SHEET. 
2.33 
RECORD FOR ACTIVITY MONITOR 
Please be as accurate as possible with this record 
SLEEPING 
DAY MONITOR ATTACHED MONITOR REMOVED 
Example 
Tuesday 9.05am 10.16pm 
BATHING OR SWIMMING 
DAY MONITOR ATTACHED MONITOR REMOVED 
I 
ANY PROBLEMS WITH ACTIVITY MONITOR 
DAY REASON MONITOR MONITOR 
ATTACHED REMOVED 
I 
I 
~ 
, 
! 
-------~ . 
_ .. 
. -
---- -
----
APPENDIX E 
PHYSICAL ACTIVITY RECORDING SHEET 
Please keep a record of any activities you do over the following week. 
However, only record activities that are of a MODERATE INTENSITY 
OR ABOVE. Moderate intensity activities require about the same effort 
as a brisk walk. 
DAY 
e.g. Monday 
TYPE OF ACTIVITY & DURATION 
Attended an exercise class lasting 30 minutes. 
---- -~~---GU,SGOVV 
UNIVERSITY 
BRARY 
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